





The University of Edinburgh
1999
The work presented in this thesis is the original work of the author, except where
specific reference is made to other sources. It has not submitted in part, or in whole,












I want to thanks my supervisor, Prof. Malcolm D. Walkinshaw for his advice and
encouragement during this project, and the great patience showed throughout the
course of my work for this thesis. I am indebted to my supervisor Dr. Paul Taylor for
instructing me in the tools and techniques of crystallography and for the computing
help.
I am also indebted to Ms Jacqueline Dornan for her advice on procedures and
techniques in the laboratory, and encouragement and help at all stages of this work.
I am further indebted to Dr Dimitri Alexeev for sharing his considerable experience
and knowledge in the field of protein crystallography and for his friendship.
I would like to thank all the members of the Institute of Cell and Molecular Biology
and the Department of Biochemistry, with special thanks to Dr David Apps for their
help and support during this work.
Finally, I would like to thank my wife for her support, understanding and patience
during this study.
I am pleased to acknowledge the financial support of the Novartis Pharma Basel.
Summary
The general aim of the project is to predict and select small molecule ligands which
may bind to 3D protein templates. Proteins from the immunophilin family were used.
Immunophilins are a class of proteins, which bind immunosuppressive drugs and also
catalyse the cis<->trans isomerisation of peptidyl-prolyl bonds. Two families of
immunophilins have been established: cyclophilin (CyP) which binds the
immunosupressive drug cyclosporin A (CsA) and FKPB which binds the
immunosupressive drug of FK506 and rapamycin. The proteins used are cyclophilin
A (165 residues, MW 17.8 kDa) cyclophilin B (184 residues, MW 22kda), FKBP-12
(107 residues, MW 12 kDa) and cyclophilin Brugia (177 residues, MW 20 kDa).
Where required proteins were produced and purified in house. Cyp-A and Cyp-B
were expressed in E.coli and purified using chromatographic techniques. CypBr was
provided as a fusion protein which then cleaved and purified in house. The purity of
the initial protein samples were tested with SDS gels and then the samples were
concentrated to an appropriate concentration for crystallization. Crystals of Cyp-A
and of FKBP-12 were obtained of orthorhombic space group P212121 and monoclinic
space group C2 respectively. Two new crystals of CypBr were obtained a trigonal
and tetragonal form. Molecular replacement methods were used to solve the crystal
structure of the tetragonal form of CypBr using Cyp-A as starting model. The final R
factor was 19,9 % and Rfree=23,4 %. Atomic co-ordinates are deposited in the
Brookhaven Database with the code 1A58.
The putative ligands were selected by two different methods, by structure similarity
and using the docking program LIDAEUS, which was developed in house by Dr P.
Taylor. Twenty nine small molecules were selected from a small molecule database
and were tested with a fluorescence assay, a PPIase assay and x-ray crystallography
for binding activity. Six new ligands have been discovered which bind to Cyp-A. In
this work the IC50 (concentration in which half inhibition occurred) of the putative
ligands were determined by rotamase inhibition assay. In addition the binding of the
ligands was also confirmed by crystallographic experiments. The X-ray structures of
3-acetyl-1 methyl piperidine, ethyl-piperidine glyoxylate, dimethyl sulfoxide,
tetramethylene sulfoxide, cyclopentanone and 5,5-dimethyl-l,3-cyclohexanedione
bound to Cyp-A have been solved and refined with Rfactors for each structure of less
than 20%.
The structural analysis of the native and ligand structures revealed a hydrophobic
pocket surrounded by residues Asn 102, Met 61, Arg 55 and His 122, a hydrogen
bond donor site of the main chain nitrogen Asn 102, and another hydrogen bond
donor site of the guanidinium of Arg 55.
The six novel ligands have been classified into 3 different families of compounds. 3-
Acetyl-1 methyl piperidine and ethyl-piperidine glyoxylate belong to the piperidine
family and shares structural similarities with a natural substrate of Cyp-A the
dipeptide Ala-Pro. Dimethyl sulfoxide (DMSO), tetramethylene sulfoxide and
cyclopentanone form the DMSO family and they do not share any similarities with
known Cyp-A ligand. Only one compound has been discovered in the third family.
This compound 5,5-dimethyl-l,3-cyclohexanedione also known as dimedone shows





AS sat Ammonium sulphate saturate
BCA Bicinchonic acid protein assay method
BSA Bovine serum albumin
B factor Temperature factor
Cyp-A Human cyclophilin A protein
CypA-AlaPro Human cyclophilin A protein complex with Ala-Pro dipeptide
CypA-AAPF Human cyclophilin A protein complex with
N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide
Cyp-B Human cyclophilin B protein
BrCyp 20 kD Cyclophilin from Brugia malay
CSD Cambridge Structure Database
DCH 5,5-Dimethyl-1 -3 -Cyclohexanedione
DMSO Dimethylsulfoxide
ETPIPG Ethyl-piperidine glyoxylate
FKBP-12 Human FK506 binding protein
FK506 Immunosuppressive drug, FK506
CsA Immunosuppressive drug, cyclosporin A
IAA 3-(3-Indoleacrylic acid
ISIS Integrated Scientific Information System
LB Luria-Bertani medium
LB amp Luria-Bertani medium contain 50|lg/ml ampicillin
M9CA M9 Minimal Medium contain 1% Casamino acid
M9CAamp M9 Minimal Medium contain 1% Casamino acid
and 50|ig/ml ampicillin
MBP Maltose binding protein
OD600 Optical density at 600nm
PEG Polyethylene glycol
PNT Cyclopentanone
SDS Sodium dodecyl sulphate
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electophoresis
TMSO Tetramethylene sulfoxide
TRP Tryptophan




TFE 2, 2, 2-Trifloroethanol
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I ntroduction
1 Introduction
In the early days of drug discovery, drugs were found from natural products by
chance observations. The conceptual breakthrough facilitating rational drug discovery
was that any drug has a specific target at the cellular level.
If nothing is known about the structure of the target protein there is no other way to
find a drug except by screening large numbers of natural and synthetic substances to
find one which shows binding activity. There are cases in which the natural ligand of
the protein is known while the protein shape is unknown. In both cases a useful
strategy in the design of a new drug or ligand is the trial and error modification of a
lead. The increased potency or decreased toxicity monitored in conjunction with
biological and physiological evaluation (Greer et al. 1994) must also be considered in
the drug development process.
In recent years drug design has utilised knowledge of the structure of the target
molecule. The structure based methodology can yield putative drugs more quickly and
less expensively. The final products are custom tailored to their targets, they tend to
be more potent, less toxic and more specific than drugs discovered in other ways
(Bugg et al. 1993). This approach requires selecting a protein target molecule which
plays a critical role in a physiologically relevant biological pathway. If the natural
ligand is also known, it is helpful to have a three-dimensional structure of the complex
as a starting point for development.
1.1 Ligand Design
The three-dimensional structure of the target protein is the first step in structure based
design of a new ligand (Verlinde and Hoi 1994). The next step is to find a lead or




A'lead' ligand as determined by X-ray crystallography or NMR methods can be used
to direct the atom-by-atom modification in order to design a new ligand or improve
the lead (Salemme et al. 1997). This method is called the extending ligand or
stuctural similarity method and based on the principle that compounds with similar
structure are going to have similar conformation and thus bind the same 3D template.
When a 'lead' ligand is not available the target protein must serve as a template. A
number of methods have recently been proposed that attempt to automatically design
new ligands for a given protein structure (Verlinde and Hoi 1994). In the first step the
binding pocket of the protein is defined and characterised. Most programs developed
for de novo construction try to assemble novel molecules from "pieces". These
"pieces" can be ether atoms (docking method) or larger, chemically reasonable
fragments (linking recognition fragments method).
In the docking method the protein template is used to select potential ligands using a
computational docking procedure which involves matching and fitting ligand atoms
onto the protein surface (Bohm 1996). Orientation of the ligand in the active site is
generated such that a chemical and shape complementarity between the ligand and the
binding site cavity has to be fulfilled.
The linking recognition fragments method incorporates different functional groups or
small molecules bound to the target protein into a single, larger molecule (Verlinde
and Hoi 1994; Bohm 1995). The fragments are taken from a large small-molecule
database. In the current work only the structural similarity method and the docking
method were used for ligand design. The three dimensional structure of the ligand is




Structural similarity provides a method to select new ligands. The principle is that
compounds with similar structure are going to have similar conformation and thus

















ISIS* : INTEGRATED SCIENTIFIC INFORMATION SYSTEM
Fig. 1.1 : Selection of compounds based on structural similarities
The first step is a careful inspection of the residues around the candidate atom. At this
point the possibility of hydrogen bonding, electrostatic, hydrophobic and van der
Waals interactions should be examined. The next important step is the comparison of
the native (unbound) structure with the bound one. This will give a clear view of the
rigid and flexible domains of the binding site. Furthermore the water molecules which
have been replaced by the ligand (if any) can be marked.
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The water molecules in the native structure are very important since they give us an
idea which part of the ligand could be modified by extension, and try replacing one or
more of these water molecules. The water molecules also indicate favoured sites for
hydrophilic interaction or hydrogen bonding.
B) Docking Programme
The docking program LIDAEUS was developed in house by Dr P. Taylor. The













(using our in-house programme LIDAEUS)
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Fig. 1.2: Representation of how docking program LIDAEUS is working.
The program calculates the interaction energy between a "probe atom" and the
protein on a 3D grid of site points around the protein sites. Carbon and oxygen atoms
are used as probe atoms for the calculation. Carbon atom probes map out favoured
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areas for hydrophobic interaction and oxygen atom for hydrogen bonding and
hydrophilic interactions. The next step is to turn these volumes into site points and
generate a negative template of the active site of the target protein. This negative
template has the geometrical and chemical properties of putative ligands. The final
step is the search for ligands in a database (Maybridge Fine Chemicals was used)
which can fit in the above site points and select the best-fitting ligand. The list of the
ligands found in the above database were commercially available.
Selection then was based on molecular weight and hydrophobicity. The most
hydrophilic ligands were selected from the list generated by LIDAEUS.
Hydrophobicity was a criterion for discarding molecules since occupancy of the
binding sites in the crystal is proportional to concentration of the ligand in the
solution. Furthermore small molecules can easily go through crystal channels and
reach the binding site so molecules with a molecular weight larger than 300 were not
used for soaking.
1.2 Databases
There are several large databases of small molecules (ISIS, CSD, and Maybridge Fine
Chemicals). These databanks contain either three dimensional data as obtained from
X-ray/NMR structure analysis or 2D atomic connectivities. When a 3D structure is
not available, structure-generation programs that convert two dimensional connection
tables into three dimensional structures are used, for example WITNOTP (Widmer
1997) or SYBYL (SYBYL a molecular modeling program, Tripos Inc., University of
Georgia, St. Louis Missouri).
In the current work the following databases have been used:
• When a lead compound was available ISIS (Integrated Scientific Information
System) was used to search for ligands with structural similarities.
1.5
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• CSD (Cambridge Structural Database) was mainly used in order to find the
experimentally obtained 3D structure of a ligand when only 2D atomic
connectivities were known.
• Maybridge Fine Chemicals was the database used by the docking program
LIDAEUS.
A)ISIS
The ISIS database contains about 238,000 compounds and the number is increasing
daily.
Molecules in this data bank are in 2D atomic connectivities, (some entries are in 3D in
the latest version of the software)
The main advantage of this databank is that all molecules are commercially available.
Every compound listed has useful supplementary information such as suppliers,
degree of purity and price. The availability makes the time between finding a lead and
testing it shorter combined with the available information on price makes this a very
efficient way forward both financially and experimentally.
The search for structure similar compounds is performed as follows:
• The lead compound was drawn in ISIS draw in 2D atomic connectivities.
• The 2D atomic connectivities were put in query window of the ISIS program.
• The actual search was performed by search tool. This tool allows you to specify
the degree of similarity between the search structure and the target structure.
Values range from 0 (no similarity) to 100 (an exact match).
• Hits generated from the above procedure were inspected manually. Large
molecular weight (>300) molecules are put in second priority since the soaking
technique was used and it would be difficult for them to penetrate the crystal lattice
and reach the binding site.





The Cambridge Structural Database contains some 197000 3D entries (September 1999) of
small molecules. The main disadvantage of the database is that the compounds can not
be ordered and tested quickly. The database was used for the comparison of
structures generated by WITNOTP. If the candidate molecule is not in the database
the closest derivative was used for comparison with the experimental 3D structure.
1.3 Immunophilins
Immunophilins are a class of proteins which bind immunosuppressive drugs and also
catalyse the cis<->trans (Fig. 1.3) isomerisation of peptidyl-prolyl bonds.
Immunophilins are ubiquitous proteins, found in organisms as diverse as plants,
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Fig. 1.3 : Schematic presentation of cis<->trans isomerisation of peptidyl-prolyl bonds
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Two families of immunophilins have been established: cyclophilin (CyP) and FKBP.
Cyclophilin (Cyp) was discovered in 1984 as a cytosolic receptor of the
immunosuppressive drug CsA (Fig.4) (Handschumacher et al., 1984) while FKBP was
identified as the binding protein of FK506 (Fig. 1.4) in 1989 (Siekierka et al., 1989;
Harding et al., 1989). There is no sequence homology or obvious structural similarity
between cyclophilin and FKBP (Walkinshaw et al. 1992).
Fig. 1.4 : Chemical formula of the immunosuppressive drugs cyclosporin A and
PPIase activity and T cell activation are two independent properties of immunophilins
but both relate with the same binding site of the proteins. Bierer et al. (1990) and
Kimball et al. (1991) demonstrate the failure of PPIase activity to mediate T cell
activation, implying that the immunophilin-drug complex causes immunosuppression
but not the immunophilin alone. PPIase activity of peptidylproline isomerases may be
completely abolished by the immunosuppressive drugs CsA and FK506 suggesting






al. 1989; Takahashi et al. 1989). Indeed, x-ray structures of CypA with the substrate
ac-Ala-Ala-Pro-Ala-amc in the Kallen and Walkinshaw structure (1991) and with CsA
(Mikol et al. 1993) showed that both bound in the same binding pocket.
A) Biological activities of Immunophilins
Despite the chemical dissimilarity of the ligands and the structural difference between
the two immunophilin families, there is an intriguing overlap of biochemical and
biological activity. Immunophilins have been found to be involved in a number of
cellular processes (Galat and Metcalfe 1995). Both cyclophilin and FKBP are involved
in signal transduction in human T cell activation (Showstack et al. 1989; Metcalfe and
Richards 1990) and also in protein folding by PPIase activity (Fischer et al. 1984;
Harding et al. 1989; Fischer and Schmid, 1990). Other interesting biological functions
are the binding into HIV-1 virions of hCypA (Thali et al. 1994; Braaten et al. 1996),
phototransduction in Drosophila (Baker et al. 1994), transporting of procollagen
(Smith et al. 1995) and the formation of avia progesterone receptor (Johnson and Toft
1994).
Signal transduction in human T cell
Since its first clinical trial in 1976, CsA (Fig 1) has been widely used as an
immunosuppressive drug to prevent rejection following bone marrow and organ
transplantation, and has also been the subject of a clinical trial in the treatment of
autoimmune diseases (Starzl et al. 1989); Showstack et al. 1989). FK506 (Fig 1.4)
possesses very similar immunosuppressive properties both in vivo and in vitro, but is
10 to 100 times more efficient than CsA (Thomson, 1989; Metcalfe and Richards,
1990).
Both CsA and FK506 inhibit early events in T lymphocyte activation and block
lymphokine driven differentiation and proliferation of effector T cells (Emmel et al.
1989). Calcineurin, a serine/threonine phosphatase and a calmodulin binding protein
1.9
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(Klee et al, 1988) has been identified as a receptor for both Cyp-CsA and FKPB-
FK506 complexes in vitro (Liu et al., 1991). Inhibition of calcineurin will inactivate
the dephosphorylation of a lymphocyte-specific transcription factor, NF-ATp, and
therefore prevent the movement of NF-ATp from the cytoplasm to the nucleus where
it binds to the promotor of the interleukin-2 gene and stimulates expression of the
gene in the T-cell activation pathway (Loh et al. 1996; Luo et al. 1996).
PPIase activity
Another unexplained coincidence between the two immunophilin families is their
shared peptidyl-prolyl isomerase activity (Galat and Metcalfe 1995). There is no
apparent sequence similarity between the PPIase domains of the cyclophilins and
FKBPs (Harding et al. 1989). PPIase was the activity which originally led to the
isolation of cyclophilin, (Fischer et al. 1984). The sequence of this cyclophilin (Fischer
et al. 1989a) appeared to be identical with a protein which was shown to be the major
target of CsA in bovine thymocytes (Handschumacher et al. 1984).
For proteins to adopt the correctly folded conformation, the Xaa-Pro amide bonds
must be in the correct cis or trans configuration. In vitro studies show that the
cis/trans isomerisation of some X-Pro bonds is the rate-limiting step in the refolding
process (Lang et al. 1987). Depending on the nature of the substrate, CyP and FKBP
can accelerate the rate of folding of proteins or oligopeptides by over 10 times the
rate observed without isomerase (Fischer and Schmid, 1990) even at PPIase
concentration as low as 0.1 pM. At concentration about 30 pM, which is close to the
in vivo concentration of some cyclophilins (Harding et al. 1986), the refolding of
RNAse T1 was essentially instantaneous. PPIase has also been shown to accelerate
the refolding process on bovine carbonic anhydrase II (Fransson et al. 1992). Other
proteins reported to involve cyclophilins in their folding are collagen (Bachinger
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1987), ribonuclease (Lang et al. 1987) and chymotrypsin inhibitor 2 (Jackson and
Fersht 1991).
Incorporation into HIY-1 virions
Cyclophilin A has been reported to interact with the HIV-1 Gag protein (Thali et al.
1994 ; Franke et al. 1994). Furthermore, cyclosporine A inhibits the production of
replication-competent HIV-1 virions by disrupting the Gag-CypA interaction (Thali et
al. 1994; Braaten et al. 1996). The high CsA affinity to CypA (nanomolar range),
significantly inhibits the incorporation of CypA into HIV-1 virions (Kd of Gap-CypA
interaction is in micromolar range) and thus reduces HIV-1 infectivity. The anti-HIV-
1 activity of CsA seems to be independent of its immunosuppressive activity since
non-immunosuppressive CsA derivative can act as HIV virion inhibitors
(Papageorgiou et al. 1996a, b).
In vivo protein activities by Immunophilins
DmCyp-26 is a tissue specific cyclophilin and an integral ER protein. This 26 kDa
PPIase is expressed in the photoreceptor cells of Drosophila meganogaster by the
ninaA gene. DmCyp-26 has been shown to be required for the transport of the folded
isoforms of rhodopsin (Rhl and Rh2) from the rough endoplasmic reticulum through
the cytoplasm to the cell surface (Baker et al. 1994).
Another related example of chaperone function is the folding of procollagen I.
Cyclophilin has been implicated in the formation of collagen triple helices in the
endoplasmic reticulum of fibroblast cells where the folding of procollagen I is slowed
by 40% in the presence of 5 mM CsA (Steinman et al. 1991). Cyclophilin has also
been shown to catalyse the folding of thermally denaturated type III collagen
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(Compton et al. 1992). Also the hCypB and Hsp-47 has been shown to act together
to transport collagen from the endoplasmic reticulum (Smith et al. 1995).
CsA has been shown to retard the folding and secretion of transferrin from the HepG2
cells. Additionally folding and glycosylation which takes place in the endoplasmic
reticulum (ER) was not affected by FK506 or rapamycin. It thus suggested that an
ER-cyclophilin aids the formation of the prefolded segments of transferrin which
facilitate the formation of correct disulphide bridges and secretion of the protein to
the extracellular milieu (Lodish and Kong 1991).
B) Mechanism of PPIase
The torsion angle of a peptide (OC-N) bond could be in cis or in trans conformation
(see Fig. 3). Because of the steric interference the trans form is energetically favorable
and the cis form is rare in the native structure of proteins. The only exception is
proline which has higher probability (0.1-0.3) to form a cis conformation compared to
the other 19 common amino acids which have a probability of 10"3 (Galat and
Metcalfe 1995).
The higher probability of proline cis peptide bonds could be due to a lower activation
energy barrier (13 kcal/mol, Schulz and Schirmer 1979) for an X-Pro bond which for
other peptide bonds is estimated to be between 18-21 (Jorgensen and Gao 1988). The
corresponding difference between the cis and trans states of Xaa-Pro amide bonds is
estimate to be only 0.5 kcal/mol (Kallen and Walkinshaw 1992). PPIases enzymatic
activity can reduce the rotational energy barrier and speed up the cis-trans
isomerasation. Several different mechanisms have been proposed to explain the




Measurements of the secondary deuterium effect on the hCypA-CsA complex had led
to a suggestion that the complex was due to formation of a tetrahedral intermediate
(Fischer et al. 1989a). In this mechanism a tetrahedral intermediate,
hemithioorthoamide, was proposed by the nucleophilic addition of a cysteine or
nucleophilic residue to the carbonyl carbon of the Xaa-Pro peptide bond (Fischer et
al. 1989b). However, NMR studies on the FKBP12-FK506 complex and CypA-CsA
complex had shown that only the trans form of the ligands were bound to the
immunophilins without formation of tetrahedral intermediate (Harrison and Stein
1990b). Also the crystal structure of Ala-Pro with CypA revealed no cysteine or
nucleophilic residue close to the carbonyl carbon (Ke et al. 1993).
Catalysis by distortion
This mechanism proposes that the C-N bond is rotated and this distorted intermediate
is stabilised in the cyclophilin binding site. This mechanism is supported by kinetic
isotropic studied and the solvent deuterium isotropic effect (Harrison and Stein
1990a). However all published structures of cyclophilin A with linear peptides except
the HIV-1 capsid protein bind to hCypA in the cis conformation (Taylor et al. 1997).
Catalysis by protonation
The mechanism proposes a protonation of the C-N peptide bond by side chain
residues like threonine , tyrosine or serine or maybe a hydrogen bond to the lone pair
of the nitrogen atom (Fischer et al. 1989b; Kofron et al. 1991). Molecular orbital
calculations show that the protonation reaction of amide atom can reduce the energy
barrier of cis-trans isomerisation as it can deconjugate the OC-N peptide bond and
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the double bond character of the C-N bond is weaker (Armbuster and Pulman 1974 ).
However this mechanism is not proven by structural results since in the complexes of
CypA with linear peptides there are no proton-donor groups such as serine, threonine
or tyrosine close to the amide nitrogen (Zhao and Ke 1996 a; Zhao and Ke 1996 b;
Ke et al. 1993).
Catalysis by desolvation
It has been shown that the rate of cis-trans isomerisation is accelerated in nonpolar
solvents (Radzicka et al. 1992; Eberhardt et al. 1992). The mechanism suggests that
the first step of the reaction is the desolvation of the substrate. The above is also
supported by the structures of peptides contained a proline residue. The proline ring
makes strong hydrophobic interactions with the hydrophobic pocket of cyclophilin.
Solvent assisted mechanism
The mechanism is based in the structures of hCypA with Ala-Pro (Ke et al. 1993) and
most recently with a series of dipeptide Ser-Pro, His-Pro and Gly-Pro complexes
(Zhao and Ke 1996 a). The solvent-assisted mechanism is similar to the proposal of
"catalysis by distortion" (Harrison and Stein 1990a) but pinpoints water instead of
protein residues as the chemical group to cause distortion of the amide bond. A
conserved water molecule in the unligated and in the complexed structure in the
binding site appears to be the candidate. A rotation between -50° to -90° of the C-N
peptide bond (due to thermal movement) would bring the amide bond to the transition
state which can be stabilised through a hydrogen bond between the carbonyl oxygen
and the candidate water molecule. However this water molecule is not observed in the
CypA-AAPF complex so the solvent-assisted mechanism is not verified on the basis of
the tetrapeptide structure. This raises the question whether the dipeptide and
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tetrapeptide have different cis-trans isomerisation mechanisms or that the dipeptides
are competitive inhibitors of the CypA.
C) Cyclophilins
Cyclophilins are abundant and ubiquitous proteins in both prokaryotic and eukaryotic
organisms (Koletsky et al., 1986). About 50 members of the family have been
reviewed (Galat and Metcalfe 1995) and the number is growing. The majority of
procaryotic and yeast Cyps have an acidic pi whereas those from mammals are basic.
The molecular mass of known cyclophilins vary from 15kDa for a Bacillus subtilis
cyclophilin (Herrler et al. 1994) to 159 kDa (Anderson et al. 1993). Cyclophilins with
low molecular weight are relatively hydrophobic molecules whereas big cyclophilins
like Cyp-160 have both highly hydrophobic domains intertwined with those rich in
charged residues(Galat and Metcalfe 1995). The dissociation constants to CsA can
vary significantly for different members of the family. An 18kDa cyclophilin from
E.coli has a K, of 8.8pM while the same size human cyclophilin has a K; of 17nM
(Taylor et al. 1997).
1. Cyclophilin structures
Cyclophilin structures from human, yeast, parasite and bacteria have been solved by
X-ray crystallography or NMR and they share similar structural features (Taylor et al.
1997). The most common features of cyclophilins are the 8 antiparallel (3-standed
barrel capped by two oc-helices (Fig. 1.5). The main sequence differences between
different members of the family are located on the external loops.
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Fig. 1.5: Topology of CypA. Helices, [3-stands and loops are shown (Kraulis 1991).
Residues which interact with CsA are highlighted.
The topology of cyclophilins is unique and unlikely to be related to retinol-binding
protein, superoxide dismutase, steptavidin or trosephosphate isomerases structures
which also contain eight-standed (5-barrels. The main difference with cyclophilins is
that the centre of the barrel is completely filled with hydrophobic residues and the
ends of the barrel are blocked off at each end by two stretches of oc-helices.
The X-ray structures of hCypA with 11 cyclosporin derivatives show that there are
small alterations in the structure of CypA upon binding with cyclosporins (Kallen et
al. 1998). A similar result was derived from NMR studies on the hCypA-CsA
complex (Theriault et al. 1993). This also applied with different crystal forms where
the decameric (Pflugl et al. 1993) and the monomeric forms (Mikol et al. 1993) of
CypA-CsA complex, have an rms deviation between the two structures of less than
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0.5 A for the backbone atoms. A number of complexes of cyclophilins with linear
peptides have been solved (Taylor et al. 1997). The overall structure of CypA
complexed with peptides is similar to those of the unligated CypA.
D) FKPBs
A number of FKBPs have been discovered from different sources (prokaryotes and
eukaryotes) with a molecular weight from 12kDa up to 52kDa (Galat and Metcalfe
1995). The pi of the family is acidic for prokaryotic and basic for mammalian cell.
Most FKBPs bind both FK506 or rapamycin (Galat et al. 1992). The FK506 binding
domain of the family is conserved from FKBP-12 through FKBP-52 and the latter has
all the hydrophopic residues which make interaction with FK506 in the FKBP12-
FK506 structure (Galat and Metcalfe 1995).
1. FKBP structures
X-ray and NMR structures of hFKBP-12 (van Duyne et al. 1991) and bFKBP-12
(Moore et al. 1991) revealed that the protein fold is a five stranded anti-paralled 13-
sheet which wraps around an a-helix (Fig. 1.6). Insignificant structural changes
occurred in hFKBP-12 upon complex formation with FK506 (Galat and Metcalfe
1995). All prolines of hFKBP-12 are in trans conformation. X-ray structures of FKBP
complexes with FK506 and the antagonist L-685,818 show essentially identical
protein-ligand interactions (Becker et al. 1993).






A large amount of protein is required for crystallization trials. The only way to keep
up with the high demand of a protein is to overexpress the gene in bacteria. The
ability to overexpress genes in bacteria has improved enormously over the past few
years. The most commonly used microorganism to overexpress protein is
Escherichia coli. Two cell lines of E.coli were provided by Sandoz for the
production of Cyp-A and Cyp-B. Also a gene for FKBP-12 production was kindly
provided by Fujisawa Pharmaceutical Co., Ltd, Japan.
2.2 Material & Methods
A) Storage of bacterial lines
A single colony obtained from a LBamp (Luria-Bertani agar plate containing 50p,g/ml
ampicillin) plate was inoculated into fresh LBamp medium. The culture was incubated
at 37°C with constant shaking until the OD600 reached 0.4. The cell pellet from this
culture was resuspended in sterile 15% (v/v) glycerol. The suspension was flash
frozen in liquid nitrogen and kept at -70 °C in aliquots of 100 pi.
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B) Cyp-A & Cyp-B material and methods
1. Cell lines
The cell lines were E.coli strain 101-521 1C for expression of Cyp-A and strain 7264
121 for expression of Cyp-B. Both strains contain an IPTG (isopropyl-p-D-
thiogalactopyranoside) promoter and are ampicillin resistant.
2. Expression in E.coli
The same growth protocol was followed for E.coli/101-521 1C and E.coli/7264 121
strain.
The protocol was as follows:
Small scale expression in E.coli
1. A single colony was isolated from a E.coli culture by streaking on an LBamp plate
at room temperature. In the streaking technique, a sterilised wire is dipped into a
suspension of microrganisms and it is then used to make a series of parallel,
nonoverlapping streaks on the surface of solidified agar plate (Stanier et al 1986
page 17)
2. From a single colony, 30 ml LBamp broth (Al culture) was inoculated at 37°C.
3. When the OD60o, of Al culture, reached OD60o~0.3, 1 ml was transferred and used
to inoculate 30 ml of LBamp broth (named as B1 culture) and was kept at 37°C for
future use. The rest of the Al culture was induced by adding 0.4 mM of IPTG.
4. After 4 hours, 0.5 ml of the Al culture was centrifuged and the supernatant was
discarded. The cells were suspended in 20 pi sample buffer (0.06 M Tris-Cl,
pH6.8, 2% SDS [Sodium dodecyl sulphate], 10% glycerol, 0,025% Bromophenol
Blue). Finally the sample was heated at 95 °C for 4 min. The sample was run in 15
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% SDS-PAGE to confirm the expression of the protein.
5. If the results of SDS-PAGE were positive the protocol was carried out using large
scale cultures.
Large scale expression in E.coli
1. Six litres of LBamp medium was divided equally into six 2 L flasks and inoculated
with the 30 ml B1 culture, of small scale expression and grown at 37°C in a
shaker incubator.
2. When ODgoo reached -0.3 the cultures were induced by adding 0.4 mM of IPTG
and were grown for further 4 hours (OD60o~2.2).
3. The culture was centrifuged and the supernatant was discarded. The cells were
kept at -20°C at this stage.
C) FKBP-12 material and methods
1. Plasmid
The plasmid pFKBP333 is ampicillin resistant and has an E.coli TRP (tryptophan)
promoter upstream of the gene for FKBP-12. Therefore, FKBP-12 shall be expressed
when E.coli/pFKBP333 is cultivated in M9CA (M9 Minimal Medium contain 1%
Casamino acid) broth. 3-(3-indoleacrylic acid (IAA) is used to induced expression of





The bacterial strain BL21(DE3) (Sambrook et al 1989 Book3) was used for the
transformation. This particular E.coli strain has a very fast growth rates and is
employed for high-level expression.
3. Bacterial transformation
A modified calcium transformation method was used adapted from Sambrook et al
1989 (Book 1).
At an OD60o of 0.28 the number of viable cells is 108 cells/ml for this strain. For
efficient transformation that number should not exceed 108 cells/ml (Sambrook et al
1989 Book 1). All materials used were sterile.
The protocol was as follows:
1. Pick single colony, inoculate 10 ml of M9CA, incubate overnight at 37°C in a
shaking incubator.
2. Inoculate 100 ml M9CA with 0.5 ml of the overnight culture in a 250 ml flask and
grow for ~2 hours at 37°C in the shaker until OD60o is approximately 0.25.
3. Divide into 2x50 ml Falcon tubes and cool on ice for 10 min.
4. Centrifuge at 2500 g for 5 min at 4°C. Discard the supernatant
5. Resuspend in 50 ml 100 mM CaCl2 and leave on ice for 30 min to 4 hours.
6. Spin as above and resuspend in 5 ml CaCl2.
7. A chilled pipette is used to transfer 90 pi of suspension of competent cells to a
microfuge tube. Add 10 pi of DNA (no more than 50 ng in a volume of 10 pi).
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Mix the contents by swirling gently and leave on ice from 30 min to 1 hour.
8. Heat shock at 42°C water bath for 2 min.
9. Add 1 ml M9CA and culture for 30 min at 37°C without shaking.
10.Prepare plate of media containing ampicillin 50 pg/ml and transfer the appropriate
volume (up to 200 (ll per 90-mm plate) of transformed competent cells. Gently
spread the transformed cells over the surface of the agar plate.
4. FKBP-12 expression in E.coli
The transformed bacteria grew in M9CAamp (M9 Minimal Medium contain 1%
Casamino acid and 50 pg/ml ampicillin).
Protocol
• A single colony of E.coli/BL21(DE3)/pFKBP333 was cultivated in 10 ml
M9CAamp broth at 37°C until OD60o is approximately 0.6.
• 1 ml of the culture with OD6oo~0.6 inoculates 100 ml M9CAamp broth at 37°C.
• When the ODeoo of 100 ml culture reached 0.3, induce by adding 1 ml of IAA 2.5
mg/ml in 95% ethanol.
• After 4 hours 0.5 ml of the 100 ml culture was centrifuged and the supernatant
was discarded. The cells were suspended in 100 pi sample buffer (0.06 M Tris-Cl,
pH6.8, 2% SDS [Sodium dodecyl sulphate], 10% glycerol, 0,025% Bromophenol
Blue). Finally the sample was headed at 95 °C for 4 min.





A) Expression of Cyp-A & Cyp-B
SDS-PAGE gels of cell extracts from both bacterial strains indicated that expression
of Cyp-A and Cyp-B was successful for both proteins (Fig.2.1 and 2.2).
Cyp-B
12 3 4
Fig.2.1: SDS-PAGE (15 %) of E.colil7264 121(Cyp-B) induced with IPTG
(400|iM). Lane 1: uninduced pellets. Lanes 2 & 3: induced pellets. Lane 4: Cyp-B
standard. A strong band of molecular weight identical to the Cyp-B (Lane 4) in lanes
2 and 3 indicated that expression of Cyp-B was successful.
The effect of IPTG concentration and induction time on the expression of Cyp-A was
investigated.
Cultures of E.coli/101-521 1C in LBamp induced at different growth times and IPTG
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concentration. Results of that experiment can be seen in SDS-PAGE (Fig.2.2). The
variation of the time and IPTG concentration can be seen in Table 2.1.
MW Cyp-A uninduced
standards standard pellets j 23 45 678
Fig. 2.2: SDS_PAGE (15 %) of E.coli/101-521 1C pellets induced with different
IPTG concentration at different growth phase (determine by OD60o). The
concentration of IPTG was used in each experiment given in Table 2.1.
Table 2.1: IPTG concentration tested for determination of optimum expression in
E.coli/101-521 1C. The numbers in mM present IPTG concentration. The numbers in
the first row corresponds to the numbers of wells in Figure 2.1.
Growth phase
(ODfioo)
1 2 3 4 5 6 7
0.2 0.6 mM 0.2 mM
0.45 1.2 mM 0.6 mM 0.2 mM
0.8 0.6 mM 0.2 mM





E.coli/ BL21(DE3)/pFKBP333 cells after transformation were plated on an
ampicillin 50 |i,g/ml plate. Many colonies grew which is an indication that the
transformation actually took place since the bacteria were not ampicillin resistant
previously.
2. FKBP-12 expression in E.coli
E.coli/BL21(DE3)/pFKBP333 grew under expression conditions for FKBP-12. Cell
extract and culture medium were tested for FKBP-12 in SDS-PAGE (12 %).
Fig.2.3: SDS-PAGE (12%) of E.coli/BL21(DE3)/pFKBP333 cell extract sample and
culture medium. Lane 1: FKBP-12 standard. Lane 2: Culture medium. Lane 3 and 4:




The transformation of E.coli/BL21(DE3)/pFKBP333 was achieved since the bacteria
became ampicillin resistant. Nevertheless the expression system for FKBP-12 was
not so efficient and the band corresponding to FKBP-12 was not clearly seen in the
gel. Due to low yield the system was not used for production of the protein. No more
work was carried out with this expression system and no other promoters were used
in order to increase the production of the protein.
Both expression systems for Cyp-A and Cyp-B seemed to work well. Results of
expression of both E.coli strains are presented in the Fig.2.1 (Cyp-B) and Fig 2.2
(Cyp-A). Sample pellets of E.coli/101-521 iCrun in SDS-PAGE (Fig. 2.2) indicates
that better expression occurred when the induction takes place at OD60o between 0.2
to 0.45 and with an IPTG concentration of 0.2 to 0.6 mM.The uninduced pellets of
E.coli/101-521 1C in Fig. 2.2 contain a protein of similar MW to Cyp-A. That
protein could be indeed Cyp-A. This could be caused by basal transcription level or





The degree of purity of the protein plays an important role in enzymatic and
fluorescence studies and especially in crystallogenesis. Only when an enzyme has
been purified can the assay be regarded as reliable. The same principle applies to
fluorescence studies. The concept of purity can be applied to protein conformation
and only one conformer of that protein is acceptable. Denatured protein has the same
molecular weight but is inactive and the difference in the shape may prevent
crystallization of the native form (Lorber and Giege 1990). The main goal of
purification is to purify the protein in a single form and to maintain the initial
features and shape.
Three proteins have been purified in the current work Cyp-A, Cyp-B and BrCyp. The
amino acid sequence of each protein is shown in appendix 1. Cyp-A and Cyp-B are
both produced intracellularly so cell lysis was required. The BrCyp was supplied as
an MBP fusion protein. The reason of using fusion protein with MBP is that can be
purified on amylose resin as a single product.
3.2 Purification strategy
The proteins in cells are compartmentalised and therefore separated from other
proteins with proteolytic activity. Cells lysis results in disruption of these barriers
with the exposure of proteins to proteases and to a different environment in the cells.
The potential for degradation then is inevitable during the course of the purification.
For the above reasons the purification of all proteins in this work was carried out at
4°C and as quickly as possible. Additionally benzamidine and EDTA were added as
protease inhibitors (Deutscher 1990) and (3-mercaptoethanol was added to prevent
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oxidation of the protein (see materials and methods section).
Many techniques have been developed to purify proteins including ion-exchange
chromatography, gel filtration and hydrophobic interaction chromatography
(Rossomando 1990 and Stellwagen 1990). Previous work on Cyp-A
(Handschumacher et al 1984 and Holzman et al 1990), Cyp-B (Spik et al 1991) and
BrCyp (Page et al 1995) showed that a combination of ion-exchange
chromatography and (or) gel filtration was sufficient for purification for all of them.
Therefore the same purification techniques were employed during the course of this
work. Nevertheless modifications of the existing methods were required since the
sources which the proteins come from and cell lysis were different. Handschumacher
et al purified human cyclophilin A from human spleen. Holzman et al (1990) and Liu
et al (1990) expressed and purified human cyclophilin A from different Escherichia
coli strains (and with a different cell lysis procedure). Spik et al (1991) expressed and
purified human cyclophilin B from a different Escherichia coli strain and with a
different cell lysis procedure.
Ion-exchange chromatography separates molecules based on differences in their
surface charges. Attraction takes place between molecules of opposite electric
charge. The stationary phase of an ion exchange packing consists of functional
groups which the have either a positive charge (anion exchanger), used to separate
negatively charged molecules (anions), or a negative charge (cation exchanger), used
to separate positively charged molecules (cations) (Rossomando, E. 1990).
Gel filtration (also known as size exclusion chromatography) separates molecules
based on differences in their size. The stationary phase consists of particles with a
distribution of pore sizes. If molecules are small enough, the pores are so large that
the molecules can penetrate all of the internal volume of the particles. The large
molecules on the other hand are excluded from the internal volume and therefore
emerge first from the column while the small molecules emerge later. The
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dimensions important to gel filtration are the diameter of the pores that access the
internal volume and the hydrodynamic diameter of the molecules (Stellwagen 1990).
A) Cyp-A
All purification steps, including cell lysis took place at 4°C since previous
purification work on Cyp-A was done at this temperature (Liu et al 1990) and for
reasons described above.
The pH was adjusted to 7.5 during cell lysis for optimum activity of lysozyme. The
pH of cell extract was then adjusted from 7.5 to 6.8. Since cation exchange
chromatography was employed for purification, the protein should be positively
charged in order to bind to the stationary phase. Two isoelectric forms of cloned
human cyclophilin A have been reported, alkaline (pi > 9.0) (Liu et al 1990) and
neutral (pi > 7.4) (Holzman et al 1990). Both of these isoelectric forms of Cyp-A are
reported to have the same cDNA sequence. A possible explanation given from
Holzman et al (1990) is that the proteins were cloned from different cell types and
therefore may represent different gene products with different sequence. Obviously
one of the above reported values for pi should be wrong. The pi value of the protein
is very important for the design of purification procedure, and since it was not clear
which pi value is the right one a pH of 6.8 was used for loading the protein into the
columns. When pH is 6.8 a protein which has pi values above 6.8 (both reported
values in literature are above 6.8) should be positively charged and should bind to a
cation exchanger column. A pH of 6.8 was therefore used for loading the protein into




All purification steps including the lysis of the cell took place at 4°C. Cyp-B has
been cloned in E.coli and was purified from the same source (Spik et al 1991, Price
et al 1991) by cation exchange chromatography. Spik et al (1990) used a pH 6.0 to
load the protein to the column. The experimental pi had not been determined for
cyclophilin B cloned in E.coli/7264 121. The theoretical pi can be calculated based
on amino acid sequence. The theoretical value was calculated using programs
available on Web pages (http://www.embl-heidelberg.de) of EMBL (European
Molecular Biology Laboratory). The program determined the pi using literature
values (Lehninger et al 1993). The calculated value of the isolectric point for Cyp-B
was 9.76. A pH of 6.8 was therefore used for loading the protein into the columns in
order to be sure that the protein will be positively charged.
C) BrCyp
BrCyp original was isolated and cloned from the nematode parasite Brugia malayi by
Page et al (1995). The protein was supplied as BrCyp fusion protein with maltose-
binding protein by Dr Page (Wellcome Unit of Molecular Parasitology, Glasgow
University, Glasgow). The cleavage and the purification of the cleavage products
was carried out in house. The rest of the purification was carried out as described in
Page et al (1995).
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3.3 Material & Methods
The following material and equipment used in the current work was obtained from
Pharmacia Biotech.
A) Colums and Equipment
• FPLC and GradiFrac system
The following columns were used for purification.
• SP Sepharose; a cation exchanger (40 ml) column
• SOURCE 15S; a strong cation exchanger (8 ml) column
• 30 Q; a strong anion exchanger (10 ml) column
• Sephacryl S-200 HR; a gel filtration (120ml) column
B) Purification procedures in Cyp-A
1. Cell lysis
Pellets were produced and frozen as previously described (see Protein production
chapter). Pellets were resuspended at 10 % (w/v) in 50 mM Hepes pH 7.5 , 5 mM
benzamidine, 5 mM (3-mercaptoethanol, and 5 mM EDTA (ethylenediaminetetracetic
acid). Digestion of the cell walls followed addition of lysozyme to 0.1 % (w/v) in the
above solution and incubation for 1 hour. The suspension was mixed from time to
time.
The cell extract was centrifuged in a BECKMAN Avanti J-25 centrifuge at 16000 x
g for 30 min. The supernatant pEl was adjusted to 6.8 with 1 M Hepes pH 6.6. The
pH was monitored by narrow-range pH sticks. Supernatant was filtered first through
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glass filter (glass prefilters cellulose acetate BDH) and then through 0.45 pm (PVDF
syringe filters 25 mm BDH) to remove large particulates which may block the SP
Sepharose column in next step.
2. Purification of Cyp-A
SP Sepharose, a cation exchanger from Pharmacia Biotech, was used for the first
purification step. 40 ml SP Sepharose was equilibrated in 50 mM Hepes pH 6.8, 5
mM (3-mercaptoethanol, and 5 mM EDTA (buffer A) for one hour.
The supernatant at this stage contained large amounts of protein which could block a
column. Protein extract was therefore bound in batch mode to resin pre-eqilibrated in
buffer A. The resin/extract slurry was incubated for one hour with mixing from time
to time. The slurry was packed into an XK26/20 column.(Pharmacia). The column
was washed to base-line with buffer A and eluted with the same buffer containing 0.5
M NaCl (buffer B). The eluted material was then concentrated by ultrafiltration to 3
ml (Amicon YM 10 membranes) and dialysed (cellulose ester membrane MWCO 3.5
PIERCE) against 4 litres of buffer A by stirring overnight.
The next purification step was a strong cation exchanger column. The 3 ml sample
from above was loaded on an 8 ml mono-S column (SOURCE 15S Pharmacia
Biotech) with buffer A, washed to base-line with the same buffer and eluted with
buffer B. Elution of Cyp-A was carried out with about 250 mM of NaCl. The eluted
material was then concentrated by ultrafiltration to 3 ml (Amicon YM 10
membranes).
The final purification step made use of size exclusion chromatography with a
Sephacryl S-200 HR column (120ml). The column was washed to base-line with
buffer A. The sample applied to the column was not more than 3 ml. The applied
volume to the column should be as small as possible (in order to reduce
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bandspreading) for better separation. Buffer A was used for elution with flow rate of
0.5.ml/min. Size exclusion chromatography also ensured that the eluted protein
contained no salt.
C) Purification procedures in Cyp-B
1. Cell lysis
The method was the same as for Cyp-A plus one additional filtration with 0.2 p,m
(PVDF syringe filters 25 mm BDH) before the sample was introduced into the
Mono-S column.
2. Purification of Cyp-B
Filtered material was loaded onto a Mono-S cation exchanger column (SOURCE 15S
Pharmacia Biotech) equilibrated with buffer A (as above) and eluted with a linear
gradient of 1 M NaCl in buffer A. The next purification step was size exclusion
chromatography with Sephacryl S-200 HR column (120ml).
D) Purification of BrCyp
The starting material was recombinant cyclophilin MBP fusion protein and provided
by Dr Page (Wellcome Unit of Molecular Parasitology, Glasgow University,
Glasgow) in Tris 20 mM pH 7.4 and glycerol 40 %. The supplied material was
dialyzed against 200 volumes of Tris 20 mM pH 8.0.
The cleavage and purification procedure was adapted from Page et al 1995. After a
couple of trials it was found that the best cleavage was obtained in 20 mM Tris pH
8.0, 100 mM CaCl2 and 150 mM NaCl. Cleavage took place for 12 hours at room
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temperature in a solution of 0.7 mg/ml fusion protein, 10 fig/ml factor-Xa, 20 mM
Tris pH 8.0 100 mM CaCl2 and 150 mM NaCl. The first step was the cleavage of
fusion protein by factor-Xa purified in our laboratory by Dr Husi.
The cleaved material was dialyzed (Amicon YM 10 membranes cellulose ester
membrane MWCO 3.5 PIERCE) against 200 volumes of Tris 20 mM pH 6.9. The
dialyzed material was loaded onto a Mono-Q anion exchanger column (10 ml 30 Q
Pharmacia Biotech) equilibrated with buffer Tris 20 mM pH 6.9 and eluted with a
linear gradient of 1 M NaCl in the previous buffer. Finally the flow-through (BrCyp




After cell lysis most of the Cyp-A was released into the supernatant Fig. 3.1. This
material was then loaded on to the Sepharose column. Eluted fractions of Sepharose
column can be seen in Fig. 3.2. Fraction 6 contains a large amount of Cyp-A but it
was contaminated with lysozyme (strong band at 14 kDa). Fraction 7 was considered
as more "pure" and after dialysis was loaded on the mono-S column.
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Fig. 3.1: SDS-PAGE (15 %). Cell extract and supernatant ofE.coli/101-5211C.
Lane 1: E.coli pellets. Lane 3 to 5: Supernatant. Lane 6: Cyp-A standard. Lane 7
MW standards
1 23 456 789
wM
Fig. 3.2: SDS-PAGE (15 %). Eluted fractions from Sepharose column. Lane 7:
Fraction containing Cyp-A which was used for further purification. Lane 8: Cyp-A
standard. Lane 9: MW standards.
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The degree of purity of eluted samples from the mono-S column was high Fig. 3.3.
Fractions 4 and 5 in Figure 3.3 were contaminated with high MW proteins (65 to 94
kDa) which can be easily separated using gel filtration so these two fractions were
loaded together in the size exclusion column. Fractions 6, 7 and 8 (Figure 3.3) were
contaminated with high MW proteins (65 to 94 kDa) and low MW proteins (25 to 30
kDa) which would be difficult to separate since there almost the same size as Cyp-A.
These fractions were collected, concentrated and loaded onto a size exclusion
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Fig. 3.3: SDS-PAGE (15 %). Eluted fractions from mono-S column. Lane 1: MW




Fig. 3.4: SDS-PAGE (15 %). Eluted fractions from size exclusion column.
Lane 1: MW standards. Lane 2: Cyp-A standard. Lane 3, 4 and 5: Fractions
contained high MW proteins. Lane 6 and 7: Fractions contained pure Cyp-A. Lane 8
and 9: Fractions contained low MW proteins.
3.11
Protein Purification







Fig. 3.5: SDS-PAGE (15 %). Eluted fractions from size exclusion column.
Lane 1: MW standards. Lane 2: Cyp-A standard. Lane 2: Fractions contained Cyp-A
contaminated with low MW protein (25 kDa indicated with the arrow). Lane 2 and 4:
Fractions contained pure Cyp-A.
The size exclusion column completely separated the Cyp-A (Fig.3.4 lane 6 and 7)
from the high molecular weight proteins (Fig.3.3 lane 3, 4 and 5). The low MW
proteins were also separated from Cyp-A using the same size exclusion column.
Fractions containing these proteins can be seen in Fig. 3.4 (lane 8 and 9). Fractions
eluted from the column in the following order: lane 8 (Fig. 3.4), lane 9 (Fig. 3.4),
lane 2 (Fig. 3.5), lane 3 (Fig. 3.5),. lane 4 (Fig. 3.5). Fraction 2 (Fig. 3.4) contained a
lot of Cyp-A and a trace of 25 kDa protein and were not used further. The next pool
(lane 3 and 4 Fig. 3.4) contained pure Cyp-A and they were used further. The high
MW proteins were completely seperated from Cyp-A as can be seen in Fig.3.5 lane
3,4 and 5. In a typical experiment the yield of Cyp-A was 1.6 mg purified Cyp-A for




The first purification step used a mono-S column. An SDS-PAGE gel showing the
purity of the eluted material from this column is given in Fig. 3.6. Only fraction no 1
was used for further purification. Fraction no 2 contained a lot of Cyp-B but was
contaminated with a protein of similar MW (-20 kDa).
1 2 3 4 5 6
■
Fig. 3.6: SDS-PAGE (15 %) of eluted fractions containing Cyp-B from mono-S
column: Lane 1: Fraction containing Cyp-B used for further purification (size




Fig. 3.7: SDS-PAGE (15 %) eluted fractions from size exclusion column: Lane 1:
MW standards. Lane 2 to 5: Fractions containing Cyp-B. Lane 6 and 7: Pure Cyp-B
fractions. Lane 8: Cyp-B standard.
The next purification step was size exclusion chromatography using a Sephacryl S-
200 HR column. The eluted fraction can be seen in Fig. 3.7. Fractions 2 to 5 in
Fig.3.7 contained Cyp-B but were contaminated with high MW proteins (66 to 100
MW) and discarded. Fraction 6 and 7 contained pure Cyp-B and those were used for
further studies. In a typical experiment the yield of Cyp-B was 2 mg/1. purified Cyp-




The supplied material was dialyzed against 200 volumes of Tris 20 mM pH 8.0. The
results of 12 hours cleavage is presented Fig.3.8. Initial material (fusion protein 65
kDa lane 1) has been broken down in lane 2 to 3 band (MW 43 kDa, 22 kDa and
17kDa).
Fig. 3.8: SDS-PAGE (15 %) of eluted fractions from mono-Q column. Lane 1:
Fusion protein. Lane 2: Cleaved fusion protein. The high molecular weight band
(-65 kDa) was MBP protein, band in 22 kDa was recombined BrCyp. Lane 3: BrCyp




Fig. 3.9: SDS-PAGE (15 %) of past through of mono-Q column. Lane 1: Pure
BrCyp after ultrafiltration. Lane 2 and 3: Passed through fractions of mono-Q. Lane
4: BrCyp standard. Lane 4: MW standards.
The cleaved material was loaded onto a mono-Q column. Cyclophilin and the 17kDa
protein were passed through (Fig. 3.9 lane 2 and 3) and MBP bound. The final
separation of BrCyp from the 17kDa fragment (Fig. 3.9 lane 2 and 3) was achieved





Cyp-A required three purification steps from cell extract to pure protein. In the initial
attempt only two purification steps were used. A mono-S column and a size
exclusion column were not enough to give pure Cyp-A. An additional cation-
exchange chromatography (SP sepharose column) step was introduced at the
beginning of the procedure.
In Fig.3.1 it can be seen that most of the Cyp-A was released into the supernatant but
some can be detected in cell extract. More protein could be released into the
supernatant if its volume was increased. It was, however, difficult to handle such a
large volume of cell extract.
In the first purification step a significant amount of Cyp-A did not bind to the
Sepharose column. This was caused by high protein concentration in the eluted
material or from intracellular salt from pellets. The intracellular salts concentration
(potassium, sodium, calcium and magnesium) in E.coli could be up to 3 % of dry
weight of the pellets (Stanier et al 1986 page 22). This amount of intracellular salt,
taking account of the weight of the pellets and the volume of lysis buffer in which
they were diluted, resulted in a concentration of 30 mM salt. More protein possibly
could be recovered if the first purification step was repeated but this should be done
as soon as possible since the cell extracted material was degraded fast. Cell extracted
material after 3 days at 4°C was unusable. The yield of the pure Cyp-A was enough




Cyp-B required two purification steps from cell extract to pure protein. In the first
purification steps after elution there were four fractions that contained Cyp-B
(Fig.3.6 1, 2, 3 and 5). Only fraction no 1 was used for further purification. Fraction
no 2 contained a lot of Cyp-B but was contaminated with a protein of similar MW
(-20 kDa) which could not be separated by size exclusion. Fractions 2,3 and 5 were
contaminated with lysozyme. One way to over come this problem and increase the
yield is the use of mechanical lysis (Cull and McHenry 1990). The yield was higher
than Cyp-A probably because less purification steps were required and the higher
MW.
3. BrCyp
In Fig.3.8 lane 2 it can be seen that the cleavage was working efficiently. The yield
of pure BrCyp was only 15.8 % from that contained in the fusion protein. The
factorXa was probably contaminated with another protease which resulted in further
cleavage of BrCyp to a 17kDa protein (Fig. 3.8 lane 2 and Fig. 3.9 lane 2 and 3).
Globular solutes with MW of 10 kDa are retained at least 90 % by the YM 10
membrane. Separation of BrCyp and the 17kDa fragment (see Fig. 3.9) caused either
because 17kDa fragment pass through the membrane, nevertheless that it much






Before starting crystallization or enzymatic studies of a protein, the degree of purity,
the concentration and the activity must be accurately determined. The purity of the
protein can be estimated by polyacrylimide gel electrophoresis, which has been
described (chapter 2.4).
Protein concentration can be assayed by variety of methods including ultraviolet
absorption meaurement, the Biuret method, the Lowry method and protein-dye
binding using Coomassie Brilliant Blue G-250 method or BCA (bicinchoninic acid)
method (Burkhard 1983). The determination of protein concentration is important to
provide an accurate reference point for other measurements such a K<j (dissociation
constant) or enzymatic activity.
The protein can be further characterised by determination of size, molecular weight,
enzymatic activity and binding studies. In the current study the assay of peptidyl
prolyl cis-trans isomerisation (PPIase) was used to test the enzymic activity of
proteins purified 'in house' (Cyp-A, Cyp-B and CypBr) and to test ligand binding by
Cyp-A. Fluorescence spectroscopy was used for characterisation of proteins with
published ligands and for binding studies with novel ligands to the proteins FKBP
and cyclophilin A.
The dissociation constant (K<j) for ligands can be obtained by fluorescence
measurements. The enzymatic assay (PPIase) can also be used to calculate the
concentration of the ligand resulting in 50 % inhibition (IC50) which should related to
the Kd for that ligand.
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4.2 Material & Methods
A) Protein determination
The methods used in the current work were the BCA method (similar to the Lowry
method) and the Coomassie Brilliant Blue G-250 method.
Both of the methods used in current work require standardisation. Ideally , the assay
should be calibrated with the protein whose concentration is to be measured or with
another protein which closely matches the behaviour of the test protein. Since this
was impractical because of the price of pure CypA and FKBP-12 or similar to them
proteins and because CypBr is not commercial availiable, bovine serum albumin
(BSA) was used as the standard.
1. BCA method
The method is based on the reaction of Cu2+ ions in alkaline solution with the protein
and the production of Cu+ ions, which chelates two bicinchonic acids and forms a
complex which absorbs at 562 nm.
The working range of the BCA Protein Assay Reagent is lOjig/ml to 2mg/ml.
The protocol used comes from Wiechelman et al (1988) slightly modified.
1. Six standards of BSA (Pierce BSA 2 mg/ml) with concentration 20, 40, 60, 80,
100, and 120 pg/ml were made from 2 mg/ml BSA (PIERCE) by dilution in NaN3
0.02 % w/v.
2. 1 part of reagent B and 50 parts of reagent A both obtained from Pierce mixed
together to form the solution C.
3. 50pl of each of the above standards was added in a microfuge tube to 1 ml of the
solution C, mixed and incubated for 30 min at 37°C.
4. The absorbance was read at 562 nm against the blank sample containing 50 pi of
NaN3 0.02 % w/v and 1ml of the solution C.
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The sample consisted of 50 pi protein in NaN3 0.02 % w/v and was treated in the
same way as the standards.
Results of the method and figure can be found in appendix 2.
2. Bradford or Coomassie Blue Method
The principle of the method is that a dye (in this case Coomassie Brilliant Blue G-
250 from Pierce) binds to the protein. A shift of the absorption maximum of the dye
from 465 to 595 nm occurs upon binding of the dye to protein in an acidic medium
(Bradford 1976). The increase in absorption at 595 nm was monitored.
The Coomassie G (Coomassie Brilliant Blue G-250) seems to be bound to proteins
by electrostatic attraction enhanced by hydrophobic bonding (Tal et al 1980). The
molecules of Coomassie G interact differently with different proteins dependent upon
that amino acid composition (Tal et al 1980). The protocol used was taken from
Burkhard (1983) with a modification of the volumes used:
1. Seven standards of BSA (Pierce BSA 2mg/ml) with concentration 10, 20, 40, 60,
80, 100 and 120 pg/ml were made from 2mg/ml BSA (Pierce) dilution in NaN3
0.02 % w/v.
2. 20pl of each of the above standards were mixed in a microfuge tubewith 1ml of
the dye reagent solution (Pierce Coomassie Protein Assay Reagent) and incubated
for 5 min at room temperature.
3. The absorbance was read at 595 nm against the blank sample containing 20 pi of
NaN3 0.02 % w/v and 1 ml of the dye reagent solution.
The sample consisted of 20 pi protein in NaN3 0.02 % w/v and was treated in the
same way as the standards.
Results of the method and figure can be found in appendix 2.
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3. Extinction Coefficient (Alrag/mlicm)
Most proteins absorb ultraviolet-light with an absorption maximal around 275-280
due to their tyrosine, tryptophan and phenylalanine content. If a pure protein is
studied, the absorbance at 280 nm can be used for quantitation. The relationship
between protein concentration and absorbance is linear (Stoscheck 1990).
The BCA and the Bradford methods were first used for the determination of the
concentration of Cyp-A, FKBP-12, and BrCyp samples. The absorbance of the
sample was then measured at 280 nm relative to the buffer in which the protein is
dissolved. By dividing the absorbance at 280 nm with the concentration (mg/ml) the
absorbance coefficient is obtained.
Almg/mlicm=absorbance 280 nm / concentration (mg/ml)
The numbers are given as Almg/ra'icm and represent the absorbance (280 nm) per
1mg/ml protein when using a cuvette with a path length of 1 cm. Because
concentration values depend on the method which have been used (Bradford or
BCA), the value of Almg/m'icm reflected this difference. The concentration of a sample
then can be determined by simple measurement of the absorbance at 280 nm, divided
by the Almg/mllcm.
Table 4.1: Absorbance Coefficient (Almg/inlicm)
Method Cyp-A FKPB-12 BrCyp
BCA 0.749 1.69 -




Fluorescence spectroscopy is a powerful means of detecting interactions between
proteins and other molecules. In the current work this technique was used to measure
the binding of ligands to target proteins. A requirement is that the optical properties
of the protein-ligand complex differ from those of free ligand and free protein
(Bagshaw and Harris 1987). Aromatic residues such phenylalanine, tyrosine and
tryptophan are responsible both for fluorescence and the absorbance of proteins in the
near ultraviolet region. In most proteins tryptophan fluorescence dominates at
^emit=340 nm (Bagshaw and Harris 1987).
In this series of experiments the fluorescence of Cyp-A and FKBP-12 was examined,
each protein having a tryptophan residue near to its binding site. FKBP-12 has only
one tryptophan residue which sits at the bottom of the binding site and has no contact
to the solvent other than via the active site. Cyclophilin A also has only one
tryptophan, located about 8 A from the center of the active site making a hydrogen
bond to the inhibitor cyclosporin when bound.
Fluorescence titration in its simplest form involves fluorescence measurement on a
solution of protein with successive additions of ligand. Typically, measurement (fig.
4.1) occurs at a single wavelength and continues until no further change is observed
(apart from the dilution change due to addition of free ligand). The emission readings
can be numerically evaluated and can be used to calculate a binding constant. This
method has been used by Handschumacher et al (1984) for cyclophilin A.
After each addition of ligand, the portion of the protein bound is proportional to the
fractional fluorescence change. When 50% of the binding sites are filled, the
fractional fluorescence change is 50% when the protein ligand stoichiometry is 1:1.
The Kd (dissociation constant) has been estimated by assuming a 50% occupancy of
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the protein at fractional fluorescence change of 50%. At this point the concentration
of the bound ligand equals the free protein (Husi and Zurini 1994). The mathematical
basis of Kd calculation follows:
P + L =**" PL
[P] = free protein concentration
[P]b= bound protein concentration
[L] = free ligand concentration
[PL] = protein ligand complex concentration
[P]0 = total protein concentration
[L]0 = total ligand concentration
[L]b = bound ligand concentration
when 50% fluorescence change occured: [P] = [PL] = 1/2 [P]0
[L]0 = [L]b+ [L]




= [L]0 -1/2 [P]0 (equation 4.1)
A typical plot of ligand concentration against fluorescence quenching is given in Fig
4.1. From that figure the [L]„ (0.09 mM) can be found and by using equation 4.1 the
can be calculated. The most meaningful values in a titration curve are those near
to 50% of fractional fluorescence change because they allow more accurate
determination of ligand concentration at that point.
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50% of fractional fluorescence change because they allow more accurate
determination of ligand concentration at that point.
Fig. 4.1 : Fluorescence emission titration of FKBP-12 with 5-Beta-Pregnane-3,20-
dione. The point with 50 % signal is indicated with an arrow. The ligand
concentration at 50 % of fractional fluorescence was 9 pM.
Two other reasons may cause fluorescence quenching when the ligand concentration
becomes high and must be taken into account in every fluorescence titration.
• Inner filter effect. This can arise because the excitation or (and) the emitted light is
(are) strongly absorbed by the solution containing the fluorophore. As a result less
light can reach the detector, so there is apparent quenching of fluorescence.
• Scattering due to precipitation. Insoluble ligands can form precipitates which
scatter the emmission and the excitation light, so less quenching is recorded..
The first effect can be accounted for (Bagshaw and Harris 1987). To achieve this,
measurements are taken with the same experimental set-up but with tryptophan (Trp)
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instead of protein. By calculating the difference between the two measurements
(fluorescence of protein and fluorescence of control. Fig. 4.2) the new corrected
fluorescence values were calculated.
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Fig. 4.2 : Fluorescence emission titration of Cyp-A with CsA. Measurement starts at
intensity 88. Cyp-A titration with CsA is one of few examples in which enhancement
of fluorescence is observed.
(♦) Original measured values
(+) Values of the control measurement with Trp
(■) New corrected values
The control experiment was done for all ligands to correct the inner filter effect.
Additionally the control experiment can be used to correct for the dilution effect due
to addition of ligand. After each addition of ligand the final volume of protein
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solution increases, and the protein concentration decreases, resulting in a decrease in
fluorescence intensity.
Measurements were carried out using a Perkin Elmer LS50B fluorescence
spectrophotometer. The experiments took place at 20°C. Constant temperature was
maintained within the cuvette by a temperature control. The protein solution was
equilibrated until the signal was stable. A 1.4 ml fluorescence cuvette was used
(Hellma 6140F). The excitation wavelength was 280 nm and the emission wavelength
was varied from 330 to 345 nm according to protein and ligand. Emission and
excitation slits varied from 2.5 to 10 nm, determined by experimental parameters.
For each ligand concentration one fluorescence value was measured, and at the same
concentrations a reference emission value was taken. The difference between the two
values was calculated and a new corrected value was used to determine the Kd. The
fluorescence titration data were analysed graphically (Fig. 4.1) and the Kd was
determined graphically.
For FKBP-12 titration, solution of 3 pM FKBP-12 (determined with BCA method
section 4.2.1) in 50mMTris, lOOmM NaCl, pH=7.6 was used. Cyp-A solutions of 5 to
0.5 pM in 50mMTris, lOOmM NaCl, pH=7.4 were used. Protein concentration varied
according to the ligand under test. Water soluble ligands were dissolved in the same
buffer as the protein, the water insoluble in ethanol. The ligands tested with FKBP-12
and Cyp-A are given on Table 4.2 and 4.3.
Table 4.2: Figands tested for binding to FKBP-12
Name Ligand Abbrev. Supplier







l-Acetyl-3-methy-l- piperidine ACMPIP Aldrich
Ethyl-1 -Piperidineglyoxylate ETPIPG ACROS
Table 4.3: Ligands testing for binding to Cyp-A
Name Ligand Abbrev. Supplier
Cyclosporin A CsA Sandoz






















The enzymatic reaction of peptidyl prolyl cis-trans isomerase, also known as rotamase
(Fig.4.3) was first described by Fischer and Bang at 1984. It catalyses prolyl
isomerisation in both peptides (Harrison and Stein 1992) and proteins (Fischer and
Bang 1984). The enzymatic reaction of peptidyl prolyl cis-trans isomerase can be used
to characterise immunophilins as well as in testing binding of ligands.
Ala-Pro-Phe




1. Rotamase activity assay
PPIase activity is usually assessed with the a-chymotrypsin-coupled enzymatic assay
(Kofron et al 1991). a-chymotrypsin selectively hydrolyses the C-terminal p-
nitroanilide bond of the substrate in the trans X-Pro conformer only (Fig. 4.3). This
hydrolysis releases a chromophore 4-nitroaniline, the accumulation of which is
recorded by measuring the absorbance at 400 nm as a function of time. The trans
peptide is cleaved within the deadtime so this cleavage does not contribute to the total














Fig. 4.4 : PPIase assay: Cyclophilin catalyses cis-trans isomerisation of the substrate
and chymotrypsin instantaneously cleaves off the C-terminal blocking group (pNA) of
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experiment took place at 4°C. Constant temperature was maintained within the
cuvette by a Peltier (PTP-1) temperature control unit. A mini magnetic stirring
system (telemoduel from Variomag)) was used for mixing the solution in the cuvette
after the addition of the substrate. A Perkin Elmer UV/VIS Lambda 20
spectophotometer was used.
The following materials were used:
Substrate: Suc-Ala-Ala-Pro-pNA (Bachem AG) (N-succinyl-Ala-Ala-Pro-Phe-p-
nitroanilide)
Proteins: Cyp-A, Cyp-B and CypBr purified in house. The protein solution was
freshly prepared before the experiment from frozen stock solution, at the appropriate
concentration (see result section 3.B), by dilution in buffer 50 mM Hepes, 100 mM
NaCl pH=8.0.
50 mg/ml (of a-chymotrypsin (Sigma)
In a typical experiment 90 pi of 2.5-30 nM cyclophilin (plus the inhibitor when the
IC50 has to be determined) was made up to 2520 jxl with buffer A in a 3 ml glass
cuvette. The cuvette then was preincubated for 30 min on ice. Immediately before the
assay, 300 pi of chymotrypsin solution (6 mg/ml in 10 mM HC1) was added,
followed by 90 pi of a 3.7 pM stock solution of Suc-Ala-Ala-Pro-PNA in LiCl
(470mM)/TFE. The reaction progress was monitored by the absorbance change at
400 nm that accompanies the hydrolysis of the amide bond and the release of 4-
nitroaniline product.
2. IC50 determination
The method will be described together with the results section (4.3 B).
The following materials were used:
Substrate: as in rotamase assay
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Proteins: as in rotamase assay.
Table 4.4: Ligands testing for inhibition activity with Cyp-A
Name Ligand Abbrev. Supplier
Cyclosporin A CsA Sandoz
Ala-Pro Ala-Pro SIGMA
Dimethylsulphoxide DMSO BDH
Tetramethylene sulfoxide TMSO ACROS
5,5 Dimethyl-1 -,3-Cyclohexanedione DCH Aldrich
l-Acetyl-3-methy-l- piperidine ACMPIP Aldrich
Ethyl-1 -Piperidineglyoxylate ETPIPG ACROS
Full chemical names and chemical formulas of the inhibitors can be seen in results





A fluorescence assay was the first method used for ligand testing since was simpler
than the PPIase assay, did not require additional substances e.g substrate was used in
the PPIase and the Kd can be determined directly from the data without additional
calculations.
1. FKBP-12
Some of compounds tested during this work have been reported to bind to FKBP-12
(Peter Burkhard Thesis Basel University 1995). The compounds proposed by
Burkhard were tested by fluorescence spectroscopy assay along with other
compounds which were suggested during this work. The suggestions are based on
structural similarities with Burkhard's compounds or on structural similarities with
Ala-Pro which is a substrate for FKBP-12.
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The compounds tested share structural similarities to the natural substrate Ala-Pro or
to DMSO or to 5,5 Dimethyl-1-,3-Cyclohexanedione. 5,5 Dimethyl-1-3-
Cyclohexanedione was suggested to bind to the active site of Cyp-A by the docking
program LIDAEUS. CsA was the first ligand was tested, since it has been observed
to bind to Cyp-A by fluorescence spectroscopy (Handschumacher et al 1984). The
ligands tested by fluorescence spectroscopy are given in Table 4.6.
Table 4.6: Ligands had been tested by fluorescence assay with Cyp-A
Formula Abbrev. Name K<j Comments




























































































The only ligand shown to bind by fluorescence measurements was CsA. Suc-ala-ala-




The rotamase activity assay was performed on three proteins purified in house, Cyp-
A, Cyp-B and CypBr (see chapter 3). The characterisation confirmed that the protein
was enzymatically active. Variation of the amounts of the enzyme used gives a
family of curves in each experiment. The initial velocities were used for the
calculation of the k0bS (for definition of kobS see section 4.3 B 2) according to the
method described by Liu et al (1990). Then the value of kcat/Km was calculated from
k0bs (k0bs=v/[S], where v is the velocity and [S] is the substrate concentration) by
plotting the ratio v/[S] for different protein concentration traces against the respective
protein concentration. A linear plot can be obtained and the slope of the plot is




Three concentrations of Cyp-A were used 22.5 nM, 17.5 nM and 10.0 nM. The
results are shown in Fig 4.5.
PPIase activity of Cyp-A
♦ no CypA ■ Cyp-A (22.5 nM) Cy|>A (17.5 nM) XCyp-A(IOnM)
time (sec)
Fig.4.5: Chymotrypsin-coupled assay of rotamase activity with various amounts of
Cyp-A.
From Fig.4.5 it can be seen that recorded absorbance values for 22.5 nM Cyp-A start
at 0.93 and the reaction is complete when A4oonm=1.2. The fact that the trace with no
protein starts from 0.43 which is only 35.8 % of the end absorbance shows that about
64 % of the substrate was cis at the beginning of the reaction.
A value of kcat/Km=1.2xl07M 1 s"1 for Cyp-A was calculated from the Cyp-A traces




The experiment was repeated with three concentrations of Cyp-B: 21.8 nM, 16.3 nM
and 5.45 nM. The results are shown in Fig 4.6.
PPIase assay for Cyp-B
XNoCypB ■ Cyp-B (21.8 nM) » Cyp-B (16.35 nM) • Cyp-B (S.45 nM)
time (sec)
Fig. 4.6:Chymotrypsin-coupled assay of rotamase activity with various amounts of
Cyp-B purified in house.





The experiment was repeated with three concentrations of BrCyp: 80 nM, 40 nM and
16 nM. The results are shown in Fig 4.7.
PPIase assay of CypBr
X No BrCyp ■ CypBr (80 nM) - CypBr (40 nM) • CypBr (16 nM)
0,2-
0 -I 1 1 1 1 1 H
0 20 40 60 80 100 120
time (sec)
Fig. 4.7: Chymotrypsin-coupled assay of rotamase activity with various amounts of
BrCyp purified in house.
A value of kcat/Km=106M"1 s"1 for BrCyp was calculated from the above result.
2. Determination of IC5o for Cyp-A ligands
The reaction rate at low substrate concentrations where [S]«K,„ can be expressed as
a second-order rate equation (Fersht 1984).




v=velocity of the reaction
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At low substrate concentration [S]«Km the enzyme is largely unbound and [E] ~ [E]t
(Fersht 1984). The method used for the determination of IC50 (Fischer et al 1989, Liu
et al 1990 and Rinfret et al 1994) requires the calculation of k0b$, where
k0bs=(kcat/Km)«[E]. The next step is the calculation of kQbs in the presence of various
amounts of inhibitor.
The method required the determination of kQbS for total inhibition. Total inhibition
means saturation of the protein in the presence of high inhibitor concentration. The
above applied when [S]«Km (Rinfret et al 1994). Many ligands tested in this work
were poorly soluble in aqueous solution. The novel ligands that were found bound
weakly to Cyp-A. Together these two features made it impossible to determine total
inhibition, as many ligands formed precipitates at high concentrations. A different
approach was followed to determine IC50 values.
In general an enzymic reaction can be described by the following scheme:
Ks k ,cat
E+S —*" ES E+P equation 4.3
The dissociation constant of the enzymic-substrate complex is:
Ks=[E][S]/[ES] (equation 4.4) and the velocity of the enzymatic reaction is
v=kcat[ES] (equation 4.5) (Fersht 1984). This equation for the velocity of the
enzymatic reaction can be applied from the beginning till the end of the reaction and
not only in the initial stage. Also the total enzyme concentration [E]T the bound
enzyme concentration [ES] and the free enzyme concentration [E] are related by
[E]= [E]t -[ES] equation 4.6
Thus from equation 4.4
[ES] = [E]t[S]/ Ks+[S] equation 4.7
and from equation 4.5
v=[E]t[S] kcat/ (Ks+[S]) equation 4.8
4.23
Protein Characterisation
At low substrate concentration ([S]«Km) Equation 4.8 becomes:
v=[E][S] kcat/ (Ks+[S]) equation 4.9
For the substrate used in this method a Km=870 [iM has been reported (Kofron et al
1991) for Cyp-A. The substrate concentration in this experimental series was less than
60 pM.
Equation 4.9 applies throughout the enzymatic reaction and not only to the initial rate.
The velocity (equation 4.9) at constant substrate concentration changes linearly with
the free enzyme concentration [E], This means that by performing a series of
experiments varing the protein concentration and keeping the substrate concentration
constant the velocity v should fit to a linear plot.
An example of how the IC50 of CsA was determined follows. The same method was
used to determine the IC50 of the rest of the ligands.
Initially, Cyp-A was assayed at a range of dilutions (Fig. 4.8). The added amount of
substrate was the same in all of this series of assays. This means that at the same
absorbance, the substrate concentration is the same for each curve. Absorbance




♦ no protein "CypA (!5nM) * CypA <12,5nM) XCypA (lOnM) *CypA (5nM) 4CypA (2,5nM)
time (sec)
Fig. 4.8 : PPIase assay with various amounts of Cyp-A. Sample (♦) nonenzymatic
thermal isomerisation.
The substrate concentration during the time used for the calculation of the slope (Fig.
4.9) changes less than 3 % (A4oo= 0.762 to 0.776 Fig. 4.9) and the assumption that
substrate concentration is constant can be made. During that time the absorbance
changes linearly with time and the points fit very well to the equation y=a»x+b where
y is absorbance and x is the time, "a" is the slope of the equation and has dimensions
y/x which is equal to the rate of the change of absorbance d(Abs)/dt (velocity).
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■ CypA (15nM) » CypA (12,5nM) XCypA(IOnM) «CypA (5nM) +CypA(2,5nM)
X x-MD.l x-»0.2 x-tO.3 x+0.4 x-iO.5 x-tO.6
time (sec)
Fig. 4.9: Expression of readings at absorbance units around 0.76 from Fig.4.8.
The time at which the slope of each curve is determined (point x) is different for each
of the above curves. X corresponds to 1.5 sec, 2.3 sec, 2.5 sec, 14.8 sec and 41.8 sec
for Cyp 15nM, 12.5nM, lOnM, 5nM and 2.5nM respectively.
Using the least square method, each series of points in Fig. 4.9 is fitted to a linear
equation.
15 nM. Abs=0.0481t+ 0.7614
15nMA Abs=0.037t+ 0.7612
10 nM x Abs=0.0298t+ 0.763
5 nM • Abs=0.0128t+ 0.7601
2.5 nM + Abs=0.0062t+ 0.7607
By plotting the slopes of the above equation against the respective protein
concentrations the relationship between protein concentration and velocity can be
found (Fig. 4.10). The X axis is [P] (free protein concentration). Using Fig.4.10 the



















Fig. 4.10: Protein concentration plotted against velocity (v)
Under the conditions of this experiment ([S]«KM) the velocity reduces to a second
order rate equation v= ([S]kcal/Ks+[S])[E] (equation 4.9). With constant [S] (since
the velocities are all calculated at the same absorbance of 0.76) the previous equation
reduces to a first order rate equation v=K[P] when K=[S]kcat/(Ks+[S]). The calculated
velocities of the reaction should therefore be proportional to the protein concentration
as can be seen in Fig.4.10.
The same assay protocol was followed except that various amounts of ligand CsA (5-
40 nM) were added. The protein concentration was 15 nM. Upon addition of ligand
the free protein concentration [E] was decreased so the velocity of the reaction v. The
results are presented in Fig.4.11 from which it can be seen that inhibition of the
reaction follows the addition of CsA.





+Noptrotein » CsA (5 nM) xCsA (10 nM) ©CsA (20 nM) +CsA (40nM) OCsA (60 nM) aCypA(15nM)
time (sec)
Fig. 4.11: PPIase assay with various amounts of CsA. Sample (♦) contains protein
only.
The absorbance readings around 0.76 Abs units of each curve in Fig. 4.11 were used
for the determination of velocity. Using the least square method each series of points
in Fig. 4.12 conform to a linear equation.
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■Cyp-A (15nM) *CsA (SrM) XCsA (10rM) QCsA (20 rM) -t-CsA (40rM) QCsA (60rM)
time (sec)
Fig. 4.12: Readings at absorbance units around 0.76 from Fig.4.11. The observed
change (point x) in Fig.4.9 is different for each of the above time curves. X
corresponds to the time point at which CyplSnM, CsA 5nM, CsA lOnM, CsA 20nM,
CsA 40nM and CsA 60nM, CsA 5nM, have an absorbance of 0.762 in Fig.4.6.
15 nM. Abs=0.0481t+ 0.7614
5nM4 Abs=0.0267t+ 0.7558
10 nM x Abs=0.0175t+ 0.7545
20 nM. Abs=0.0134t+ 0.7557
40 nM + Abs=0.0105t+ 0.7553
60 nM □ Abs=0.0088t+ 0.7552
By plotting the slopes of the above equation against the respective protein




V ptotted against CsA concentration
CsA (nM)
Fig. 4.13: Plot of velocity of enzymatic cis-trans isomerisation against CsA
concentration.
Using Fig.4.8 the ligand concentration corresponding to velocity in the range 8800 to
48000 can be determined graphically. From Fig.4.11 it can be found that for
velocity=22000 the free [E] is 7.5 nM. Using Fig.4.8 the CsA concentration at which
velocity=22, is around 9 nM. Also [E]T = [E] + [EL], [E]T is the total protein
concentration which is 15 nM, and the [E] is the free protein concentration. This
means that the concentration of the CsA in which half inhibition occurs is 9 nM. CsA
was the only ligand which was shown to bind by both assays (fluorescence and




Table 4.7: IC50 values for inhibitors of CypA is determined by PPIase assay




























3. Determination of Kd
The concentration of the free protein [P] after the addition of the inhibitor for low
substrate concentrations ([S]«Km) can be calculated after determination of the
velocity according to the method previously described (section 4.3.B.2). The bound
protein concentration [EL] after addition of the inhibitor L, is [PL]=[L]T-[L] (where
[L]t= total inhibitor concentration). The free inhibitor concentration [L]= [L]T-[PL].
The dissociation constant of an inhibitor can be determined by replacing the above




When an inhibitor binds weakly a high concentration of the inhibitor is required in
order to achieve 50% inhibition (in this work under weak inhibitors the concentration
[L]t was 106 times higher than the total protein concentration [P]t at half maximal
inhibition). The free inhibitor concentration to give half inhibition, [LJicso, is much
higher than the bound [PL] ([PL]=1/2[P]T at half inhibition). With such an excess of
ligand, the assumption [L]ic5o=[L] ~ [L]T can be made. At the point at which half
maximal inhibition occurs [PL]= [P] and equation 4.10 reduces to Kd=[L]T .
Using equation 4.10 the Kd for the CsA can be calculated. From section 4.3.B.2 the
total concentration of the CsA in which half inhibition occurred is 9 nM (Fig. 4.8),
the free [E] is 7.5 nM and the concentration of E-CsA protein concentration is also
7.5 nM which means that the free inhibitor concentration is 2.5 nM. Replacing these
values in equation 4.10, the calculated Kd is 2.5 nM. This value is the same as that





The BCA assay depends on the number of peptide bonds of the protein rather than
individual amino acid residues. Therefore, the method is independent of the standard
samples and was used wherever an accurate estimate of the concentration was
required, for example calculation of IQ.
Bradford results are more dependent upon the standard, but it was the method of
choice when a quick result was required (e.g eluted sample from chromatography).
The difference between the Absorbance Coefficients obtained by BCA and Bradford
method (Table 4.1) reflected the fact that each method in based on a different
principle for determination of the concentration.
The Bradford protein assay has been reported to overestimate the actual quantity of
FKBP-12 by 3-fold (Siekierka et al 1989) and of Cyp-A by 1.7-fold (Harding et al
1985). The above overestimates fit with the observed values for FKBP-12 and Cyp-
A. It can be seen that Absorbance Coefficients, which are inversely proportional to
concentration, are much lower when calculated using the Bradford assay.
B) Fluorescence spectroscopy
The value of IQ calculated from fluorescence results for CypA-CsA was similar to
that reported in the literature (Husi and Zurini 1994 Table 4.6) and the same was true
for the Kd of FKBP12-PRG (Table 4.5). The determination of Kd values similar to
those already published suggests that the method and the procedure were correct.
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The lack of results from fluorescence titration of Cyp-A with small ligands could be
explained by structural results. Many ligands found to bind in the active site of Cyp-
A by X-ray crystallography showed no effect when tested in fluorescence. The
measurement of ligand binding by fluorescence spectroscopy requires that the optical
properties of the protein-ligand complex differ from those of the free ligand and free
protein (Bagshaw and Harris 1987). The optical properties of Trp would change
when the surrounding environment of Trp changes. This environment is solvent
molecules or residues which make contact with Trp. In fact the only compound
which clearly gave results in the fluorescence assay was CsA. Cyclophilin's
tryptophan residue makes a hydrogen bond with CsA. None of the other ligands used
during this work make contact with the tryptophan. Also the tryptophan and the
residues with which it comes into contact remain practically unchanged on binding.
All the ligands used in the current work apparently do not effect the Trp environment
when they bind.
C) PPIase assay
The method introduced for the determination of IC5o is based on the determination of
velocity of the enzymatic reaction for a series of protein dilutions not at t=0 but at the
same substrate concentration. The reproducibility of the method is highly dependent
on the protein and the substrate concentration. The determined velocity of the
reaction depends on protein and substrate concentration (section 4.3.B.2) so accurate
determination of substrate and protein concentration is required. The substrate
concentration can be easily determined by the absorbance during the experiment. The
protein concentration could be determined accurately but the amount of active
protein could not be determined. As active protein concentration is involved in the
calculation of IC50 the protein solution should be freshly prepared before the
experiment (to prevent any denaturation).
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The enzymatic results for Cyp-A, Cyp-B and BrCyp confirmed that all the proteins
are active. The kcat/Km values found during this work are similar to those reported in
the literature. The activity of Cyp-A (kcat/Km=1.2xl07M~' s"1) is similar to that
reported by Liu et al (1990) for the same protein (kcat/Km= 1.37x107M~1 s"1). Also the
activity of BrCyp (kcat/Km=lxl06M"1 s"1) is close to that reported by Page et al (1995)
for the same protein (kcat/Km=7.9xl06M~1 s"1). Cyp-A seems to have the highest
activity of all.
The enzymic assay was used mainly because no results were obtained from
fluorescence titration or dynamic light scattering, for Cyp-A and small ligands. The
ligands used during this work are relatively small compounds, from 4 up to 13 atoms
(non-hydrogen). Also the natural substrate Ala-Pro has a similar size (13 atoms). It
was expected this dipeptide would act as an alternate substrate inhibitor (Harrison
and Stein 1990) and an attempt was made to determine its dissociation constant.
Even after clear evidence that this dipeptide bound in the active site of Cyp-A (Ke et
al 1993) the binding affinity of this dipeptide has not been reported. The only
indication was given by Harrison and Stein (1990) who placed a conservative lower
limit on K; of 20 mM. The same applied to all other oligopeptide-cyclophilin
complexes which have been studied by X-ray (Zhao and Ke 1996). The Kd of 18 mM
found during this work was very close to the value suggested by Harrison and Stein.
The Kd was calculated using the total concentration of the Ala-Pro in the solution (cis
and trans isomers) since was not able to determine the concentration of each
individual isomer.
All non-peptide ligands found during this work bound with similar strength (Kd
values 22-35 mM) except AMPIP (Kd 335 mM). ETPIPG and ACMPEPG are very
similar molecules and both fit the same way into the binding site (crystallographic
results), nevertheless their Kd values are significantly different. Further investigation





Crystal growth is perhaps the most crucial step in protein crystallography. There is
no clear way to predict the conditions that will cause protein crystallization which
can be one of the most time consuming steps in protein crystallography. Many
different methods to crystallize proteins have been developed like vapour diffusion
and dialysis methods (Ducruix, A. and Giege, R., 1990), all of which aim at bringing
the solution of protein to a supersaturated state.
Several techniques have been developed to improve the quality of the crystal as well
as the size. Screening procedures (McPherson 1985) are the most common. The
screening first starts with crystallization conditions to obtain the first crystal and then
optimisation of these conditions to improve crystal size and quality. Also seeding has
often been used as a method to improve size and quality. Seeding requires crystals as
a starting point to generate nuclation. This has often been used as a method of last
resort rather than a standard practice for crystal growth. There are three different
methods, streak seeding , macroseeding and microseeding (McRee, 1993). The streak
seeding can be used to carry out a search quickly over a wide range of growth
conditions and later the use ofmacro and micro seeding could be used to grow larger
crystals with good degree of reproducibility.
Re-chromatography has also been proposed (Ducruix, A. and Giege, R., 1990) before
crystallization trials in order to increase the chance for crystal growth. Trace
contaminants and denaturate forms, which are not detectable by SDS-gels, of the




The quality of the crystals affects the resolution, survival during fast freezing, and
the time of survival in soaking solution as well as crystal parameters like mosaicity.
The size of the crystal can also affect the resolution, larger crystals tend to diffract
better but on the other hand tend to crack during flash freezing.
5.2 Methods and Materials
A) Proteins
1. Cyp-A
Cyp-A was obtained from two different sources. Initial protein kindly provided by
Sandoz and later on when the cell line for this protein was available the protein was
produced and purified in house.
2. Cyp-B
Cyp-B was obtained from two different sources. Initial protein kindly provided by
Sandoz and later on when the cell line for this protein was available the protein was
produced and purified in house.
3. BrCyp
BrCyp was obtained from two different sources. Initial protein kindly provided by Dr
Page (Glasgow University). Also was provided as fusion protein (from the same




FKBP-12 was obtained from two different sources. Initial protein provided by
Sandoz and later on from Dr. Villafranca (Agouron pharmaceuticals INC USA).
B) Crystallization and crystal handling
1. Crystallization by vapour diffusion
The principle of vapour diffusion crystallization is that a droplet containing protein,
buffer, crystallizing agent, and additives, is equilibrated against a reservoir (mother
liquor) containing a solution of crystallizing agent at higher concentration than the
droplet. Equilibration takes place by diffusion of the volatile contents (water or
organic substance) until vapour pressure in the droplet reaches that of the reservoir.
The hanging drop technique was used in all crystallization experiments in this work.
A 1:1 ratio between the mother liquor and the protein solution was used to set up the
drop. The volume of the reservoir was 0.5 or 1 ml and the droplet between 2 to 10 |il.
Commercially available Linbro boxes are used in all experiments for crystallization.
2. Screening
Three different approach have been used
1. Screening with common precipitants like PEG (polyethylene glycol) 4000 PEG
8000 and AS (ammonium sulphate).
2. Published conditions
3. Using Hampton Research screening solutions. Crystal screen formulation kit
(Jancarik & Kim 1991) and crystal screen 2 formulation kit (Cudney et al 1994)
were used. The protocols utilized in these two kits evaluates 98 unique
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combinations of pH, additives, precipitant.
The initial drop volume was usually 2pl (or even less when not much protein was
available). Once crystallization conditions were found, the drop size was increased (6
to 10 pi) to obtain larger crystals.
3. Seeding
A seed crystal provides the nucleation for the assembly of molecules to form a
crystal with the same characteristics as the crystal from which the seed originated.
Streak seeding was performed with a glass needle. The end of the needle was used to
touch an existing crystal and dislodge seeds from it. A glass needle was then used
immediately to introduce seeds into several (3 to 5) other pre-equilibrated drops by
running the probe across the drops.
In macroseeding a single crystal, which was free from twinning or any other
crystallites, was picked up into a glass capillary. The crystal then was washed in
mother liquor twice to insure that any microseeds or unwanted nuclei has been





A native, well diffracting crystal is introduced to a solution containing the
appropriate ligand concentration.
There are three requirements for this operation.
• The crystal can stand in the soaking solution without cracking or dissolving
• The ligand should be small enough to go through solvent channels in the crystal
lattice and access the active site.
• The binding site is unoccupied.
The soaking technique has the advantage of reducing the complexity of the
crystallographic problem to that of determining the position of the newly introduced
atoms by difference Fourier methods. Also screening for crystallization conditions
for the protein-ligand complex is not required unlike co-crystallization.
A) Soaking ligands into Cyp-A crystals
The crystal was picked up using a glass capillary (0.3-0.5 mm diameter). As the
crystals were grown in presence of DMSO, which binds in the active site of the
protein (see chapter 5), the DMSO was soaked out before any soaking experiment. In
a typical experiment a single crystal of CyP-A was soaked for 30 min in a solution
which was the same as the precipitating solution in the well but less DMSO (4 %
v/v) and including 5 mM ligand (substance). This soaking procedure was repeated a
total of 6 times. In each soaking step the DMSO concentration was decreased
eventually to 0 % (v/v) and the ligand concentration was gradually increased to the
maximum allowed by solubility.
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The crystal was soaked for approximately 30 min in each step. For example when
ACMPIP ligand (see Table 5.3) was soaked into a Cyp-A crystal the soaking took
place in six steps as follows:
Steps Time of Soaking Solution (mM)
soaking in Concentration of ACMPIP DMSO
hours
1 0.5 5 560
2 0.5 10 230
3 0.5 20 100
4 0.5 40 40
5 0.5 100 20
6 1.5 150 0
Final solution
The time in the final solution (DMSO 0 %) ranged from 30 min to 2 days and
depended on how well the crystal behaved in the soaking conditions. The ligand
concentrations ranged between 40mM and 400mM.
Finally the crystal was soaked in cryoprotectant solution before mounting. The
ligand concentration was kept the same in cryoprotectant solution as in its final
soaking solution in order to eliminate any chance of the ligand being washed out
(despite the fact that the crystal was soaked in cryoprotectant solution only for couple
of seconds). The cryoprotectant solution had the same composition as the final
soaking solution plus glycerol (see chapter 5 Table 5.1). All ligand complexes in this




B) Soaking ligands into FKBP-12 crystals
The same procedure for the cyclophilin crystals was followed with FKBP-12
crystals.
C) Soaking ligands into BrCyp crystals
Since the BrCyp binding site is occupied only by water two soaking steps were used
which gradually increased the concentration of the ligand to 200 mM.
5. Co-crystallization
The size and the configuration of the channels within the crystalline lattice determine
the maximum size of the solute molecules that may diffuse into the crystal. In the
case where a complex with a relatively 'big' molecule is required, co-crystallisation
is the only method to obtain it.
In co-crystallization, the formation of the complex does not have to contend with
lattice forces, but the solubility and the conformation of the complex may be
sufficiently different from that of the native molecule to prevent the formation of
isomorphous crystals. As a result, the conditions for crystal growth of a protein-
ligand complex need not necessarily be the same as the native one and screening of
crystallization conditions is indispensable. This was the main reason that the method
was not used as much as soaking in order to make protein-ligand complexes.
Nevertheless complexes can however grow crystals that are isomorphous with the
native crystals (Stura et al 1987). The conditions in which native Cyp-A, FKBP-12




In the co-crystallization of protein ligand complexes, the droplet contains
additionally a ligand which binds, or is expected to bind, to the protein. The ligand
concentration in the drop was 3 times more than the K<j value. If the ligand is volatile
the mother liquor contains the ligand in a concentration double that in the drop. If the
IQ was unknown then a concentration in the range of mM was used, provided the
ligand was sufficiently soluble. If the ligand could not be dissolved to mM
concentration then a saturated solution was used.
5.3 Results
TABLE 5.1 Crystals forms of FKBP, Cyp-A, and BrCyp
Protein FKBP-12 Cyp-A BrCyp
Precipitants AS PEG8000 PEG4000 AS
Buffer pH Tris pH 8.0 Tris pH 8.0 Tris pH 7.4 imidazole pH 6.5
Space group C2 P212,2, P3A2. P4j2i2.
a, b, c (A) 102.7, 36.4 55.7 36.2, 57.6, 70.2 88.9, 88.9, 106.4 58.1,58.1, 141.7
a, (3, y (deg) 90, 96.2, 90 90, 90, 90 90, 90, 120 90, 90, 90
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1. Crystallization of native cyclophilin A, cyclophilin B, FKBP-12 in forms
suitable for soaking experiments with novel ligands
A) Cyclophilin A
1. Crystallization
The vapour diffusion method was used to grow crystals of CyP A (Ducruix and
Giege, 1990). The precipitating solution in the well consisted of lOOmM Tris HC1
(pH 8.0), 19 %(w/v) PEG 8000, 5%(v/v) DMSO, 0.02% NaN3. The hanging drop
consisted of 50mM Tris HC1 (pH 8.0), 9.5%(w/v) PEG 8000, 2.50% DMSO, 40 mM
NaCl, 0.02% NaN3j and 8.9mg/ml cyclophilin (Mikol, et al. 1993). The 1 ml
precipitating solution was prepared by addition of 100 pi of Tris E1C1 1 M (pH 8.0),
475 pi of 40 % (w/v) PEG 8000, 50 pi 100 % DMSO and 375 pi 0.02% (w/v) NaN3.
The initial 4pl drop consisted of 2 pi of the precipitant solution plus 2 pi of 17.8
mg/ml cyclophilin in 80 mM NaCl, Hepes 20 mM pEl (7.4).
With the above conditions, crystals only grow at 25°C in in the drop solution (Mikol
and Due 1994). However our procedure (without the presence of CsA) yielded large,
well formed, orthorhombic single crystals of native CyP A at 17 °C with dimensions
of about 0.4mm x 0.2mm x 0.2mm (Fig 5.1 A to D). The drops that did not give
crystals after 10 days were seeded by streak seeding which was found to give single
crystals suitable for data collection but not reproducibly. By increasing the hanging
drop size from 4 pi to 8 pi the crystal dimension could be increased to about 0.65
mm x 0.25 mm x 0.25 mm (Fig.5.1). The cell dimensions are a=36.2 A, b=57.6 A
,c=70.2 A, the space group is P2i2j2i.
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Fig 5.1: Improvement of quality and size in Cyp-A crystal during this work.
Crystallization conditions shown in Table 5.2.
TABLE 5.2 Crystallization conditions for crystals shown in Figure 5.1. All
crystal grow in 6, at 17 °C, Tris 100 mM pH 8.0, 2.5 % v/v DMSO, 40 mM NaCl and
7.8 protein and in PEG 8000 from 9.5 % to 11.5 % w/v as shown below.
Crystal Protein (mg/ml) Drop size (|il) PEG 8000 (w/v)
A 7.8 6 9.5
B 7.8 6 11.5
C 7.8 6 10.5
D 11 8 11
2. Co-crystallization
Co-crystallization was also used as a technique for crystallizing Cyp A/ligand
complexes when large ligands were employed. The two novel ligands were N-CBZ-
Ala- Pro (43 atoms MW=320) and N-Benzoyl-Phe-Ala-Pro (59 atoms MW=437.5).
The crystallization conditions were the same as the native plus 1 mM N-CBZ-Ala-
Pro or N-Benzoyl-Phe-Ala-Pro in the drop solution.
The above co-crystallization experiments however did not yield any crystals even





The hanging drop method was used to grow crystal of CyP B (Ducruix and Giegd,
1990). The reported (Mikol, et al, 1994) conditions were used to grow crystal of
CypB/CsA. The precipitating solution in the well consisted of lOOmM Tris HC1 (pH
8.0), 16 to 14 % (w/v) PEG 8000, 4 to 2%(v/v) DMSO, 0.02% NaN3. The initial 4pl
drop consisted of 50mM Tris HC1 (pH 8.0), 8 to 9%(w/v) PEG 8000, 1 to 2 %
DMSO, 0.02% NaN3. and 8.9 mg/ml cyclophilin B. The 1 ml precipitating solution
was prepared by addition of 100 pi of Tris HC11 M (pH 8.0), 375 pi to 400 pi of 40
% (w/v) PEG 8000, 40 pi 100 % DMSO and the volume made up to 1 ml with 0.02%
(w/v) NaN3 solution. The initial 6pl drop made up of 3 pi of lOOmM Tris HC1 (pH
8.0), 16 to 14 % (w/v) PEG 8000, in 0.02% NaN3 solution plus 3 pi of 17.8 mg/ml
cyclophilin, 0.5 mM CsA in 4% DMSO and Hepes 20 mM pH (7.4).
Crystals of CypB/CsA grew in the above conditions and were used for seeding.
Seeding, however did not yield any crystals. A number of other crystallization trials
were used, including screening in different PEG 8000 concentrations 14 to 25% w/v,
pH from 7,4 to 8,2 and the variation of DMSO from 5 to 7% v/v. The crystal screen
from Hamilton Research, containing fifty unique reagents, did not yield any crystals.
C) FKBP-12
1. Crystallization
The crystallization conditions for FKBP-12 were adopted from Burkhard, P., Ph.D
Thesis (1995). The precipitating solution in the well consisted of lOOmM Tris HC1
(pH 8.0), 58 to 61% (w/v) ASsat, 4 %(v/v) DMSO, 0.02% NaN3. The initial 4pl drop
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consisted of 50mM Tris HC1 (pH 8.0), 29 to 30.5%(w/v) ASsa«, 2% DMSO, 0.02%
NaN3 and 7 to 9 mg/rnl FKBP-12. The 1 ml precipitating solution was prepared by
addition of 100 pi of Tris HC11 M (pH 8.0), 580 pi to 610 pi of ASsat, 40 pi 100 %
DMSO and the volume made up to 1 ml with 0.02% (w/v) NaN3 solution. The initial
6 pi drop consisted of 2 pi of the precipitant solution plus 2 pi of 14 to 18 mg/ml
FKBP-12 in 0.02% (w/v) NaN3.
Crystals grew within a week. This procedure yielded large, well formed crystals with
space group C2 and dimensions of about 0.8mm x 0.22mm x 0.22mm. Increasing the
size of the hanging drop from 6 pi to 10 pi gave crystal dimensions of about 1.0mm
x 0.25mm x 0.25mm. The drops which did not grow crystals after 4 days were
seeded by streak seeding but the technique produced only small crystals.
Macroseeding was however successful. A singe crystal (0.6mm x 0.2mm x 0.2mm)
was transferred to another pre-equilibrated drop and the crystal size increased to
1.22mm x 0.25mm.
During the course of this work, other reported conditions for the growth of FKBP-
12/ligands crystals were tried out. Screening took place in sodium citrate-cocodylate
conditions (Tatlock et al 1995) and ammonium sulfate-hexanedion (Babine et al
1995). The above co-crystallization experiments did not however yield any crystals





^ ^ 0.1 mm
Fig 5.3. Crystal of FKBP-12 grew after macroseeing
2. Soaking
Cyclooctanone was shown to bind to FKBP by fluorescence studies (Burkhard, P.,
Ph.D Thesis). This ligand was added to a hanging drop containing crystals of FKBP
to a concentration of 7.6 mM (maximum solubility). A single crystal (0.85mm x
0.22mm x 0.22mm) from this drop was selected after 2 hours. After 2 hours soaking,
the crystals developed cracks. After two unsuccessful experiments it was decided
that the soaking technique must be divided in two parts i) soaking in the same
solution as the original drop but without DMSO (in order to remove DMSO from the
crystal) and ii) soaking again in a new solution containing no DMSO, and 7.6mM
cyclooctanone.
D) Brugia malayi Cyclophilin (BrCyp)
1. Crystallization
Two crystal forms of BrCyp were grown using the hanging drop method.
Trigonal form: The 4 pi hanging drop consisted of 50 mM Tris/HCl at pH 7.4, 6.5
% w/v PEG 4000, 50mM ammonium acetate, 25 mM sodium acetate, 0.02 w/v
NaN3, 0.4 mM BrCyp. The drop was suspended over a well containing lOOmM
Tris/HCl at pH 7.4, 13 % w/v PEG 4000, 100 mM ammonium acetate, 50mM
sodium acetate, 0.02 w/v NaN3. The 1 ml precipitating solution was prepared by
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addition of 200 jul of Tris/HCl 0.5 M (pH 7.4), 260 |il of 50 % (w/v) PEG 4000, 100
pi of 1 M ammonium acetate, 50 pi of 1 M sodium acetate and 390 pi of 0.02%
(w/v) NaN3 solution. The initial 6pl drop was made up of 3 pi of well solution plus 3
pi of 0.8 mM BrCyp in Tris 20 mM pH (7.4). The crystals are trigonal with
a=b=88.9 A and c=106.4 A and space group P3i2i2.
0.1 mm
Fig. 5.4: Crystals of BrCyp Trigonal form
Tetragonal form: The 3 pi hanging drop consisted of 50 mM imidazole at pH 6.5,
15% saturated ammonium sulphate, 0.02% w/v NaN3, and 0.38 mM BrCyp. The
drop was suspended over a well containing 100 mM imidazone at pH 6.5, 30 %
saturated ammonium sulphate, 0.02% w/v NaN3. The 1 ml precipitating solution was
prepared by addition of 100 pi of imidazone 1 M (pH 6.5), 300 pi of saturated
ammonium sulphate and 600 pi of 0.02% (w/v) NaN3 solution. The initial 3 pi drop
was made up of 1.5 pi of well solution plus 1.5 pi of 0.76 mM BrCyp in Tris 20 mM
pH (7.4).
The crystals are tetragonal with a=b=57.2 A and c=141.9 A and space group P4i2i2.
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Fig. 5.5. Improvement of quality in BrCyp crystals Tetragonal form.
Crystals in Figure5.5 A grew in a 3 pi drop consisting of 50 raM imidazole at pH 6.5,
15% saturated ammonium sulphate, 0.02% w/v NaN3, and 0.38 mM BrCyp. Crystals
in Figure 5.5 B grew in a 3 pi drop consisting of 50 mM Hepes at pH 7.5, 15%
saturated ammonium sulphate, 0.02% w/v NaN3, and 0.38 mM BrCyp. Crystals in
Figure 5.5 C grew in a 3 pi drop consisting of 50 mM Bis-Tris at pH 6.8, 15%
saturated ammonium sulphate, 0.02% w/v NaN3, and 0.38 mM BrCyp.
2. Soaking
A) Soaking Cyciophilin A crystals
The last soaking step continued for 0.5 to 48 hours depending on how long the
crystal can survive in the soaking solution. The above procedure was necessary
because the DMSO bound in the active site of the Cyp-A. To introduce a new
molecule in this binding site DMSO must first be washed out. The reason that the
procedure was carried out gradually (6 steps) was to keep the ionic strength for each
soaking solution about the same and this helped prevent the crystals from cracking.
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Table 5.3: List of ligands soaked into Cyclophilin A crystals
























5 Cycloheptanone CHPN 0
C*)
500 48
6 1- Acetyl- piperidine ACPIP
ol
800 20
7 3N-PMP 3N-PMP XJ 200 24













B) Soaking FKBP-12 crystals
The same technique as for Cyp-A was used. The soaking in pregnane took place in a
solution containing 5 % v/v ethanol.
Table 5.4: List of ligands soaked into FKBP-12 crystals








1 Cyclohexanone hex 0
A
10 2
Cyclooctanone oct_l 3.5 1
oct_2









C) Soaking BrCyp crystals
The tetragonal crystal form was used. The crystal was transferred from the mother
drop to a soaking solution containing 50 mM imidazole at pH 6.5, 15% saturated
ammonium sulphate, lOOmM ACMPIP (l-Acetyl-3-methyl piperidine) 0.02% w/v





Conditions under which a given protein is likely to crystallize can be found
experimentally. These conditions then can be tested by screening in order to improve
the size and the quality of the crystal. Further improvement can be carried out by
different techniques like streak seeding and macroseeding.
FKBP crystals can be increased in size by macroseeding (Fig.5.3). Also the streak
seeding technique seems to work well for this crystal form. Nevertheless the
particular crystal form did not withstand different environments. As a result a lot of
crystals were lost during soaking experiments. This was one of the reasons for
screening different crystallization conditions.
The macroseeding technique did not seem to work so well for Cyp-A. Streak seeding
worked quite well but not always. This could be explained by the fact that the surface
of old crystals, specially when grown from polyethylene glycol, tends to become
cross-linked (McRee 1993 page 6) and it is difficult to dislodge seeds from it.
The real improvement in crystal quality came after screening around starting
conditions (Fig 5.1). As a result Cyp-A crystals (0.1 x 0.1 x 0.05 mm) collected at the
home source diffracted to 1.7 A (see X-ray diffraction data). Also the quality of the
crystals allowed us to try different ligands at high concentration. This was one of
main reasons for the success of the project. This also relates to the age of the crystal
since old crystals may be more stable due to cross-linking (McRee 1993 page 6). Age
of the protein may be an important factor in the success of cryprotectant experiments
also.
The starting conditions (crystallization results Dl), for BrCyp trigonal form, yielded
good quality crystals (Fig. 5.4). Streak seeding then was used to grow crystals in
equilibrated drops around those conditions. This technique was used for all proteins
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in the current work. Equilibrated drops which did not yield any crystals around the
starting conditions, provided crystals after streak seeding.
The trigonal form of crystals turned into a gel after a period of four months. These
crystals did not diffract any more and were unable to be used for seeding. It has been
reported that light causes free radical chain reactions which cross-link and eventually
destroy the crystal (McRee 1993) specially in polyethylene glycol solution. That was
probably the case in trigonal form of BrCyp since the crystals were exposed to light
and high polyethylene glycol concentration.
The conditions in which made tetragonal BrCyp crystals form were repeated on two
occasions. The first attempt did not yield any crystals while on the second attempt
crystals grew (Fig.5.5 A). The only difference between those two trials, was that the
second time, the protein was used 3 to 4 days after purification. In the first
crystallization trial the protein was used two weeks after purification.
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6. X-ray Diffraction Data
6.1 Introduction
The home X-ray source (rotating anode) was used for most of the data collected
during this work. A number of data sets were collected at the Synchrotron radiation
source in Daresbury. The main advantage of the synchrotron source is, the higher
intensity beam. An image plate was used in all data set as detector device during this
work.
Since X-rays damage crystals, a flash-freezing technique had to be employed. Flash
freezing is the technique of freezing crystals and data collection at cryogenic
temperatures. The main advantages of the technique are minimisation of radiation
damage (increase of lifetime of the crystal), reduction of background scatter (crystals
mounted in capillaries scatter X-rays due to excess mother liquor and glass/quartz),
often an increase in resolution limit (Garman, E. and Schneider, T., 1997) and long-
term storage.
6.2 Material & Methods
1. Data Collection Strategy
High exposure time enables higher resolution data to be collected, but on the other
hand may overload the low resolution data. A compromise between different
parameters has to be made. The approach used was to collect a few images with
different setting parameters and analyse the preliminary data. Two or three images
were processed to determine crystal mosaicity. The parameters changed were size of
the collimator, crystal distance from the detector, exposure time and rotation step
size. The parameters are discussed further in section 2.C.
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Reflections which are measured on different images, are called "partials," in contrast
to reflections fully recorded on a single image. Mosaicity is a measure of the order
within a crystal. The DENZO (Otwinowski 1993) program used for processing the
data can estimate this value using information about partially recorded reflections.
Nevertheless the partially recorded reflections rely on scaling for accurate
determination of the intensity. Therefore the rotation step was chosen such that it was
slightly bigger than the mosaicity of the crystal in order to observe fully recorded
reflections.
2. X-ray source
X-rays for diffraction analysis are typically produced either by a generator
bombarding an anode with electrons from the cathode or by a synchrotron. Data sets
were collected at the home source and at Daresbury SRS (Synchrotron Radiation
Source).
The rotating anode generator is a widely used example of the first type of X-ray
source. When in an evacuated chamber electrons travelling at high speeds from the
cathode hit the outer edge of an fast rotating anode, a continuum of radiation (white
radiation) is emitted due to collison of the electrons with the target. Anodes are made
of metal and an incoming electron can ionise metal atoms of the anode by smashing
through the outer electron shell and expelling an inner shell electron. When an
electron from the outer shell moves to the inner shell to fill the gap, a "characteristic"
radiation is emitted, depending on the initial and the final energy state of the
electron. This radiation is anode material specific and presents itself as a few intense
peaks in the emission spectrum at the wavelengths equivalent to the energy state
difference between which the electron moved. To obtain a monochromatic beam all
wavelengths save one of the characteristic wavelengths are removed by one or more
monochromator crystals and the beam is focused by mirrors. The home source was a
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CuKa rotating anode generator FR571 (Enraf Nonius) of the Department of
Biochemistry (The University of Edinburgh) which emits at 1.5418 A wavelength.
The setup of the generator was as followed:
• The voltage was always set to 40kV
• The current was always set to 80mA
• Bias was 25 to 30 V
• Focal spot size was set to 0.3 x 3 mm
For X-ray diffraction experiments synchrotron radiation is far superior to the
radiation generated by a rotating anode generator. Synchrotron radiation is far more
intense, has a high degree of polarisation, and a wide range of wavelengths can be
selected. It is emitted when very high-energy electrons travelling in an electron
storage ring are accelerated. X-rays are emitted tangentially to the ring as
nanosecond pulses with very high intensity and a continuous spectral distribution.
The desired wavelength can be selected with similar tools as for the rotating anode
radiation. Those data collected in Daresbury SRS came from stations 7.2 and 9.5
which had different wavelength. The wavelength used is given in Tables 6.2, 6.3 and
6.4 for each data set.
3. X-ray Detector
The requirements for X-ray area detectors become more strict when the molecular
weights of the specimen of interest become larger and/or the crystal sizes available
become smaller.
The most fundamental of the requirements for an X-ray area detector are high
detective quantum efficiency, wide dynamic range, linearity of response, high spatial
resolution, large active area and uniformity of response.
Developing technology has allowed fast and accurate data collection using an image
plate. It has been shown experimentally that the image plate meets the above
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requirements for X-ray detector in macromolecular crystallography (Amemiya,
1997).
All data were collected using a MAR 300 image plate (radius: 150mm, pixel size:
150x150pm. The image plate works in the following way:
• X-ray photons cause a chemical change in the plate coating.
• Image plate is scanned with light of a proper wavelength.
• Plate coating releases a fluorescence (due to the previous step) that is detected by
a photomultiplier.
The output of the photomultiplier is amplified and converted to a digital image which
can be processed by a computer. Image plates are erased by exposing to white light
(and be ready for another exposure) so they must be protected from light after
exposure.
4. Cryoprotection and Mounting
Cryoprotectants are employed to prevent the crystallization of water both within the
crystal and within the surrounding solvent during freezing. A large number of
compounds have been used successfully (Rodgers D., 1997) for the cryoprotection of
macromolecular crystals. Glycerol was used in all flash freezing experiments in the
present work. High glycerol concentration prevents formation of ice but can result in
cracking or dissolution of the crystal.
For crystal mounting, a suitable loop (Cryoloops Hampton Research) is first selected.
The size of the loop depends on the size, and the shape of the crystal. Loops were
produced from fine fibres which are supported by a fine wire, which is itself attached
to a steel base. The crystal is picked-up using the loop and transferred to the
cryoprotectant solution where it is held for a few seconds. It is then picked up using
the loop and plunged into liquid nitrogen. Immersed in liquid nitrogen the crystal
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was taken to the mounting device in front of the detector and mounted on the
goniometer head keeping the crystal in a stream of gaseous nitrogen cooled to 100K
by the Cryostream cooler (Oxford Cryosystems).
For data collected at room temperature the crystal was mounted in a glass capillary.
5. Data reduction
The data were processed by the program Denzo (Otwinowski 1993). The program
takes X-ray diffraction data and reduces it to a file containing the hkl index and
background and LP corrected intensity of the spots (Gewirth 1995). The analysis and
reduction of the diffraction data of a single crystal, takes place through seven major
steps (Otwinowski and Minor1997):
• Visualisation and preliminary analysis of the original, unprocessed detector data.
• Indexing of the diffraction pattern.
• Refinement of the crystal and detector parameters.
• Integration of the diffraction maxima.
• Finding the relative scale factors between measurements.
• Precise refinement of crystal parameters using the whole data set.
• Merging and statistical analysis of the measurements related by space-group
symmetry.
A) Visualisation of diffraction image
Before data processing, the first diffraction image is visualised, in order to accurately
check that the detector is correctly positioned, check if spots are overlapping,
measure the spot maxima and view the spot shape. The high resolution limit of
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diffraction can also be estimated. If the spots are overlapping the rotation step may
have to be changed or this indicates a twinned crystal. The spot maxima, should be
always less than the saturation value of the pixels, and the exposure time should be
reduced if they are not. Problems with the detector, spots overlapping and spots
maxima should be discovered and corrected before the whole data set is collected.
B) Indexing of the diffraction pattern
The indexing program requires the crystal detector distance and the rotation step. The
spot size was evaluated, at this stage, to be slightly bigger than the actual reflection
size without overlapping the neighbouring reflection. The background size was
chosen 0.1 mm larger than the spot size.
The indexing starts with a peak search. The peaks found are used for autoindexing
the image. The results of autoindexing is a table containing the 14 Bravais lattices
along with the amount of distortion the unit cell would suffer in order to fit the
lattice. The lattice of higher symmetry and minimal distortion was chosen.
C) Refinement of the crystal and detector parameters
The crystal detector distance, unit cell dimensions, unit cell angles, Bravais lattice,
detector centre respective to the X-ray beam and crystal orientation parameters
determined from the indexing step above are used in this process. At this stage the
crystal and detector parameters were refined in order to get accurate prediction of
spot position and measurement of intensities. Both detector and crystal parameters
can be fitted simultaneously by a fast-converging least squares method which
minimises the deviation of the reflection centroids from their predicted position.
A good estimate of the crystal mosaicity can be evaluated at this stage. If the
mosaicity value in the command file was lower, than that estimated from the
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program, the new higher value was set and the processing program run again. Also if
the number of rejected reflections was high the spot size was re-evaluated in this
stage, in order to minimise this number.
DENZO also integrates the reflection intensity. Strong reflections can be used to
determine profiles which are then applied to weak reflections. The average profile
was fitted to the reflection as closely as possible and the area under the profile was
counted as intensity. The area outside the profile was considered as background. The
background was subtracted from the intensity to get the correct measurement. The
output of the above process is a list of indices (hkl) for each reflection, an unsealed
integrated intensity and an estimated standard deviation for the intensity.
D) Scale and merge of the integrated reflections
The scaling procedure puts all the reflections on the same intensity scale and a
merging procedure finds reflections with symmetry related indices and merges their
intensities together. Scaling and merging of the reflections is done by the program
SCALEPACK. The output values from the SCALEPACK were examined after
each iteration. The %2 values should be close to 1 for all resolution shells. This was
achieved by adjusting the estimated errors in the command file. A value of %2 close
to 1 improves the accuracy of the estimated standard deviations for the intensities.
The mosaicity is determined accurately for each frame. The maximum mosaicity
value was compared with that one used during data processing. If the determined
value, was higher than the one used in the command file in processing program, the
data were processed again using the new value.
A criterion of how well symmetry related reflections merge is the Rmerge number.
Rmerge=£h II " <I> I / Eh III
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I = the intensity of hkl reflection
<I>=average intensity of all reflections with same hkl
An Rmerge < 5 % reflects good data, values from 5 % to 10 % are regarded as
acceptable, values above 10 % required further investigation before use.
SCALEPACK is also used for space group determination when this was not known.
The primary space group of that lattice type determined by DENZO was used first to
scale the data. The next higher symmetry Laue group of the same Bravais lattice
class was used and data scaled again. The %2 output values from the SCALEPACK
was examined after each iteration. The %2 values and the systematic absences of each
candidate space group was used for the determination of the space group. The
candidate space group with the best %2 values and with appropriate systematic
absences was chosen.
6. Ice removal
Crystals which during data collection developed ice were taken off the cryostream,
plunged into liquid nitrogen and then transferred to the cryoprotectant solution,
where they are held for a few seconds. They were then picked up using the loop and
plunged into liquid nitrogen and mounted again. The data collection was continued.
The above technique cleaned the crystal from any ice particles without destroying it.
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7. Data Collection set-up
Size of collimator
The best results can be obtained when the whole crystal volume is illuminated. The
size was chosen according to the largest crystal dimension, which was measured
using a microscope. The size of the slits was varied between 0.1 and 0.4 mm.
Crystal distance from detector
The smaller detector to crystal distance allowed us to collect higher resolution data.
The distance was chosen after visual inspection to be as short as possible to obtain
the maximum resolution. Visual inspection determined the resolution limits and the
distance at which overlap of the spots occurs.
Exposure time
Longer exposure times enable higher resolution data to be collected, but this also
increases the background scatter. The exposure time was chosen depending on the
crystal size, quality, and varied between 20 min to 30 min per rotation step for data
which were collected in house. Data collected at the SRS had exposure times which
varied between 60 to 120 seconds.
Rotation step
If the rotation increases, the spots at some point will start overlapping. This will
affect first the high resolution spots at the edge of the image. The maximum rotation
angle in degrees can be estimated from the formula A(j)=57.3.(d/a) where d is the
resolution limit and a is the cell dimension (Dauter 1997). This formula does not take
into account the effect of crystal mosaicity and beam divergence. Another limit to the
rotation is the amount of background that can be tolerated.
A small step size allows the reflection profile to be determined more exactly (McRee
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1990). The minimum rotation step size was chosen regardless of mosaicity of the
crystal and the available beam time. The rotation step was each time slightly bigger
than the mosaicity of the crystal. The rotation step was from 1° to 2° degrees.
6.3 Results
1. Cryoprotection
High glycerol concentration prevents formation of ice rings but can result in cracking
or dissolution of the crystal. The correct concentration of glycerol for each particular
system was found by trial and error. All the cryoprotectant solutions contained
between 26 and 30 % v/v glycerol. The cryoprotectant solution contained the ligand
in the same concentration as the last soaking solution (see crystallization chapter).
The cryoprotectant solutions were as follows:
Table 6.1: Cryoprotectan solutions used in the current work.
Protein Cryoprotectan solutions
FKBP-12 61% (w/v) ASsat 29 % (v/v) glycerol
ligand in X concentration * 0.02% NaN3
Cyp-A lOOmM Tris HC1 (pH 8.0) 21 %(w/v) PEG 8000
26 % (v/v) glycerol ligand in X concentration * 0.02%
NaN3.
Cyp-B lOOmM Tris HC1 (pH 8.0) 16 %(w/v) PEG 8000
26 % (v/v) glycerol 0.02% NaN3.
BrCyp
(trigonal form)
lOOmM Tris/HCl pH 7.4 13 % w/v PEG 4000
lOOmM ammonium acetate 50mM sodium acetate




100 mM imidazone pH 6.5 30% ASsat 30 % (v/v) glycerol
0.02% w/v NaN3




The following tables contain statistics for the different data sets. In total 45 data sets
have been collected of three different proteins (CypA, FKPB12 and BrCyp). Where
data sets were collected in Daresbury (SRS) the wavelength is given. The low
resolution limits vary from 17 to 24 A. The last column of each of the following
tables contains mosaicity values which were obtained after scaling the data.
A) CypA
All cyclophilin data sets were collected at 100°K except PG data which collected at
room temperature. In total 36 data sets have been collected (Table 6.2), in Daresbury
SRS or in home source and all belonging to space group P2j2i2i. Some data were
collected from the same crystal at the home source and in Daresbury therefore a
comparison between them is more reliable.
DMSO data sets of resolutions 1.8 A, 1.8 A and 1.7 A, were collected from different
crystals. The DMSO data at 1.8 A resolution collected in Daresbury SRS (A=0.9 A)
had a very low Rmerge and relatively high completeness. This data set should be
considered as the best.
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Table 6.2: Statistics for the cyclophilin A data collection. All crystals belong to
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(1.488 A) 71.10 2.0
ETPIPGdl2 68571 17641 Daresbury 36.26 109 3.9 75 0.5°
1.65 A SRS 54.54
(1.488 A) 71.10 1.5
AAMP 92660 13886 home 36.09 120 6 99
oino
1.8 A 56.41 1.25
70.05
ACMPIP 103411 13522 home 36.08 120 5.9 98.7
cino
1.8 A 54.31 1
70.97
PCA 63373 13837 home 36.12 120 9.5 83.2 1.02°
1.8 A 56.30 1.5
70.10
APD 60468 14149 Daresbury 36.36 270 11. 87.1 0.47°
1.8 A SRS 56.87 1.5 1
(0.9 A) 70.39
CAP 129344 14177 home 36.18 120 4.7 99.7 0.37°





120 4.955.07 Q7 1 1.14°
70.93 1.25
27 / . 1
TDD 94720 14523 home 36.26 120 5.0 98.6 0.3°
1.78 A 57.06 1.25
69.89
DCH 141509 14540 home 36.24 120 5.7 94.6 1.02°
1.78 A 57.20 1.5
69.86
ST3567 101747 14024 home 36.23 120 7.9 97.7 0.38°
1.8 A 56.79 1
70.16
DAMC 126301 16511 home 36.17 105 5.0 99.5
cino
1.7 A 56.56 1.25
70.28
TCH 124633 14046 home 36.34 105 7.2 92.9 0.85°
1.8 A 56.58 1.25
70.32
1.86 A 65942 12788 Daresbury 36.28 138 6.1 94.3 0.43°
SRS 56.62 2
(1.488 A) 70.47
ST3267 133583 12043 home 35.98 130 10. 98.1 1.09°
1.7 A 55.77 1.25 2
70.07
HDUR 134190 13975 home 36.22 120 6.9 98.1 0.75°















































































TCH data to 1.8 and 1.86 A from Table 6.2 were collected from the same crystal so
any comparison can be regarded as reliable. Even when the TCH data was collected
on the home source processed and scaled to 1.86 A resolution the Rmerge was 7.0 %
compared to 6.1 % for the synchrotron using all data. Clearly from those data sets,
the one that was collected in Daresbury SRS (1.488 A) was better.
The TCH crystal developed ice during data collection and was taken off and the ice
removal method was performed (see material and method in this chapter). The ice
was removed and the mosaicity was improved after the procedure. The technique
was repeated a further two times during data collection. The reduction of the
mosaicity is given in Table 6.3.
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Table 6.3. Changes of the crystal mosaicity after numbers of flash cooling in TCH
crystal.
Times of flash 1 2 3
cooling
Average 0.85 0.63 0.41
mosaicity
Data set ETPIPG was collected to 2.05 A. The resolution of the data was improved
when the same crystal was collected at Daresbury SRS (A,=1.488 A). Two data sets
were collected, ETPIPGdll (110 degrees rotation) and ETPIPGdl2 (90 degrees
rotation). The first data set in Daresbury (ETPIPGdll) was collected at 2 degrees per
image due to lack of time. Later during data processing it was found that lot of spots
overlaped so another data set was collected (ETPIPGdl2) at 1.5 degrees per image.
Both data sets had low completeness due to ice developing in the crystal. The
completeness, calculated by program SCALEPACK, in resolution zone 1.78 to 1.74
A for example was 89 % for ETPIPGdl2 nevertheless the total completeness was 75
%. The completeness of ETPIPGdll was worse than that of ETPIPGdl2, despite the
fact that 110 degrees data set were collected compared with 90 degrees in
ETPIPGdl2.
Since none of the data collected in Daresbury SRS was complete enough to use for
structure determination, data sets of ETPIPG, ETPIPGdll and ETPIPGdl2 were
merged together using the program Scalepack. The completeness of the merged data
was 90.4 % for the whole data set of 24 to 1.65 A and the Rmerge was 4 % for the




In total five data sets of FKBP-12 crystals have been collected. Data oct_l and oct_2
in Table 6.4 were collected at room temperature. All other FKBP-12 data sets were
collected at 100°K. The Rmerge of the data collected at room temperature appeared to
be worse than those collected at 100°K. The unit cell volume of oct_l was 205519
(A)3 when for hex it was 200631 (A)3.
Table 6.4: Statistics for the FKBP-12 data collection, (see also Table 5.3 in chapter 5





































Four data sets of BrCyp crystal have been collected belonging to two different space
groups (Table 6.5 ). Any comparison of trigonal data sets in Table 6.5 collected at
home and at Daresbury SRS (1.488 A) can be reliable since both came from the same
crystal. The same applied to the tetragonal form. The mosaicity from data sets
collected in Daresbury was lower than that from home for both tetragonal and trigonal




Table 6.5: Statistics for the Cyclophilin Brugia data collections
Crystal Total Unique Source Distance Rmerge Compet. Mosaicity

























From the statistics given in Tables 6.2 it is clear that crystal parameters (Rmerge>
Mosaicity), of the same protein, grown in the same conditions can vary significantly.
Comparison of data sets collected from the same crystal are more similar compared
to those derived from different crystals. Thus only data collected on the home and at
SRS from the same crystal, are compared and discussed in this chapter.
Data sets collected on the home source and at Daresbury SRS of BrCyp crystals
confirms that those collected in Daresbury SRS have better Rmerge and mosaicity
(Table 6.4). The smaller mosaicity reflects the smaller beam divergence of Daresbury
SRS beam. When the mosaicity is low, more spots can be collected in one image
without overlapping. Also the more intense synchrotron beam results in a higher
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intensity of the recorded spots, which affect the accuracy of the measurements.
Accurate measurement of spots gives better Rmerge for the same crystal. The data set
collected on the home source had an Rmerge=10.2 and 9.9, when the SRS data had
Rmerge=9.2 and 6.3 for the tetragonal and the trigonal forms respectively.
In Cyp-A, data sets of TCH (Table 6.2) exhibited better Rmerge values from the data
sets collected in Daresbury SRS. The difference in the mosaicity of the data sets was
partially because of the beam source and also because of the number of flash cooling
cycles (Table 6.3) which took place. At the time which these results were observed
no publication was available about the reduction of mosaicity due to rapid cycles of
thawing and refreezing. The technique was reported for the first time as flash-
annealing technique to improve diffraction limits and lower mosaicity on August of
1998 by Yeh and Hoi (1998). Crystals of glycerol kinase were used by Yeh and Hoi
(1998) for studying the flash-annealing technique. In all of the crystals, resolution
increased by 0.5 A to 0.9 A and mosaicity values decreased by between 0.4° to more
than 1° in the best case. The mosaicity of the Cyp-A crystal decreased by 0.44° after
two freeze-thaw cycles (0.22° after each cycle) tests to check whether increasing the
annealing time and number of the cycles further affected the mosaicity were not
performed. Nevertheless it has been reported by Yeh and Hoi (1998) that optimizing
the timing and the number of freeze-thaw cycles affects the result obtained.
Data sets ETPIPG, ETPIPGdll and ETPIPGdl2 (Table 6.2) were collected from the
same crystal. These data sets are not directly comparable since the number of






Crystals are defined as solids with a regular repeated internal arrangement of atoms
contained in a unit cell. The unit cell is a box defined by width, height and length and
the three interaxial angles. Usually the longest axis is called c and the shortest a. The
angle a is defined as the angle between b and c, (3 as the angle between a and c, and y
as the angle between a and b.
If each unit cell is replaced by a point, disregarding the actual atomic content of the
unit cell, the crystal lattice is formed. The crystal lattice describes the repeated
translations of unit cells in all dimensions to form the crystal. Another way to
consider the crystal lattice is to see it as three intersecting sets of parallel planes. The
three sets of plane can simply be defined by the Miller indices h k 1. The number of
times a set of parallel planes intersects unit cell axis a is the value of h. The value of
k is the number of times this same set intersects b, and 1 is the number of times it
intersect c. The three sets of planes describing the crystal lattice are therefore (1 0 0),
(0 1 0), and (0 0 1).
The crystal structure can also be described in terms of symmetry. The asymmetric
unit is the smallest collection of atoms of a crystal structure from which the complete
structure can be derived, first by use of point group symmetry operations, then by
translational symmetry operations. Point groups are sets of symmetry elements which
leave at least one point of the object, which they are applied to, unmoved. Examples
are rotation axes, inversion centres, and mirror planes, which pass through or lie
within the object.
The structure of a crystal can be determined from X-ray diffraction data. Each
diffraction maximum has associated with it both an amplitude and a phase. The
7.1
Structure Determination
phases are not directly measurable in a typical diffraction experiment and must
therefore be estimated by indirect means. Three different methods can be used for
phase determination, depending on knowledge of the protein structure:
• Multiple isomorphous replacement (MIR)
• Multiple wavelength anomalous diffraction (MAD)
• Molecular replacement (MR)
If nothing is known about the protein structure, the isomorphous replacement or the
multiple wavelength anomalous diffraction method has to be used (Blundell and
Johnson 1976). The MIR method depends on making isomorphous derivative crystals
(with a heavy atom) of the macromolecule under investigation and estimation of
phases from the differences between the amplitudes of native and derivative. The
heavy atoms can be located in the unit cell, using the difference data of the native and
the heavy atom crystals. At least two, and often more, derivatives are required for
successful phase determination.
Isomorphous derivatives are also required for multiple wavelength anomalous
diffraction (Wayne et al 1997) for reliable phase determination. The phase is
determined using anomalous diffraction information which involves the
measurement of diffraction data at different wavelengths and estimation of phases
from the differences between the amplitudes of each wavelength.
When the structure of the protein or a similar structure exists, then the molecular
replacement method (Brtinger 1997) can be used to solve the phase problem. In this
method, the homologous protein structure is fitted into the unit cell of the unknown
structure and the phases are used as an initial guess of the unknown structure phases.
In this work the molecular replacement method was used to determine the structures
of BrCyp and mainly difference Fourier techniques for the structures of Cyp-A and
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FKBP-12. Structures with protein-ligand complexed are isomorphous with the native
and difference Fourier techniques were used to solve the structures. The structure of
BrCyp is homologous to Cyp-A, which was used as a probe during molecular
replacement to solve the BrCyp structure.
The study of protein complex structures with "small molecules"requires high
resolution data. At low resolution the configuration and the conformation of the
ligand can not be determined accurately. Also at low resolution, electron density
from water molecules could be mistaken for ligand density. All the protein complex
structures that have been determined during this work had a resolution better than 1.9
o
A.
7.2 Material & Methods
1. Molecular replacement
A frequent crystallographic proplem arises when a known molecule exists in an
unknown orientation in a crystal. Object A1 (protein target) and A2 a protein model
(model), can be related by six rigid body parameters; three angles of rotation and
three translational components.
In principle the correct position of the model (protein), in the new unit cell can be
found by a trial and error using a six dimensional search. Every orientation and
position of the previous molecule can be used. These positions then can be compared
by calculating R factors.
The R factor is the agreement between the observed and the calculated amplitudes
and can be used for estimating the error in the structure. It is usually the sum of the
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difference between observed structure amplitudes IF(hkl)l0, and calculated structure
amplitudes IF(hkl)lc over the sum of the observed structure amplitudes (Glusker et al
1994).
R=£allhk. ||F(hkl)l0-IF(hkl)lcl/X ali hkl |F(hkl)l0
|F(hkl)l is the structure factor amplitude of the scattered X-ray beam caused by h k 1
set of planes.
If the positions of all atoms in the unit cell are known, e.g. from a model structure
and the asymmetric unit content and spacegroup is known, then the structure factor
amplitudes IFc(hkl)l and the corresponding phase angle ochki can be calculated:
IFc(hkl)l = ( (Zj[fj*cos27t(hXj+kyj+lZj)])2 + (EJ[fi*sin27i(hxJ+kyJ+lzl)])2 )m
othki = tan"'[ Ej[fj*sin2jt(hxj+kyj+lzj)] / Ej[fj*cos27t(hXj+kyj-l-lZj)] ]
fj is the atomic scattering factor which gives the scattering power of an atom of an
element j relative to the scattering power of a single electron modified by a factor
describing the disorder or vibration the atom experiences in the crystal structure.
fj = fj0 * e-Bj(sin20/^
fjo atomic scattering factor for a stationary atom j
A wavelength
0 scattering angle
Bj = 87t2<u2> the displacement paramenter (B-factor)
<u2> isotropic mean square amplitude of atomic vibration
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The Patterson function is
P(uvw) = 1/V*£h2k£i[ IFhkil2 * cos27t(hu + kv + lw) ]
The interatomic vectors which can be identified in the Patterson map (Glusker et al
1994) do not allow a localisation of atoms in the unit cell but the shorter
intramolecular vectors can be used to find all orientations of the model structure in
the unit cell. When the space group of the crystal is taken into account, the results of
the rotation search can be narrowed down to the orientations to be found in the
asymmetric unit.
Using only the longer interatomic vectors of the Patterson map the positions of the
model in the unit cell can be identified in a translation search. The model atom co¬
ordinates thus obtained can then be used to calculate an electron density (Fo) map
(Stout & Jensen):
p(x,y,z) = l/V«Wi[ IFo(hkl)l*e"27ti*(hx + ky + lz "a'hkl)
IFo(hkl)l structure factor amplitudes calculated from the
observed diffraction intensities
a'hki = {tan1 [ Zj[/)*sin27t(hxj+kyj+lzj)] / £jD)*cos27t(hxj+kyj+lzj)]
]}/2tc
Xj,yj,zj co-ordinates of model atom j




A) Adding water molecules
The water molecules can be located using difference Fourier, (Fo-Fc) maps which
will show unaccounted density. The addition should be started with the largest peaks
in the difference map. It is better to avoid adding too many waters too quickly
(McRee 1993). The last place where water molecules were added was the binding
site, and only if the shape of the difference electron density map indicated water
molecules. The potential water molecule should make a hydrogen-bond with the
protein with interatomic distance greater than 2.2 A. The addition of water molecules
was carried out by the program XPLOR (Bruenger 1992) or by SHELX (Sheldrick
and Schneider 1997). Between one half and two ordered water molecules are found
per residue in protein crystal structures (Levitt and Park 1993).
The addition procedure was as follows:
1. Calculation of a difference Fourier map (Fo-Fc)
2. Examination of local maxima with peaks higher than 3o of the main electron
density.
3. Addition of up to 15 water molecules if the electron density peaks were closer
than 4 A to the protein hydrogen bonding atom (N, O) but not closer than 2.2 A.
4. Refinement of position and temperature factor of the new water molecules. If the
temperature factor was higher than 70 A2 the water molecule was removed from the
model.
The occupancies of the water molecules were not refined. The addition of the water
molecules was carried until the free R factor started to increase.
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B) Addition of Ligands
When a ligand has been found to bind to the protein the correct conformation of the
ligand has to be found and modelled into the density contour found for the ligand.
Usually protein crystals do not diffract to such a high resolution and it is useful to
have information about the conformation of the ligand from other sources. The
conformation of small molecules can be found by experimental high resolution data
which have been deposited in the CSD. Databases also were used for searching of
available molecules which share structural similarities with ligands bound in
proteins.
The databases used in the current work are described in chapter 1.
3. Evaluating errors of the model
When a structure has been solved by x-ray crystallography the geometry of the
structure has to be examined. There are geometrical restraints on the possible values
of torsion angles of proteins, so that many combinations are not possible (Glusker et
al 1994). The same is also true for all angles between three atoms and bonds lengths.
The structure must not only have a good R factor but a good geometry compared with
other structures. The program PROCHECK (Laskowsky et al 1993) was used for the
stereochemical parameter evaluation which was derived by Morris et al (1992). 118
protein reference structures were used to derive mean bond length and angle values
with a resolution higher than 2.0 A and an R factor less than 20 %.
A) Ramachandran Plot
The torsion angles of O (torsion angle about the Ca-N bond) and T* (torsion angle
about the Ca-C(=0) bond) can not take all possible values. One evaluation criteria is
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the plot of O against angles for each amino acid to give the Ramachandran Plot.
Only certain combinations of O and angles are allowed. Glycine, which has only a
hydrogen atom as the side chain, has more conformational flexibility, and hence variability
in its torsional parameters. For a good quality model it is expected that 90 % of the residues
have a conformation lying in the most favoured region of the Ramachandran Plot (Fig 7.2).
B) Q, £ and % angles
The co angle describes rotation about the peptide bond C(=0)-N. This angle should be
near 180° for a normal trans peptide or 0° for a cis peptide. The £ angle is a "virtual"
torsion angle of Ca-N-C-CP with a mean value around 34 degrees (Morris et al
1992). The % is the torsion angle of the side chains (x1 is the torsion angle of N-Ca-
Cp-Cy). These are denoted by %' to x" working along the chain away from Ca. The
distribution of these angles are clustered and standard deviations could be calculated
for the same 118 proteins structures (Laskowsky et al 1993). The standard deviations
of the x angles decrease with resolution, whereas standard deviations of co and C,
angles are independent of the resolution (Fig 7.3).
C) Bad contacts and hydrogen bond energies
Bad contacts are defined as contacts where the distance of closest approach violates
the van der Waals close contact criteria (Laskowsky et al 1993). When atoms are very
close, this will give rise to high repulsive forces and this part of the structure should
be re-examined. The hydrogen bond energies were calculated by the Kabsch and
Sander (1983) method. The mean value of hydrogen bond energy is -2.03 (Kcal/mol)






Three dimensional structures have been determined for the unligated human T cell
CyP A (Ke et al., 1991; Ke, 1992) and for CyP A complexed with a pro line-
containing tetrapeptide (Kallen et al., 1991). CyP-A (165 residues) has 64% overall
sequence identity with CyP-B (184 residues) and the overall structures of CyP-B and
ofCyP-A are similar; however significant differences occur in two loops and at the N
and C termini (Mikol et al., 1994).
Human T cell CyP A is a water-soluble protein with a molecular weight of about
18,000 dalton (Harding et al. 1986). The main structural feature is an eight-stranded
antiparallel (3-barrel, which consists of two roughly perpendicular four-stranded
|3-sheets connected by short loops (Fig 7.1). The binding site for CsA is in a cleft on
the surface of the barrel (Pfliigl et al., 1994).
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Fig. 7.1 : X-ray structure of Cyp-A. Residues which interact with CsA are highlighted.
The three-dimensional structures of CsA by NMR showed that the bound CsA has a
trans amide bond between MeLeu 9 and MeLeulO (Fesik et al., 1990; Weber et al,
1991; Fesik et al., 1991), in comparison to cis configuration in the free crystal or in
solution stage (Loosli et al., 1985). However, both structures of CyP A complexed
with Ala-Pro (Ke et al., 1993) or with the tetrapeptide N-acetyl-Ala-Ala-Pro-Ala-
amidomethylcoumarin (Kallen and Walkinshaw, 1992) showed that only the cis form
of the substrate, binds to the enzyme. Both Ala-Pro and N-acetyl-Ala-Ala-Pro-Ala-
amidomethylcoumarin bind to the same site and form either hydrophilic or
hydrophobic interactions with Arg 55, Phe 60, Met 61, Gly 63, Ala 101, Asn 102, Phe
113, and Leu 122 (Ke et al, 1993; Kallen and Walkinshaw, 1992).
The structural comparison between CyPA-CsA and CyP-Ala-Pro suggests that CsA
probably is not a transition state analogue of substrate. Also the two features of
cyclophilin, its abilities to participate in immunosuppression and to catalyse peptidyl-
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prolyl cis<->trans isomerization, are not structurally related and probably functionally
unrelated.
The first non-peptide ligand for Cyp-A was found during this work. All the reported
Cyp-A ligands before this work were peptides (Taylor et al 1997a). Of ligands found
to bind to Cyp-A in this work some share structural similarities with the natural
substrate of Cyp-A, Ala-Pro (piperidine family), another with the immunosuppressive
drug CsA (dimedone) and some (DMSO family) have no similarity with known Cyp-
A ligands.
2. Overview
Crystals grown in PEG8000 and DMSO were used for soaking in all ligands. The
DMSO was soaked out of a crystal and this refined structure is referred to as native.
The native structure was compared with the liganded and to the published structures.
Evidence of ligand binding was the difference map made from the observed data and
the native model.
Six small ligands showed clear electron density in the binding site during refinement.
The rest of the ligands, (see list of ligands soaked into Cyclophilin A crystal in Table
7.2) did not show any electron density in the binding site consistent with a bound
ligand. So all those ligands are not discussed in the current work.
The six novel non-peptide cyclophilin ligands found during this work have been
classified into 3 different families (Table 7.1). 3-Acetyl-l methyl piperidine and ethyl-
piperidine glyoxylate belong to the piperidine family and share structural similarities
with a natural substrate of Cyp-A, the dipeptide Ala-Pro. Dimethyl sulfoxide
(DMSO), tetramethylene sulfoxide and cyclopentanone form the DMSO family and
they do not share any similarities with known Cyp-A ligands. Only one compound has
been discovered in the third family. This compound 5,5-dimethyl-l,3-
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cyclohexanedione also known as dimedone shows some structural similarities with the
Val 11 residue of the Cyp-A ligand cyclosporin.
The refined structures of this work were compared to the published structures of
CypA-CsA complex (lcwa) from Mikol et al (1993), cyclophilin Ala-Pro complex
(lcyh) from Ke et al (1993) and unliganded Cyp-A (2cpl) from Ke (1992). The
stucture of the cyclophilin complex with Ala-Pro (lcyh) has been solved to a
resolution 1.64 A with an R factor of 19.6 %, the Cyp-CsA, complex (lcwa) has been
solved to 2.1 A with an R factor of 16.7 % and the native CypA from Ke et al (2cpl)
to 1.63 A with an R factor of 18 %. The Ala-Pro is a ligand similar in size with most
of the ligands found during this work and is bound in the same active site. The CypA-
CsA complex crystal was crystallized under the same conditions as used during this
work. Also the Cyp-A structure of CypA-CsA complex was the one used initially
during this work as a starting model.
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Table 7.1: Families and members of novel cyclophilin A ligands























The crystal form of Cyp-A in PEG8000 (space group P2i2i2i, see chapter 5 Table
5.1) was used in all crystal structure determinations. Only the first structure solved
during this work (DMSO) required a rotation and translation search and afterward the
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Cyp-A coordinates of this structure were used as a model for the following data sets.
The unit cell dimensions changed slightly from data set to data set and a translation
search was necessary to locate exactly the molecule in the unit cell. Mainly the
refinement was carried out with the program XPLOR and when no reference is given
then XPLOR was used.
The structures of Cyp-A complexes have been solved with R factors less than 19 %
for all of them (Table 7.2). The resolution of all structures is considered as high (<1.9
A) which was essential for accurate determination of the configuration and the
conformation of the ligand.
No sigma cut offs were applied and all the reflections were used for the refinement of
the models except for 10 % of the reflections which were chosen randomly and not
used in the refinement. These reflections were used for calculation of the free R
factor.
Table 7.2: Refinement results for the Cyp-A complex structures
Cyp-A R free R Resolution water
complex factor factor range molecules
Structure per protein
Native 17.4 21.9 1.7-24 A 192
DMSO 17.8 21.3 1.73-24 A 187
TMSO 17.7 26.1 1.88-24 A 266
PNT 18.6 24.3 1.8-24 A 243
ETPIPG 18.8 22.8 1.65-24 A 244
ACMPIP 17.8 23.1 1.8-24 A 189
DCH 18.4 23.6 1.9-24 A 231
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3. Stereochemical quality of CypA-ligand complexes and comparison
The structures refined during this work were compared with published structures
(lcwa, lcyh and 2cpl see above). The <J> and T angles of the above structures can be
seen in Table 7.3. The disallowed residues in the lcwa structure in Table 7.3 belong
to CsA.
Table 7.3: Ramachandran plot values. Numbers show the percentage of O and T
angles found in each region defined in Figure 7.2.










disallowed (%) 1.4 0 0
The root mean square deviation (rmsd) from ideal bond lengths is between 0.006 and
0.007 A and the rmsd from ideal angles is between 1.25° and 1.57° (Table 7.4). The
conformation of the cyclophilin molecules in all the CypA/small-ligand structures are
in general very similar with the native structure. A least squares fit on to the 562 C, N,
Coc and O main chain atoms of residues 2 to 164 of the native (unliganded) structure
was carried out for all CypA/ small-ligand structures (Table 7.5).
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Table 7.4: The root mean square deviation least (rmsd) from ideal bond lengths and
angles for CypA complexes structures






0.007 0.006 0.006 0.007 0.007 0.007 0.007
angles
(rmsd) °
1.321 1.279 1.291 1.567 1.302 1.252 1.306
An overlay of the native CypA (this work) with the lcwa structure on C,N, Cot and O
main chain atoms of residues 2 to 67 and 76 to 164 was also carried out by least
squares fit. The two structures are very similar with a (rmsd) of 0.271 A. The '70
loop" was excluded because it has been reported to show atomic displacements of up
to 1.7 A for main-chain atoms for different cyclophilin structures (Kallen et al 1997).
Table 7.5: rmsd fit of CypA structures. Each structure was fitted onto the native
structure. A least-squares fit was carried out using the Ca, C, N and O atoms of the
main chain of the cyclophilin residues 1 through 164.




0.097 0.314 0.088 0.188 0.175 0.149
A comparison of all cyclophilin structures solved during this work and those selected
from the literature can be seen in Table 7.4. More, than 82 % of the <f> and T angles,
of the structures solved during this work, lay in the most favoured region and the rest
in the additional allowed (Table 7.6). In Fig 7.2 the Ramachandran plot of the








Fig.7.2: Ramachandan plot for Cyp-A complexed with PNT.
Glycine residues shows as a, non-glycine and non-proline residues shows as a
Plot statistics
Residues in the most favoured regions (A, B, C)
Residues in additional allowed regions (a, b, 1, p)
Residues in generously allowed regions (~a, ~b, ~1, ~p)








No generously allowed or disallowed values of <1> and T angles were found for any
structure. The values of <t> and T angles have the same distribution (Table 7.4) for all
structures with the best example the cyclophilin-ETPIPG complex. Comparing the
structures in Table 7.3 with those of Table 7.4, the structures solved during this work
have a comparable geometry with the lcwa structure.
Table 7.6: Ramachandran plot values. Numbers shows the percentage of d> and T
angles found in each region defined in Figure 7.2.
Region Native DMSO TMSO PNT ETPIPG ACMPIP DCH
most
favoured
83.6 84.3 85.1 84.3 85.8 84.3 82.8
additional
allowed
16.4 14.9 16.4 15.7 14.2 15.7 17.2
generously
allowed
0 0 0 0 0 0 0
disallowed 0 0 0 0 0 0 0
The main chain parameter values of refined structures and those from the published
structures are given in Table 7.7. As a representative example of the geometric
parameters of the main chain the CypA-PNT complex is shown (Fig 7.3). The bad
contacts of TMSO and ACMPIP are genuine, due to the alternative conformations
adopted by side chains of residue Glu_69 and Arg_55.
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Table 7.7: Main chain parameter values. The typical value is the value (standard
deviation) for all 118 protein reference structures, lcwa is the CypA-CsA complex,











Typical value 6 RD 3.1 RD
Native 1.5 0 1.3 0.8
DMSO 1.5 0 1.3 0.7
TMSO 1.5 0.5 1.3 0.7
PNT 1.4 0 1.3 0.7
ETPIPG 1.7 0 1.4 0.8
ACMPIP 1.5 0.3 1.3 0.7
DCH 1.5 0 1.3 0.8
lcwa 4.2 8 5.8 0.7
lcyh 4.1 0 0.6 0.7
2cpl 4.3 2.4 0.6 0.7
RD = resolution dependant value (see Fig.7.3).
The bad contact is the contact of the side chain with itself in both cases and not with
another residue. In general the small non-peptide ligand complexes have better
stereochemistry of the main chain parameters than the three reference structures. The
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Fig 7.3: Statistical values of the main chain parameters for Cyp-A complexed with
PNT. The typical value (magenta colour) is the value with band showing standard
deviation for all 118 protein reference structures.
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The quality of the side chains are given as standard deviations of the dihedral angles
X1 and x~ (for definition of x' and X see section 3). The structure of the cyclophilin
PNT complex is shown as a representative example (Fig 7.3) of the structures refined
during this work. In general the seven structures solved during this work have better
stereochemistry of the side chain parameters than the three reference structures.
Table 7.8: Side chain parameter values, lcwa is the CypA-CsA complex, lcpl is the
native and lcyh the CypA complex with Ala-Pro.
Cyp-A complex Chi-1 Chi-1 Chi- Chi-1 Chi-2
Structure gauche trans gauche pooled trans
minus plus
Native 7.7 6.8 9.2 8.3 12.5
DMSO 7.4 9.3 9.7 9.1 10
TMSO 7.9 9.9 10.1 9.5 14.8
PNT 7.8 9.9 10.1 9.5 14.8
ETPIPG 8.2 10.9 9.9 9.9 14.6
ACMPIP 8.0 8.0 8.9 8.7 12.6
DCH 7.6 9.4 11.8 10.1 12.5
lcwa 8.5 12.1 10.5 10.7 14.6
lcyh 8 11.6 12.1 11.0 14.1
2cpl 6.3 10.1 10.5 9.2 14.1
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4. Temperature factor evaluation and comparison
The mean values for the temperature factors of CypA complexes with the small
ligands are summarised in Table 7.9. The temperature factor for the protein molecule
are in the range from 10 A2 to 16 A2 in all small ligand complex structures and
significant higher in the lcyh and 2cpl structures (Table 7.9). This difference in the
overall temperature factors could be an effect of the crystal packing, or the effect of
cooling during data collection, or/and the effect of different refining procedures and
programs.
Table 7.9: Overall temperature factors for CypA complexes (A2), lcwa is the CypA-
CsA complex, lcpl is the native and lcyh the CypA complex with Ala-Pro.
In ETPIPG and TMSO structures the ligand adopts an alternate conformation.
Structure Protein Ligand Solvent
Native 12.83 - 31.26
DMSO 10.85 32.87 23.91
TMSO 11.35 ALT1 37.6
ALT2 49.5
29.23
PNT 15.14 22.79 31.85
ETPIPG 15.93 ALT1 20.21
ALT2 23.27
29.11
ACMPIP 14.35 25.91 30.84
DCH 15.37 27.4 31.36
lcwa 13.11 15.88 29.65
lcyh 26.49 25.47 39.75
2cpl 27.13 - 47.51
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The structure of CypA complexes with the small ligands were refined with the same
program (XPLOR) following the same protocol. The first obvious explanation of the
difference of the average temperature factor of protein atoms between CypA
complexes with the small ligands and lcyh and 2cpl structures is the effect of the
cooling during the data collection (lcyh and 2cpl 293°K, CypA-small ligand 100°K).
The values of VM[A3/Da] for lcyh, 2cpl, lcwa, and DMSO are 2.82, 2.12, 2.08 and
2.01 respectively. According to the above values the DMSO (all the small molecule
CypA complexes have the same packing) has the closest packing followed by lcwa
lcyh and 2cpl. Closer packing causes the atoms to be less mobile. The overall
temperature factor of protein atoms for the above structures ( Table 7.9) follows the
same order was the Vm values.
The binding of a big ligand (lcwa) could be an additional explanation of the difference
between overall temperature factor of protein atoms between lcwa and lcyh and
2cpl. lcwa is the CypA-CsA complex, lcpl is the native and lcyh the CypA complex
with Ala-Pro. The surrounding residues in the liganded structure are less mobile than
the unliganded due to the contacts with the ligand. This is something observed also
during this work (see section 4). Such an effect will be dependent on the size of the
ligand and will be unlikely in a small size ligand (Ala-Pro, lcyh) to have the same
effect as a big ligand (CsA, lcwa structure) in the overall temperature factor of
protein atoms.
The overall temperature factor of protein atoms for the native structure (Table 7.9) is
lower than the DCH complex. Nevertheless the binding site is more rigid due to ligand
binding i.e the overall temperature factor for NH1, NH2, CZ and NE of Arg_55 for
the native structure and DCH are 42.3 A2 and 36.2 A2 respectively. The same effect is
observed in the DMSO structure where again the ligand makes contacts with Arg_55.
The overall temperature factor of protein atoms in the DMSO structure is about 20 %
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lower than the native but the overall temperature factor for NH1, NH2, CZ and NE of
Arg_55 is about 26.9 A2, 60 % lower than the native.
5. Native structure (unliganded)
In the original conditions used to obtain cyclophilin crystals, the binding site was
occupied by DMSO and all crystals used in the current work were crystallized in the
presence of DMSO (crystallization conditions given in chapter 5). By soaking out the
DMSO the binding site should be occupied only by water molecules. The availability
of a good unliganded structure was essential since any indication of side chain
movement and replaced water molecules due to the ligand binding was based on the
comparison of the unliganded and liganded structures.
The coordinates of Cyp-A complexed with DMSO found in this work (R factor 17.8
%) were used as a starting model for a translation search in the native data. All atoms
(except the ligand and the solvent) from the model structure were used in the search
since the homology is 100%.
A translation search using XPLOR (Briinger 1992) was enough to locate the molecule
in the unit cell. Data from 4 to 15 A were used during the translation search. The R
factor for the model generated after the translation search was 33 %. The refinement
proceeded with rigid body refinement as well as positional and individual B-factor
refinement and the R factor dropped to 27 %. At that point the first difference
electron density map (lFo-lFc) was calculated and the binding site was inspected
(Fig. 7.5). The electron density convincingly showed that only water molecules
occupied the binding site and no trace of DMSO was present.
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Fig. 7.5 : Difference electron density map (lFo-lFc) of the water molecules in the
binding site of unliganded Cyp-A. The difference electron density was calculated
before including the water molecules in the model. The water molecules shown in the
figure were taken from the final refined structure.
The refinement procedure was continued with addition of water molecules in cycles.
In each cycle 10 to 15 water molecules were added followed by positional and
temperature factor refinement. 196 water molecules were added in total. The binding
site was occupied by six water molecules (Fig 7.6) W_105, W_106 W_109, W_121,
W_198 and W_208. The water molecules W_121 and W_198 did not show up in the
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first difference electron density map (Fig. 7.5) because they diffracted weakly but as
the model improved their electron density became visible.
Fig. 7.6: Difference electron density map (2Fo-lFc) of the water molecules in the
binding site of unliganded Cyp-A. The water molecules were included in the model
used for the calculation of the phases. The map was contoured only around the water
molecules.
The solvent molecules make a number of contacts with the protein (Fig. 7.7) in the
binding site. Waters 105, 106 and 121 form hydrogen bonds to Asnl02/N,
Gln63/0E1 and Hisl26/NE2 (Table 7.10) respectively.
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Fig. 7.7 : Contacts of solvent molecules in the cyclophilin binding site. The
temperature factors of these six water molecules presented in Table 7.10 are related
to the number of contacts which each water makes and to the location of each water.
Water molecule 105 makes five contacts and has the lowest temperature factor of
12.7 A2 followed by W_106 (four contacts B=24 A2). Further from the binding site
are, W_121 which makes three contacts and has a temperature factor of 34.5 A2and
W_109 which makes two contacts has a temperature factor of 34.8 A2. W_208 and
W_198 are even further than the previous two water molecules from the binding site
and have temperature factors of 60.5 A2 and 63.1 A2 respectively.
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Table 7.10: Contacts of solvent molecules in the binding site with surrounding atoms








12.7 W_105 2.90 Asn_102/N
66 66 3.14 W_107
66 66 2.97 W_198
66 46 3.11 Asn_102/O
46 46 2.83 W_106
24.0 W_106 2.92 Gln_63/0E1
66 66 3.08 Met_61/CE
44 66 3.32 Phe_113/CD1
66 66 2.83 W_105
34.5 W_121 2.86 His_126/NE2
46 66 3.32 W_198
66 66 2.9 W_109
34.8 W_109 2.9 W_121
66 66 2.8 W_93
60.5 W_208 2.6 Arg_55/NH2
66 66 3.11 Arg_55/CZ
66 66 3.12 Gln_63/OE 1
63.1 W_198 2.97 W_105
64 66 3.32 W_121
The temperature factors of these six water molecules present in Table 7.10 are related
to the number of contacts which each water makes and to the location which each
water has. W_105 and W_106 are deep inside the binding pocket and form hydrogen
7.28
Structure Determination
bonds with the protein as well as other contacts (Fig. 7.7). This makes them more
rigid. As a result of this the temperature factor of those waters is lower than for
W_198, W_121, W_109 and W_208 (Table 7.10).
Water molecule 105 makes five contacts and has the lowest temperature factor of
12.7 A2 followed by W_106 (four contacts B=24 A2). Further out of the binding site
are, W_121 which makes three contacts and has a temperature factor of 34.5 A2and
W_109 which makes two contacts has a temperature factor of 34.8 A2. W_208 and
W_198 are even further than the previous two water molecules from the binding site
and have temperature factors of 60.5 A2 and 63.1 A2 respectively. Also the contact
atoms ofW_208 have high temperature factors, 44.7 A2 and 41.1 A2 for NH1 and CZ
atoms of Arg 55 respectively.
Water molecules 198 and 109 do not make any contact with protein residues but only
with other water molecules in the binding site (W_105, W_106 and W_121). Those
water molecules could be replaced by hydrophilic or hydrophobic atoms depending
upon the nature of the substitution replacement seen in the neighbouring water
molecule. The water molecules which form hydrogen bonds (W_105, W_106 and
W_121) are more likely to be replaced by hydrophilic atoms.
The native structure ofCyp-A, refined during this work was compared with the native
CypA structure (2cpl) from Ke (1992). An overlay of the two structures has an rmsd
fit of 1.68 A for the main chain atoms (Fig. 7.7A). Water molecules 198, 106, 121
and 109 were not observed in the 2cpl structure (Fig. 1.1A).
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Fig. 7.7A: Overlay of native CypA (this work, with data sets collected at 100 K°)
with the 2cpl (Ke 1992) native structure (data sets collected at room temperature).
The 2cpl structure is in green. The two structures have an rmsd fit of 1.68 A for the
main chain atoms. Water molecules 198, 106, 121 and 109 were not observed in the
2cpl structure
An inspection of the binding (Fig. 7.7A) shows that the side chains of Gin 63, Met 61
and Arg 55 adopt almost the same positions in both structures. The side chains of
these residues can apparently adopt a range of conformations and make contacts with
the ligands in all small molecule structures of CypA. Also these side chains have
different conformations when the binding site is occupied by water molecules or by
small ligands. The other side chains in the binding site did not show any significant





The DMSO family are named after the first ligand found during this work;
dimethylsulphoxide. The family consists of three members DMSO, TMSO and PENT
(Table 7.11). All members of the family are of similar size and also have one hydrogen
group acceptor (sulfoxy group or carbonyl group). DMSO was the first and smallest
ligand found during this work and the only one which was co-crystallised with CypA.












Dimethylsulfoxide was found to bind to Cyp-A by chance. DMSO was an additive in
the crystallization solution which was used for growth of Cyp-A crystals (see chapter
5 section 2). At that time nothing was known about its binding with Cyp-A.
The structure of Cyp-A complexed with CsA (lcwa see section 2.2) from Mikol et al
(1993) was used as a starting model for rotation and translation search of DMSO
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data. All atoms (except the ligand and the solvent) from the model structure were
used in the search since the homology is 100%.
The rotation search was carried out using the program XPLOR. The rotation function
search was performed by maximising the function: RF = < P0bs * Pmodei(O) >
Pobs Patterson vectors calculated from the observed data
Pmodel Patterson vectors calculated from the model structure at orientation Q.
First a rotation search was carried out using data from 10 to 4 A and with an angular
grid step with an interval of 2.5° degrees. The highest value of the standart deviation
of the rotation function was 2.22 and corresponds to a rotation of 0i=O, 02=2.5 and
03=0 degrees from the original Cyp-A model (lcwa). The second rotation solution
had a much lower value of 1.25. The first and the second rotation solution was tried
out with a translation search to locate the molecule in the unit cell of space group
P2i2i2i. Data from 4 to 15 A were used during translation search. The R factor for
the model generated after the translation search was 39.2 % for the first rotation
solution and 62.34 % for the second. The first rotation solution was used and the
refinement proceeded with rigid body refinement, positional and B factor refinement
and the R factor dropped to 34 %. At this point the first difference electron density
map (lFo-lFc) was calculated and the binding site was inspected (Fig. 7.8).
The electron density map of the active site was compared with that of the native. In
the native structure (unliganded) the binding site is occupied only by water molecules
(Fig.7.6). The difference electron density map for DMSO data indicated a molecule
with the shape of DMSO in the active site ofCyp-A (Fig. 7.8).
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Fig. 7.8 : Difference electron density map (lFo-lFc) for the ligand DMSO. The
difference electron density was calculated before including the ligand and the water
molecules in the model. The position of the water molecules and ligands are taken
from the final refined structure.
The conformation and charges of the DMSO molecule were calculated by the
program SYBYL using force field minimisation (SYBYL a molecular modeling
program, Tripos Inc., University of Georgia, St. Louis Missouri). The DMSO
molecule as it is generated from the program SYBYL has a dipole. The positive
charge is on the carbons (0.15 partial charge each carbon atom) and sulfur (0.25
partial charge) and the negative (-0.55 partial charge) on the oxygen, the total charge
of the whole molecule is zero.
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The refinement proceeded with the addition of water molecules. After the addition of
187 water molecules and with an R factor less than 20 % the addition of the DMSO
molecule followed. The R factor of the final model was 17.8 % and the free Rfactor
21.3 %. The root-mean-squared deviations were 0.007 A and 1.28° from the ideal
bond and angle geometries. This model was used for the calculation of a 2Fo-lFc
electron density map (Fig 7.9). All the atoms of the DMSO molecule were covered by
the electron density contour as can be seen in Figure 7.9.
Fig. 7.9: Difference electron density map (2Fo-lFc contoured around DMSO
molecule) for the ligand DMSO from final refined model. Both water and ligand were
included in the phases calculation. The ligand electron density was well defined in the
first difference electron density map (Fig. 7.8) and did not change significantly as can
be seen from Figure 7.8 to 7.9.
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DMSO has an approximate three fold symmetry around the sulfur atom and can be
fitted into electron density contour in three different ways. One given in Fig. 7.10.
The alternative positions have the O atom overlaping with CI (position 1) or C2
(position 2). Crystallographically position 2 and the current position of DMSO
molecule are equivalent since the sigma level of electron density around C2 and O
atom are almost the same (carbon atom CI has much less). The reason that the
DMSO molecule was put in the current position was to prevent a bad contact
between Arg_55/NH1 and CI or C2.
The DMSO molecule makes a number of contacts with protein and the solvent (Fig.
7.10). The O of the DMSO forms hydrogen bonds to the guanidinium group of Arg
55 and to W_176 (Fig. 7.10). The contacts of DMSO with the protein and
surrounding water molecules are listed in Table 7.12.
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Fig. 7.10: Contacts of DMSO ligand with surrounding atoms of the protein and the
solvent. The sulfoxy group of DMSO hydrogen bonds with Arg 55/NH1 and W_176.
The carbon atoms of DMSO have partial positive charges and could form
hydrophobic and hydrophilic contacts.
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Table 7.12: Contacts of DMSO ligand with surrounding atoms




















A) Structural similarities and selection of TMSO ligand
Structural similarity provides a method of selecting new ligands. The principle is that
compounds with similar structure are going to have similar conformation and thus
bind the same 3D template. The method is schematically described in Figure 7.11. The


















ISIS* : INTEGRATED SCIENTIFIC INFORMATION SYSTEM
Fig. 7.11: Selection of compounds based in structural similarities
TMSO was chosen because of its similarity with DMSO (see Table 7.11). After study
of the active site it was found to be large enough to accommodate the two extra
carbons of TMSO (see Table 7.8). TMSO was the closest structurally similar
molecule to DMSO, which was found running the structural similarity search in the
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program ISIS (see material and methods section 2). The conformation of TMSO was
found in CSD (Cambridge Structure Database). TMSO was part of the structure of
tetra (mu-trifluoroacetato)-bis (trilluoroacetato) tetrakis (tetramethylenesulfoxide)
dineodymium (III) (Castellano et al 1985) found in that database.
Modelling in the binding site followed using the TMSO structure found from above.
TMSO was fitted over DMSO using common atoms of the two molecules (see Table
7.11). The active site was found to be large enough to accommodate the two extra
carbons of TMSO. The picture of the ligand in the binding site will give an idea of
what kind of interaction could be formed. The first step is a careful inspection of the
residues around the candidate ligand (TMSO). At this point the possibility of
hydrogen bonding, electrostatic, hydrophobic and van der Waals interactions should
be examined. Since the binding site is very hydrophobic, the addition of two extra
carbons (from DMSO to TMSO) was expected to increase the binding strength.
The next important step is the comparison of the native (unbound) structure with the
bound one. This will give a clear view of the rigid and flexible domains of the binding
site. Furthermore the water molecules which have been replaced by the ligand (if any)
can be marked. The water molecules in the native structure (Fig. 7.6) are very
important since they give us an idea which part of the ligand could be modified by
extension, replacing one or more of these water molecules. The release of the water
when it is replaced by a ligand, leads to a net increase in entropy. It has been
estimated that by replacing a water molecule with a part of a ligand with exactly the
same binding enthalpy (van der Waals interaction, hydrogen bonding interaction), this
increases binding strength by -2 kcal/mol (Burkhard 1995). The water molecules also
indicate favoured sites for hydrophilic interaction or hydrogen bonding.
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B) Refinement of TMSO data
The refinement procedure was started with a translation search and followed by a
rigid body refinement and finally positional and individual B-factor refinement. At that
point the first difference electron density map (lFo-lFc) was calculated and the
binding site was inspected (Fig. 7.11). The electron density map around the active site
was compared with that of the native (unliganded, Fig.7.6). The electron density
showed convincingly that the binding site was not occupied by water molecules but by
a molecule of the size of TMSO.
Fig. 7.11: Difference electron density map (lFo-lFc at 2.3-sigma level) for the ligand
TMSO. The difference electron density was calculated before including the ligand and
the water molecules in the model.
7.40
Structure Determination
The refinement proceeded with addition of water molecules. The first attempt to
model the ligand was after the addition of 243 water molecules and with the R factor
of the model at 21.1 %. The ligand was introduced into the model and the refinement
was continued with positional and individual B-factor refinement. From the electron
density map (2Fo-lFc) the ligand fits very well to the contour except the area
between carbons C2 and C3. A difference electron density map (lFo-lFc) calculated
around carbons C2 and C3 showed positive density in that area (Fig. 7.12).
Fig. 7.12: Difference electron density map (2Fo-lFc) for the ligand TMSO (green
color). W_106 was not used in the calculation of the phases. The red contour (lFo-




Three different models (1, 2 and 3) were developed to explain the additional unfilled
density around carbons C2 and C3 in Fig. 7.12. This density was overlapped with the
W_106 of the native structure. In all models the binding site is occupied (not 100%)
at least by one TMSO molecule. In model 1 an additional water molecule is added, in
model 2 there is an extra TMSO molecule and finally in model 3 there is one TMSO
molecule plus a water molecule. Partial occupancy refinement was carried out by
program XPLOR.
Model 1
In model 1 W_106 from the native structure was renamed W_310. W_310 was added
to the model and the refinement was continued with positional, individual B-factor
and occupancy refinement. The occupancy was refined to 80 % for the TMSO and 20
% for W_310 (the sum of the occupancy was constrained to 100 %) and the average
B factor to 40 and 2 respectively. Model 1 containing TMSO and W_310 in the
binding site (Fig.7.13) has an R factor of 17.6 % and a free R factor of 23.5 %.
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Fig 7.13: Difference electron density map (2Fo-lFc) for the ligand TMSO and
W_310 (model 1). Occupancy was 80 % and 20 % for TMSO and W_310
respectively. Both water and ligand were included in the phases calculation.
Model 2
The B factor of W_106 (W_310 in the TMSO structure of model 1) in the native
structure was refined to 23.4. In the TMSO structure, the same water even when the
occupancy was set to 100 %, has a B factor of 21.0. During refinement of model 1 it
was found that a minimum occupancy of 70 % was required for the TMSO molecule
in order to eliminate any positive electron density (lFo-lFc) around it. When the
occupancy of W_310 was set to 30 % the B factor dropped to 4.5. A low temperature
factor of W_310 could mean that something heavier than O (8 electrons) occupied
that area, and the only heavier atom in the structure is the S (16 electrons). This area
can be occupied by an S atom only if the position of the TMSO ligand changes. Since
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the initial position of TMSO (Fig. 7.13) fits well to the contour of the density and
makes good chemical sense (with hydrogen bonding between Arg_55/NH1 and O
atom of TMSO). An alternate position was given (Fig. 7.14) in which the sulfoxy
group of the TMSO 2 fits into the positive electron density found around W_106 (see
Figure 7.12). The model was refined with these two alternatives of the TMSO ligand
(Fig. 7.14).
The occupancies were refined to 52 % and 32 % for alternative sites 1 and 2
respectively. The restraint that occupancy of site 1 plus occupancy of site 2 should
sum up to 100% was set (the above values sum up to 84 %). Because of that restraint
the original values of occupancies were multiplied by 100/84 in order that they sum to
100 %. In the final model the average temperature factor for site 1 and site 2 was
37.6, 49.5 respectively with occupancies 62 % and 38 %. When TMSO binds then the
side chain (Gln_63) has to adopt an alternative position also (Fig. 7.13) in order to
form a hydrogen bond with the O of the TMSO (Gln_63/ALT2/NE2—
0/TMS0/ALT2). A total of 243 water molecules were added into the final model and
the R factor was 17.7 % with free R factor being 23.6 %. Model 2 contains two
positions of TMSO in the binding site.
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Fig. 7.14: Difference electron density map (2Fo-lFc contoured around TMSO
molecule) for the ligand TMSO. The ligand can adopt two alternative positions 1 and
2 (model 2). Both sites were included in calculation of the phases. Also the side chain
ofGln_63 can adopt two alternate positions according to TMSO ALT1 and ALT2.
Model 3
In a last attempt at refinement of TMSO data, a model (Fig. 7.15) containing the two
sites of TMSO (see Fig. 7.14) plus W_310 (see Fig. 7.13) was used. This trial was
based on the fact that during refinement of model 2 (see above ) the occupancy of
TMSO/ALT1 was refined to 52 % and TMSO/ALT2 to 32 % respectively. The
remaining 16 % (in order to reach 100 % occupancy) of the binding sites should be
occupied by water. The refinement was run by fixing the occupancies of TMSO/ALT 1
to 52 %, TMSO/ALT2 to 32 % and W_310 to 16 %. Positional and individual B-
factor refinement was run on that model. The R factor was refined to 17.7 % and the
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free R factor to 23.6 %. The average B factors were 30.3 for the TMSO/ALT1, 48.5
for the TMSO/ALT2 and 6.1 for the W_310.
All the models used for the refinement of the TMSO data set are summarised in Table
7.13. The TMSO molecule in model 1 has practicaly the same position as
TMSO/ALT! in models 2 and 3. TMSO/ALT2 occupies almost the same position in
model 2 and 3. Also model 1 has the lowest free R factor which is probably an
indication that models 2 and 3 are overrefined.
Table 7.13: Refinement results for the three models used for the refinement of TMSO
data set. The binding site is partial occupied of TMSO and W_310 in model 1, of two
alternates in model 2 and of two alternates and W_310 in model 3.
Model 1 Model 2 Model 3
R factor 17.6 % 17.7 % 17.7 %
free R factor 23.5 % 23.6 % 23.6 %
B factor TMSO 39.4
(average)
Occupancy 80%
B factor TMSO 37.6 30.3
ALT1 (average)
Occupancy 62% 52%
B factor TMSO 49.5 48.5
ALT2 (average)
Occupancy 38% 32%





The TMSO molecule makes a number of contacts with protein and the solvent (Fig.
7.15). The O of the TMSO forms a hydrogen bond to the guanidinium group of Arg
55 in model 1, 2 and 3 and a hydrogen bond to Gln_63/OEl, when it adopts the
second position. The contacts of TMSO with the protein and surrounding water
molecules are listed in Table 7.14.
Fig. 7.15: Contacts of sites 1 and 2 of the TMSO ligand with surrounding atoms
of the protein and the solvent of model 3. The O of the TMSO makes a hydrogen
bond to the guanidinium group of Arg 55 in model 1, 2 and 3. When TMSO adopts
the second position (ALT2) it makes a hydrogen bond to Gln_63/OEl.
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Table 7.14: Contacts of sites 1 and 2 of TMSO ligand with surrounding atoms
of the protein and the solvent of model 3 as shown in Fig. 7.15.
Ligand atom Distance (A) Residue/Atom
O/ALTl 3.21 Arg_55/NH 1
O/ALTl 3.20 Met_61/SD
O/ALTl 3.30 Met_61/CE
C2/ALT1 3.05 Phe_l 13/CD1
C3/ALT1 3.00 W_24 (W_105 in native)







The selection of the ligand was based on the structural similarities as described in the
TMSO section above. PNT shares high structural similarities with TMSO (Table
7.11). The conformation of the PNT was found in CSD as part of the methacryloul
chloride structure (Fischer et al 1985).
The refinement procedure was as described for TMSO. The first difference electron
density map was calculated at that stage of refinement and showed the clear presence
of a ligand (initial electron density map Fig. 7.16). The refinement proceeded by
addition of water molecules. 204 water molecules were added before the ligand was
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introduced into the model. The difference electron density map (lFo-lFc) in the
binding site clearly indicated a molecule with size and shape to fit to PNT (Fig. 7.16).
Fig. 7.16: Difference electron density map (lFo-lFc at 2.5-sigma level) for the ligand
PNT. The difference electron density was calculated before including the ligand and
the water molecules in the model.
The ligand was introduced into the model and the refinement was continued with
positional and individual B-factor refinement. The ligand fits very well to the contour
of the electron density (Fig. 7.16). A total of 243 water molecules were added into the




Fig. 7.17: Difference electron density map (2Fo-lFc contoured around PNT
molecule) for the ligand PNT. A total of 243 water molecules and the ligand were
included in the phase calculation.
The PNT molecule makes a number of contacts with protein and the solvent (Fig.
7.17). The O of the PNT forms a hydrogen bond to Asn_102/N. The contacts of PNT
with the protein and surrounding water molecules are listed in Table 7.15. One
hydrogen bond forms between Ol of PNT and Asn_102/N.
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Fig. 7.18: Contacts of PNT ligand with surrounding atoms of the protein and the
solvent. The O of the PNT makes a hydrogen bond (3.3 A) to Asn_102/N and a
number of contacts with side chain of His_126 and Gln_63.
Table 7.15: Contacts of PNT ligand with surrounding atoms
of the protein and the solvent as shown in Fig. 7.18.





C2 3.09 W_206 (W_106 in native)





Members of this family are derivatives of piperidine. Piperidine shares structural
similarity with the proline ring (Fig.7.19). Dipeptides containing proline are well
known to bind to Cyp-A (Ke et al 1993, Zhao and Ke 1996). Piperidine derivatives
were chosen as putative ligands for that reason. Also both ligands of the piperidine
family (table 7.13) share an amide group. The oxygen of that amide group always
forms a hydrogen bond with Asn_102 in all CypA-XPro complexes (Ke et al 1993,
Zhao and Ke 1996).
Fig. 7.19: Structure of Ala-Pro and piperidine. The partial structure of the dipeptide
shown in the box was used as a guide to search for putative ligands of Cyp-A.
The search for putative ligands sharing the above features was carried out using the
ISIS data base using the structure of 1-Acetyl piperidine as a template. A number of
















The refinement procedure started with a translation search and proceeded on with
rigid body refinement, positional and individual B-factor refinement using as a model
the co-ordinates of the CypA/DMSO structure. The first difference electron density
map (lFo-lFc) was calculated and the binding site was inspected (Fig. 7.19A). The
electron density map in the active site was compared with that one of the native
(unliganded, Fig.7.5). The electron density convincingly showed that the binding site
was not occupied by water molecules but by a molecule of the size of ETPIPG. An
initial conformation of the ETPIPG molecule was calculated by the program
WITNOTP using force field minimisation (Widmer 1997). ETPIPG has many







Fig. 7.19A: Difference electron density map (lFo-lFc) for the ligand ETPIPG. The
difference electron density was calculated before including the ligand and the water
molecules in the model. The water molecules and ligands shown were taken from the
refined structure.
Refinement ofETPIPG using data to 2.05 A
The refinement proceeded by addition of water molecules. The first attempt to model
the ligand was after of the addition of 161 water molecules and with a R factor about
19 %. The ligand was introduced into the model and the refinement was continued
with positional and individual B-factor refinement. From the electron density map
(2Fo-lFc) the ligand's atoms fit very well to the contours of the electron density
except two carbon atoms of the piperidine ring and the area around carbonyl oxygen
03 (Fig. 7.20). The six-membered ring can adopt more than one conformation
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(Glusker et al 1994) and as a result the electron density of the ring could become
weak. The electron density which extended from atom 03 of the ligand suggests an
alternative conformation of the ligand tail. The ligand was modeled into the electron
density with its tail (after 02) adopting two conformations ALT1 and ALT2 (Fig.
7.21). All the above results derive from the 24 to 2.05 A resolution data set.
Fig. 7.20: Difference electron density map (2Fo-lFc) for the ligand ETPIPG. The
extension of electron density from atom 03 could be explained by an alternate




Fig. 7.21: Difference electron density map (2Fo-lFc) for the ligand ETPIPG when its
tail (3 atoms) adopts two alternate conformations ALT1 and ALT2. The model was
refined against data from 24 A to 2.05 A. The atoms of both alternate conformations
of the ligand were included in the phase calculation.
Refinement of ETPIPG using Synchrotron data to 1.65 A
A high resolution data set was collected at the SRS (Daresbury see chapter 6) to 1.65
A from the same crystal. The new high resolution data were refined against the model
of the CypA-ETPIPG complex where ETPIPG adopted two conformations
(Fig.7.22). This showed continuous density extending from from 04 (Fig. 7.22). Two
carbon atoms (CI and C2 Fig. 7.23) of the piperidine ring are not covered by the
density contour. The ring can adopt two different twist conformations, (see Fig.
7.23). This results in a weaker electron density in that area (see Fig. 7.22). The atoms
of the two conformers (ALT1 and ALT2 Fig. 7.23) almost overlap except the atoms
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C8, C9 at the tail and atoms CI, C2 in the piperidine ring. The result from the
refinement for low resolution data (24 A to 2.05 A) and for high resolution data are
given in the Table 7.17.
Fig. 7.22: Difference electron density map (2Fo-lFc) for the ligand ETPIPG when its
tail (2 atoms) and piperidine ring (2 atoms) adopts alternative conformations. The
model was refined against data from 24 A to 1.65 A. Two molecules of the ligand




Data sets 24 A to 2.05 A. 24 A to 1.65 A.
R factor 17.9 % 18.8 %










Fig. 7.23: ALT1 and ALT2 of ETPIPG in the binding site of CypA. The main
differences between the two molecules are in carbons CI, C2 of the piperidine ring
and C8, C9 of the tail of the molecule.
Table 7.17: The model of ETPIPG bound with two alternative conformations (Fig.
7.21 and 7.22) in the active site of Cyp-A was refined against two data sets one low
resolution and one high resolution.
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The ETPIPG molecule makes one hydrogen bond (Fig. 7.23 A and B) as well as
contacts with the surrounding residues. The piperidine ring of ETPIPG (Fig. 7.23 A
and B) makes hydrophopic contacts with the phenalanine side chain of residues 60,
113 and histidine 126. Also it makes contacts with the side chain of residues Met 61
and Arg 55.
Table 7.18: Contacts of ETPIPG ligand ALT1 and ALT2 with surrounding atoms

















CI 3.23 Phe_60/CZ C6 3.56 His_126/CE1
CI 3.63 Phe_60/CE1 03 3.32 Gln_63/NE2
C4 2.95 Arg_55/NH1 02 3.26 His_126/CE1
C3 3.66 His_126/CE1 02 2.98 Ala_101/CA
C3 3.66 Phe_113/CE1 02 2.79 Asn_102/N
C6 3.64 His_126/CE1 C4 3.56 His_126/CE1
02 3.24 His_126/CE1 C4 3.61 Phe_113/CE1
02 3.06 Ala_101/CA C3 2.88 Arg_55/NH1
02 2.80 Asn_102/N C5 3.68 Phe_113/CD1





Fig. 7.23A: Contacts of conformer 1 of ETPIPG ligand with surrounding atoms of
the protein. ETPIPG (ALT1) makes a hydrogen bond to the N/Asnl02 (2.80 A) and
to NE1/Gln63 (3.3 A). The most hydrophobic part of the ETPIPG (ALT1) molecule
(piperidine ring) fits into the hydrophobic pocket and forms a number of contacts with




Fig. 7.23B: Contacts of conformer 2 of ETPIPG ligand with surrounding atoms of
the protein. ETPIPG (ALT2) makes a hydrogen bond to the N/Asnl02 (2.8 A) and to
NE1/Gln63 (3.3 A). The most hydrophobic part of the ETPIPG (ALT2) molecule
(piperidine ring) fits into the hydrophobic pocket and forms a number of contacts with
side chains of Phe_60, Phe_113 and Met_61. The hydrophilic part of the ligand faces
the solvent.
2. ACMPIP
The same refinement procedure as in ethyl-piperidine glyoxylate was used at the
beginning of the refinement. The first difference electron density map (lFo-lFc) was
calculated and the binding site was inspected (Fig. 7.24). The electron density map in
the active site was compared with that of the native (unliganded, Fig. 7.5). The




molecules but by a molecule the size of ACMPIP. An initial conformation of ACMPIP
was calculated by the program WITNOTP using force field minimisation (Widmer
1997).
Fig. 7.24: Difference electron density map (lFo-lFc) for the ligand ACMPIP. The
difference electron density was calculated before including the ligand and the water
molecules in the model. The water molecules and ligands were taken from the refined
structure.
The refinement proceeded by addition of water molecules. The first attempt to model
the ligand was after the addition of 169 water molecules and with an R factor of about
20 %. The ligand was introduced into the model and the refinement was continued
with positional and individual B-factor refinement. From the (2Fo-lFc) electron
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density map it is clear that the ligand fits very well to the contour of the electron
density (Fig. 7.25).
Fig. 7.25: Difference electron density map (2Fo-lFc) for the ligand ACMPIP. Both
water molecules and ligand were included in the phase calculation. The map was
contoured only around ACMPIP molecule.
The (2Fo-lFc) electron density map around residue Arg 55 shows that the side chain
adopts two different positions (Fig. 7.26). These two alternative conformations
refined to 50 % for ALT1 and 50 % for ALT2 with the program XPLOR. Both
alternative conformations of Arg_55 form hydrogen bonds; ALT1 with Asn 164 and
ALT2 with Gin 63 and water 164.
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Fig. 7.26: (2Fo-lFc) difference electron density map for the side chain ofArg 55. The
side chain adopts two conformations and both of them form hydrogen bonds with
surrounding residues and the solvent. These two alternative conformations refined to
50 % for ALT1 and 50 % for ALT2 with the program XPLOR.
The ACMPIP molecule makes a number of contacts with the protein (Fig. 7.27). The
amide O of ACMPIP forms a hydrogen bond to N of Asn 102 similar to that formed
to the amide 02 of ETPIPG (see Fig. 7.23A and 7.23B). The piperidine ring makes a
number of hydrophopic contacts with the side chains of Phe 133 and Phe 60.
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Fig. 7.27: Contacts of ACMPIP ligand with surrounding atoms of the protein.
ACMPIP makes one hydrogen bond to the N/Asnl02 (2.8 A). The most hydrophobic
part of the ACMPIP molecule (methyl-piperidine ring) fits into the hydrophobic




A) Selection and modification of the putative ligands
Selection of the putative ligand was based on molecular weight and hydrophobicity.
The most hydrophilic ligands were selected from the list generated by LIDAEUS (see
chapter 1 section l.B). Small molecules can easily go through crystal channels and
reach the binding site so molecules with molecular weight larger than 300 were not
used for soaking.
The putative ligand found by the LIDAEUS program was the 2,2,5-trimethyl-l,3
dioxane-4,6-dione (Fig. 7.29). A Cyp-A crystal was soaked in a solution containing
20 mM of this ligand and a data set collected. The model was refined following the
same procedure as in ETPIPG. The electron density (lFo-lFc) showed convincingly
that the binding site was occupied only by water molecules. The R factor of the model
was 25.4 % when the electron density in the binding site was inspected.
The 2,2,5 trimethyl-l,3-dioxane-4,6-dione (TDD) molecule was partially modified
(Fig. 7.29). The modifications were based on crystallographic results from other
ligands and from modelling. Previous studies (crystallographic results) had shown that
the side of the molecule which faces the binding site should be hydrophobic. This
theory was based on the fact that 1-acetyl-methyl piperidine binds (see section 3.6) to
Cyp-A while 1-acetyl-piperidone does not bind (Fig. 7.29). The main difference
between the two molecules is that the 1-acetyl-piperidone is hydrophilic on the
piperidine ring side. The piperidine ring of ACMPIP goes into the binding site and is





























Fig. 7.29: Modifications applied in the ligand (TDD) found by the docking program,
based on crystallographic data from ligands APD and ACMPIP. The result of these
modifications was the DCH molecule.
The TDD molecule was modelled by the LIDAEUS program to bind with the two
methyl groups and two ether oxygens going into the binding site. Since it was known
that the binding surface of the ligand should be hydrophobic, the two ether oxygens
were replaced by carbon atoms (Fig. 7.28). That molecule was used as a template to
search for structurally similar molecules in ISIS. The most similar molecule found by
this search was the dimedone (Fig. 7.29).
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B) Refinement ofDCH data
The refinement procedure was started with a translation search (protein model from
DMSO structure) and proceeded with rigid body refinement, positional and individual
B-factor refinement. At that point the first difference electron density map (lFo-lFc)
was calculated and the binding site was inspected (Fig. 7.30). The electron density
map on the active site was compared with that of the native (unliganded, Fig.7.6). The
electron density showed convincingly that the binding site was not occupied by water
molecules but by a molecule of the size of DCH. The R factor was about 28 %.
Fig. 7.30: Difference electron density map (lFo-lFc) for the ligand DCH. The
difference electron density was calculated before including the ligand and the water




The refinement proceeded by addition of water molecules. The first attempt to model
the ligand was after of the addition of 147 water molecules and with the R factor of
the model at 21.8 %. The side chain of Arg 55 adopts a different position compared
to the DMSO complex (the DMSO structure of Cyp-A was used as a starting model)
Fig. 7.31: Difference electron density map (lFo-lFc) for the ligand DCH. The
difference electron density was calculated before including the ligand in the model.
The ligand was taken from the refined structure. The side chain of Arg 55 moved
further back in order to allow the ligand to bind. The yellow colour shows the
position of the side chain of Arg 55 in the starting model (DMSO structure).
The ligand was introduced into the model and the refinement was continued with
positional and individual B-factor refinement. From the electron density map (2Fo-
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IFc) the ligand fits very well to the contour of the electron density (Fig. 7.32). The
DCH molecule makes a number of contacts with protein and the solvent (Fig. 7.33).
Fig. 7.32: Difference electron density map (2Fo-lFc) for the ligand DCH. Both water




Fig. 7.33: Contacts of DCH ligand with surrounding atoms of the protein and the
solvent. DCH makes five hydrogen bonds, two with the side chain of Arg_55 and
three with W_99, W_149 and W_212. Also it forms hydrophobic contacts with side





As with CyP, several classes of FKBP have been found: one is cytosolic with a
molecular weight of 12,000 daltons (FKBP-12, Maki et al, 1990). Another is
membrane-associated with a molecular weight of 13,000 daltons (FKBP-13, Jin et al.,
1991) with 43% sequence identity to FKBP-12 and exact identity for all amino acids
lining the FK506 binding pocket. There is also a rapamicin-selective immunophilin,
FKBP-25 (215 amino acids, Galat et al., 1992).
Although CyP and FKBP share some common properties such as immunosuppressant
binding and rotamase activity, FK506 does not bind to CyP nor inhibit its rotamase
activity, and similarly CsA does not bind to FKBP( Siekierka, et al., 1989; Harding et
al., 1989).
Three-dimensional structures of FKBP have been solved for the unligated form
(NMR, Michnick et al., 1991; Moore et al., 1991), for the FK506-FKBP complex (X-
ray, Van Duyneet al., 1991a), and for the rapamycin-FKBP complex (Van Duyne et
al., 1991b). Overall, the structure of FKBP is different from CyP (Ke et al., 1991).
FK506 has a trans configuration around the N7-08 bind (Fig. 33A) in the bound state
(Van Duyne et al., 1991) and cis in the unbound state (Tanaka et al., 1987). It is
striking that FK506 changes it configuration from cis to trans upon binding to the
FKBP-12. The overall FKBP-12 structure observed for all new FKBP-12 inhibitor
complexes was not significantly different from that found in the uncomplexed protein
or in the FKBP12 -FK506 or FKBP12-rapamycin crystal structures (Lepre et al.,
1994; Michnick et al., 1991; Wilson et al., 1995; Van Duyne et al., 1991).
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Fig. 7.33A: Structure of FK506 the arrow indicates the N7-08 bond which changes
from cis to trans when FK506 binds to the FKBP-12.
High affinity FKBP ligands, which bind to the active site of FKBP interact with: Phe
36, Asp 37, Arg 42, Phe 46, Glu 54, Val 55, lie 56, Tyr 82, His 87, lie 90, and He
91(Holt et al., 1993). Another series of smaller FKBP ligands bind to the same pocket
and form bonds with Asp 37, He 56, Tyr 82 (Burkhard, 1995). These three residues
(Asp 37, He 56, Tyr 82) were principally responsible for the binding of eight small
compounds in the FKBP-12 binding pocket.
The ligands tested by x-ray crystallography were cyclooctanone, cyclohexanone, and





Crystals grown in AS and DMSO were used for soaking in all ligands (see chapter
6.3.C). DMSO binds in the active site of FKBP-12 and before introduction of any
new ligands DMSO must be soaked out of the binding site.
The structure of FKBP complexed with DMSO (Burkhard 1995) was used as a
starting model for rotation and translation searches. All atoms (except the ligand and
the solvent) from the model structure were used in the search since the homology is
100%. A translation search using the program XPLOR, was enough to locate the
molecules in the unit cell since the unit cell dimensions are similar to that of the
model. The refinement and the addition of water molecules was done using SHELX
(Sheldrick et al 1997).
3. Cyclooctanone
Two cyclooctanone data sets were refined during this work, one with data to 1.8 A
(oct_l) and one with data to 2.05 A (oct_2) (see table 5.4 chapter 5). Data from 3.5
to 15 A were used during the translation search. The R factor for the model generated
after the translation search using data oct_l was 36.2 % (program XPLOR). The
refinement procedure was continued with rigid body refinement, positional and
individual B-factor refinement and the R factor dropped to 35.9 %. At this point the
first difference electron density map (lFo-lFc) was calculated and the binding site
was inspected (Fig. 7.34).
7.74
Structure Determination
Fig. 7.34: Difference electron density map (lFo-lFc). The electron density has the
shape and size of DMSO. The difference electron density was calculated before
including the ligand and the water molecules in the model.
A trace of DMSO was present in the binding site of FKBP (Fig. 7.34). The refinement
did not proceed further since the cyclooctanone was not present.
The second data set (see Table 6.4 chapter 6) was refined as described for the first
one. The first difference electron density map (lFo-lFc) was calculated with an R
factor of 35.5 % and the binding site was inspected (Fig. 7.35). The electron density
in the binding site was different than that obtained from the first data set (Fig. 7.34).
The refinement proceeded with addition of water molecules. After the addition of 62
water molecules the R factor dropped to 23.8 %.
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Fig. 7.35: Difference electron density map (lFo-lFc) in the binding site of FKBP-12.
The electron density is different from that in Figure 7.34. The difference electron
density was calculated before including the ligand and the water molecules in the
model.
The ligand was introduced into the model and refinement continued with positional
and individual B-factor refinement. The R factor of the model was 21.5 % and the
free R factor 29.7 % (SHELX for all reflections). The root-mean-squared deviations
were 0.005 A and 1.67° from the ideal geometries. This model consisted of the
protein molecules A and B, 57 water molecules and the two cyclooctanone molecules
one for each protein molecule . This model was used for the calculation of a 2Fo-lFc
electron density map (Fig 7.36). All the atoms of the cyclooctanone molecule were
covered by the electron density contour as can be seen in Figure 7.35. It is known that
cyclooctanone can adopt more than one conformation and this can be seen also from
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the electron density. The refinement did not proceed further since it was clear that the
ligand (cyclooctanone) occupied the binding site and was covered completely by
electron density.
Fig. 7.36: Difference electron density map (2Fo-lFc) for the ligand cyclooctanone.
Both water and ligand were included in the phases calculation. The map was
contoured only around cyclooctanone molecule.
3. Cyclohexanone
The refinement procedure was as described for cyclooctanone. The first difference
electron density map (lFo-lFc) was calculated with a R factor of 31.8 % and the




difficult to decide if the density was DMSO or cyclohexanone since the difference in
shape and size between them is not great. The refinement proceeded by addition of
water molecules. With an R factor of 27.9 % and 105 water molecules added into the
model an electron density map (lFo-lFc) was calculated (Fig. 7.38).
Fig. 7.37: Difference electron density map (lFo-lFc). The electron density has the
shape and size of DMSO. The difference electron density was calculated using only
the coordinates of the protein without the ligand and water molecules.
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Fig. 7.38: Difference electron density map (lFo-lFc). The difference electron density
was calculated after addition of 105 water molecules in the model. The DMSO
molecule fitted into the density and was not used for the calculation of the phases.
The refinement did not proceed further since only DMSO was present in the binding
site.
3. Pregnane
The refinement procedure was as described for cyclooctanone. The first difference
electron density map (lFo-lFc) was calculated with a R factor of 34.8 % and the
binding site was inspected (Fig. 7.39). The refinement did not proceed further since
only DMSO was present in the binding site.
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Fig. 7.39: Difference electron density map (lFo-lFc). The electron density has the
shape and size of DMSO. The difference electron density was calculated without





Cyclophilins have been found in numerous parasites, including the human filarial
nematode Brugia malayi. B. malayi is a medically important parasite found in tropical
countries, and infection is transmitted via mosquito vectors and can result in chronic
debilitating filarial disease symptoms, which can include elephantiasis (Page et al
1995). BrCyp is a protein of the cyclophilin family from Brugia malayi nematode
parasite with a molecular weight about 22kD (the sequence of BrCyp can be seen in
appendix 1).
The protein has been characterised biochemically and has been shown to possess
PPIase activity which can be inhibited by CsA (Page et al 1995a). Independent of its
immunosuppressive activity CsA has powerful killing properties against a wide range
of infectious organisms including large multicellular helminth parasites (Page et al
1995b). The precise mode of action of CsA, or its derivatives, against protozoan and
helminth parasites is presently unknown and may involve an interruption of an
essential signal transduction pathway, or inhibition of PPIase activity resulting in
improper protein folding of a vital parasite molecule(s). BrCyp was purified (chapter
3) and crystallized (chapter 4) in the current work and the structure determination of
the protein is described here.
2. Refinement ofBrCyp data
A) Trigonal form
The space group P3i2i2 was indicated as the best candidate for this data set (trigonal
1.9 A, see chapter 6, section 3.2.C) from SCALEPACK program (see chapter 6,
section 5.D). A rotation search was run in XPLOR for data in the resolution range 10
to 2.6 A with the search model consisting of CypA from the CypA/CsA complex
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(Mikol et al 1993). Only one peak was found in the rotation function search. The
translation function (XPLOR) showed a solution consistent with two molecules in the
asymmetric unit related by an almost exact translation of c/2. The same results were
observed by using the molecular replacement protocol from AMORE (Navaza &
Saludjian 1997) by Dr P. Taylor (Taylor et al 1998). 10 % of the reflections were
chosen randomly and not used in the refinement. These reflections were used for
calculation of the free R factor. The structure was refined further by Dr P. Taylor
using alternating rounds of positional and B factor refinement using the data in
resolution range 5-1.9 A, with water molecules added to the model. Refinement stuck
at 32 % and the packing arrangement suggested that the crystal may be composed of
an intimate twin.
It was possiple to refine the structure using half of the data set with a unit cell of a= b
= 88.9 A, c= 53.2 A, and space group P322i2. The above suggest that one possible
twin may be a mixture of this small unit cell with one molecule per asymmetric unit
overlapped with a larger cell with two molecules per asymmetric unit. No further
attempt was made to refine the trigonal structure and an effort was put in
crystallization trials into order to get a different crystal form.
B) Tetragonal form
A second crystal form grown from ammonium sulphate was found to have space
group P4i2i2 (see chapter 6, section 3.2.C) from SCALEPACK program (see chapter
5, section 5.D). A rotation and translation search was carried out by Dr P. Taylor (see
Taylor et al 1998) as well as most of the building of the protein model. Further
refinement proceeded with addition of water molecules followed by positional and B
factor refinement (XPLOR). The final structure has an R factor of 19.9 % and R free
23.4 %. RMS deviation from ideality in bond length, bond angle and torsion angle are
0.008 A, 1.426° and 26.02° respectively. The mean temperature factor for the protein
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and water molecules are 27.2 A2 and 43 A2 respectively. The parameter values of
stereochemical quality of the refined BrCyp structure can be seen in Table 7.19.








BrCyp 84.5 % 15% 0% 0%
Main Chain Omega Bad Zeta H-
Parameters angle contacts angle bond
energy
Typical 6 3.7 3.1 0.8
value
BrCyp 1.6 0 1.6 0.7
Side Chain Chi-1 Chi-1 Chi- Chi-1 Chi-2
Parameters gauche trans gauche pooled trans
minus plus
Typical 17.7 18.6 17.2 17.8 20.1
value
BrCyp 15.9 18.0 11.9 14.8 12.5
The amino acid N-terminal fusion derived from the vector multiple cloning site (ile-
ser-glu-phe-gly-ser the sequence of BrCyp can be seen in appendix 3.1) was not
visible in the final electron density map. Mass spectrometry was used to measure the
molecular weight of the protein at 20095Da (major peak Fig.7.41). This compares
with a calculated weight of 20100Da for the 183 aa total protein and confirmed that
no N-terminal cleavage had occurred. The mass spectrum was performed by Ms
Violet R. Anderson. Electrospray ionisation spectra were acquired on a Micromass
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Platform II mass spectrometer with an atmospheric pressure electrospray ion source
and a maximum range of 4000 m/z. The sample was at 20pmoles/microlitre in 50%
acetonitrile with 0.05% acetic acid was introduced via an infusion pump. Data was
collected from 500-3000m/z at a cone voltage of 70V. The data was collected and





2C005 O 20025.0 20350.0
19950 20000 20O5D 20100 2C250 203CO 2040C
Fig. 7.41: Mass spectrum of BrCyp. The major peak 20095 Da is practically the same
as the calculated weight of 20100Da for the 183 aa.
The divergent family of cyclophilins contain two cysteines (see sequence of BrCyp in
appendix 1). The sulphur atoms of C-43 and C-173 are well defined in the difference
electron density map (Fig. 7.42) and are separated by 5.43A. Those two cysteines
could form a disulphide bond by a small adjustment in the torsion angles. This
crystal is apparently composed of the reduced cysteine form.
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Fig. 7.42: Difference electron density map (2Fo-lFc) for the side chains of the two
cysteines (Cys 43 and 173) of BrCyp. The electron density map shows that no





The small ligand/CypA complexes and the native structure refined during this work
were compared with published structures lcwa, 2cpl, lcyh of CypA (see section 2.2).
All small molecule complex structures have a similar rmsd when overlaid with the
native structure refined during this work (Table 7.20). All protein atoms were used
except residues 1 to 4, 67 to 76 and 162 to 165. The loop Phe/67 to Lys/76 also
known as "70 loop" was excluded. It has been shown to adopt a different
conformation and has significant atom displacements (1.7 A for main chain atoms)
when different CypA-CsA structures are overlaid (Kallen et al 1998).
Table 7.20: Rms differences between native CypA atom position and small ligand












The active site of the native CypA structure is occupied by six water molecules. W
105, W 106, W 109, W 121 W 198 and W 208 (Fig. 7.7). Depending upon which
ligand is bound, a number of these water molecules are replaced. It may also be
possible to incorporate some of these water molecules into the design of a ligand.
Water molecules 198, 106, 121 and 109 (Fig. 7.7A) were not observed in the 2cpl
structure (native structure of Cyp-A, Ke 1992). In the current work 192 water
molecules have been found compared to only 119 in the 2cpl structure. This was not
as a result of overrefming the structure as the R factor (17.4%) is very close to the
Rfree (21.9%) the Rfree was not reported for the 2cpl structure.
Water molecules in the 2cpl structure have an overall temperature factor much higher
(47.5 A2) than the native structure reported in this work (31.2 A2). Some of the water
molecules in the Ke structure have a temperature factor higher than 70 A2 whereas in
the current structure all water molecules have temperature factors below 70 A2. The
high temperature factor of water molecules in the 2cpl structure means that water
molecules are less well defined. This was probably the effect of the temperature at
which the data was collected. The current structure comes from data collected at
100K° while the 2cpl structure is derived from data collected at room temperature.
The additional water molecules seen in the active site in this work (198, 106, 121 and
109) are important because they occupy the ligand binding site and make contacts to
side chain of residues involved in the mechanism of the cis-trans isomerisation (Zhao





DMSO is the smallest ligand found during this work and the only one which binds
both Cyp-A and FKBP-12 (Burkhard 1995). The DMSO dissociation constant with
Cyp-A was around 45 mM, the second worst interaction seen with all small ligands
tested. The most hydrophobic part of the DMSO molecule fits into the hydrophobic
pocket, the hydrophilic part faces the solvent (Fig. 7.10).
The main difference between the native protein structure and the structure with
DMSO in the binding site is seen in the movement of the side chain of Met 61,
replacement of W_106 and a slight movement of the Arg 55 side chain (Fig. 7.43).
The rest of the side chains in the binding site are practically the same including the
water molecules (W_105, W_109, W_121 W_208 and W_198 see section 4.1).
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Fig. 7.43: Overlay of native CypA with the CypA-DMSO complex. The CypA native
structure is in green. The main difference between the native protein structure and the
structure with DMSO in the binding site is seen in the movement of the side chain of
Met 61, replacement of W_106 and a slight movement of the Arg 55 side chain.
As a result of DMSO binding the CE carbon of Met 61 is pushed away from the
centre of the binding site. The side chain of Met 61 was very mobile in the native
structure and the mean temperature factor for CG, SD and CE was 17.4 A2 which
dropped to 9.42 A2 in the DMSO structure. A similar effect happened to the Arg_55
where, because of the hydrogen bond (2.63 A) between sulfoxy group of DMSO and
Arg 55/NH1 (Fig. 7.42) the side chain becomes more rigid. The overall temperature
factor for NH1, NH2, CZ and NE of Arg 55 is 26.9 A2 compared with 41.37 A2 in the
native structure. The difference in the overall temperature factor of protein atoms
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between native and DMSO structure is very small (15.6 %) when compared to that
for the side chain ofMet 61 and Arg 55 referred to earlier.
Water molecule 106 in the native structure was replaced by atom C2 of the DMSO
ligand (see Fig. 7.43). Initially this was a surprising result, the replacement of a
hydrophilic atom by a hydrophobic one. In the native structure (Fig. 7.40) this
particular water makes one hydrogen bond and two hydrophobic contacts. Therefore
this water could be replaced by an amphiphilic atom (an atom which can make
hydrophobic as well as hydrophilic contacts). The carbon atoms of DMSO satisfy the
above conditions because the methyl groups have partial positive charges (see chapter
7 section 3.A.6.1). This explains the hydrophobic and hydrophilic contacts which both
carbon atoms make (Fig. 7.10).
The distance between the sulfur atom of the DMSO and Met 61 (3.99 A) is long but
nevertheless represents a genuine contact because of the high van der Waals radii of
sulfur atoms. The interaction is electrostatic since the sulfur of the DMSO has a
positive charge and sulfur of the Met 61 is electronegative. A calculation of the partial
charge for DMSO using the SYBYL program (see section 3.6) gave -0.55 for the O,
0.25 for the S and 0.15 for each carbon atom.
3. TMSO
TMSO was chosen because of the high similarity with DMSO (see Table 7.8). The
active site was examined and seen to be large enough to accommodate the two extra
carbons of TMSO (see Table 7.11). The structure of TMSO (Model 1 section 3.6.2)
reveals that the prediction was correct. TMSO molecule (ALT1) binds almost in the
same position as DMSO and makes the same contacts with the common atoms of
DMSO (Fig. 7.44). The only significant difference in the binding site is the movement
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of the Arg 55 side chain. The side chains of His 126 and Phe 60 move slightly to
accommodate the two extra carbons of TMSO. Both side chains make contacts with
the two extra carbon atoms of TMSO. The movement of the Gin 63 side chain is as a
result of the hydrogen bond made with the O of TMSO ALT2 (Fig. 7.45).
Fig. 7.44: Overlay of CypA with TMSO and DMSO bound in binding site. The
DMSO structure is in green. TMSO molecule (ALT1) binds almost in the same
position as DMSO and makes the same contacts with the common atoms of DMSO.
An overlay of the native structure with the TMSO bound structure (Model 3 see
section 3.A.6.1) shows similar features to that seen with DMSO. As a result of ligand
binding, the side chain of Met 61 was pushed away (Fig. 7.44). Also W_106 was
replaced by the ligand (Fig. 7.45) but not 100% (about 80% based on the occupancy
of TMSO see section 3.6.2). W_106 in the native structure is equivalent to W_310 in
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the TMSO structure. The explanation how the hydrophobic part from a ligand can
replace W_106 is the same given for DMSO and has been discussed in section 4.A.2.
W_109 was also displaced by the ligand. Since the occupancy of the ligand is arround
80% it might therefore be expected that W_109 might contribute towards the
remaning 20% of the electron density seen in the native structure in this position.
Nevertheless no electron density was seen around that position. This can be explained
by the fact that W_109 diffracts more weakly than W_106 as can be seen in Table





Fig. 7.45: Overlay of CypA with TMSO (Model 3) bound in binding site and native
structure in binding site. Native structure is in green. The movement of the Met 61
side chain is the result of ligand binding. Water molecule 106 of the native is
equivalent to W_310 in the TMSO structure.
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The difference in mean temperature factor of all protein atoms between the native and
the TMSO structure is only 11.5%. However the difference is much greater in the side
chains which make contacts with the ligand. The mean temperature factor for CG, SD
and CE ofMet 61 is 17.4 A2 in the native which dropped to 11.5 A2 (34 % difference,
3-times higher compares to the 11.5% difference for all protein atoms) in the TMSO
structure. A similar result is seen with Arg 55 due to hydrogen bonding between the
sulfoxy group of TMSO and Arg 55/NH1 (Fig. 7.15) the side chain becomes more
rigid. The overall temperature factor for NH1, NH2, CZ and NE of Arg 55 becomes
30.8 A2 (27 % difference) from 42.3 A2 in the native structure.
With a Ka of 33 mM (determined by PPIase assay Table 4.7) and a soaking solution of
TMSO of 180 mM (see Table 6.2) the calculated occupancy is 86% which is very
close to that calculated by the refinement program XPLOR (82% for Model 3 and
80% for Model 1 section 3.6.2 ). The agreement seen between the solution studies
(PPIase) and crystallographic (XPLOR) values of occupancy, mean that the
crystallographic results provide an estimate of Kd.
Three models (1, 2 and 3) have been proposed for the binding of TMSO in the active
site ofCypA in section 3.6.2. When the TMSO molecule is bound to the active site of
Cyp-A the side chain of Gin 63 adopts two different positions (ALT1 and ALT2). The
ALT 1 position of the side chain of Gin 63 is similar to the position found in the native
structure and it is adopted when TMSO in its (ALT1) position occupies the binding
site (Fig. 7.45). As a result of binding of TMSO (ALT2) molecule, the Gin 63 side
chain is adopted position ALT2. Crystallographically it is not possible to discriminate
between the position ALT1 and position ALT2 of the side chain of Gin 63 side chain,
since both OE2 and NE2 of Gin have the same scattering power. The conclusion that
the Gin 63 side chain adopts two positions is based on the fact that the position ALT2
can explain the contact of O/TMSO with the Gin 63 side chain (Fig. 7.45).
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TMSO (ALT1) makes similar contacts to DMSO (Fig. 7.46) with a hydrogen bond to
Arg 55/NH1 and a S"'S contact (Fig. 7.45) to the sulfur atom of Met 61. This is an
electrostatic interaction since both sulfur atoms are partially charged (see section
4.A.2 DMSO).
Fig. 7.46: Contacts of site 1 of TMSO ligand with surrounding atoms of the protein.
DMSO makes the same contacts with the side chains of Arg 55 and Met 61. The O of
the TMSO(ALTl) forms a hydrogen bond to the guanidinium group of Arg and a
number of hydrophobic contacts to the side chains of Phe_113, His_126 and
Leu_122. The occupancy was refined to 80 % for the TMSO and 20 % for W_310.
TMSO (ALT2) binding causes a rotation of the Cy-C5 bond of Gin 63 (Fig. 7.45) and
generates a new hydrogen bond with NE1/Gln63 (Fig. 7.47). The contact of
SD/Met61 to a carbon of TMSO/ALT2 (Fig. 7.47) is an electrostatic interaction, both
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atoms are partially positively and negatively charged respectively. The partial positive
charge of the sulfur atom of TMSO also explains the interaction seen with the ring of
Phe 113. The sulfur atom of TMSO is partially positively charged when the 7t-
electrons of the Phe ring induce a partial negative charge above and below the ring.
The remaning contacts of TMSO (ALT2) with surrounding residues (Fig. 7.47) are
hydrophobic interactions.
Fig. 7.47: Contacts of site 2 of TMSO ligand with surrounding atoms of the protein.
The O of the TMSO (ALT2) forms a hydrogen bond to Gln_63/OEl Arg and a
number of contacts to the side chains of Phe_l 13, His_126, Phe_60 and Met_61. The
occupancy was refined to 38 % for the TMSO (ALT2).
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Three models have been proposed for the binding of TMSO in the active site of
CypA. Comparison of these three models shows no significant difference (0.1%) in
both the R factors and the R free (see Table 7.13). This means that the addition of an
extra TMSO molecule (ALT2 seen in model 2) can account for the additional density
in the difference (lFo-lFc) map around carbons C2 and C3 (Fig. 7.12), but does not
actually improve the model (in fact both R factors increase by 0.1%). By comparing
only the R factors (free and working) of model 1, 2 and 3 of the TMSO structures
model 1 is the best. Nevertheless the B factor of water 310 failed to refine to a
reasonable value therefore models 2 and 3 were proposed. With a total of 8 electrons
and an occupancy of not more than 20% the B factor of W_310 has practically no
effect on the R factor of a model containing 1539 atoms of a similar size. This also
applied to the second TMSO molecule (ALT2) which has an occupancy of only 20%.
One thing that is revealed in all models (1,2 and 3) is that the binding site is not fully
occupied by TMSO. Higher resolution data will be required to provide a more
detailed picture of TMSO binding.
4. PNT
PNT belongs to the DMSO family of ligands and shares structural similarities with the
other two members but surprisingly binds in a different position in the binding site of
Cyp-A. PNT was chosen because of its high similarity seen with TMSO (see Table
7.8). The only difference between these two molecules is one atom (carbon replaced
by sulfur). Carbon atoms have different chemistry to that of sulfur resulting in an
effect seen on the binding of PNT. The PNT is almost a flat molecule while in DMSO
and TMSO the torsion angle of 0-S-C1-C2 (see Fig. 7.44) is around 105°. This seems
to be the reason that PNT binds in a different place in the binding site of Cyp-A. The
PNT binding site is similar to ACMPIP and ETPIPG (Fig. 7.48). The common feature
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of those ligands (PNT, ACMPIP and ETPIPG) is the carbonyl group. In all these
ligands the carbonyl group forms a strong hydrogen bond with the N of Asnl02.
Fig. 7.48: Overlay of PNT, ACPIP and ETPIPG structures bound in the binding site
of CypA. ACMPIP is in green, ETPIPG is in yellow. The common feature of those
ligands (PNT, ACMPIP and ETPIPG) is the carbonyl group. The common oxygen
which forms a hydrogen bond with N/Asnl02 is coloured red.
An overlay of both native and PNT structures show similar features to that seen with
DMSO. The side chain of Met 61 was pushed away due to binding and W_106 and
W_105 were replaced by the ligand (Fig. 7.49). W_208 was not included in the model
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ofCypA complexed with PNT since the electron density of this water was very weak
and the temperature factor was refined to a number greater than 70 A2 (see section
2.2.A addition of water molecule). The rest of the side chains in the binding site are
practically the same including the water molecules (W_109, W_121 and W_198 see
section 4.1).
Fig. 7.49: An overlay of native and PNT structures show similar features to that seen
with DMSO. The side chain of Met 61 was pushed away due to binding and W_106
and W_105 were replaced by the ligand. CypA native structure is in green.
W_106 is placed in an amphophilic environment (close to hydrophopic as well as
hydrophilic atoms see contacts in chapter 7 section 3.A.5) and was replaced by carbon
atom in the PNT structure (Fig. 7.49). W_105 was replaced by the oxygen atom of





The ETPIPG ligand binds as predicted in the proline binding pocket with a conserved
hydrogen bond between N/Asnl02 and the carbonyl oxygen atom (Fig. 7.49). An
rmsd value of 0.54 A was obtained after least squares fit on to the N, C, O and CA
atoms of residues 4 to 67 and 76 to 160 of the two structures. The side chain of
Arg_55 of ETPIPG moved further into the binding site and the Gln_63 side chain
moved closer to the ETPIPG molecule making a hydrogen bond with 03 of the
ETPIPG. The rest of the binding site did not show any significant difference.
Fig. 7.50: Overlay of ETPIPG and CypA-AlaPro (lcyh) complex structures. The
ETPIPG ligand binds as predicted in the proline binding pocket with a conserved
hydrogen bond between N/Asnl02 and the carbonyl oxygen atom. In green is the
CypA-Ala Pro structure.
The main difference between the native protein structure and the structure with
ETPIPG in the binding site is the movement of the side chain of Met 61, replacement
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of six water molecules by ETPIPG and a slight movement of the Arg 55 side chain
(Fig. 7.51). The rest of the side chains in the binding site are practically the same.
W_105 was replaced by an oxygen atom of ETPIPG. This is comparable to the
situation in the PNT structure. W_ 106 has always been replaced by a carbon atom in
previous structures (DMSO, TMSO, PNT) because it is placed in an amphophilic
environment and this is true for the ETPIPG structure also. In the native structure,
W_107 makes a hydrogen bond with NE1/Gln63 (3.2 A). This has been replaced by
03 (see Fig. 7.50) of ETPIPG which also makes a hydrogen bond to NE1/Gln63 (3.3
A). W_198 was replaced by a carbon atom of ETPIPG. This is not an unfavourable
replacement since W_105 which makes a strong hydrogen bond with W_198 in the
native structure, has now been replaced by ETPIPG. W_208 are displaced due to bad





Fig. 7.51: Overlays of native CypA with the CypA-ETPIPG complex. The main
difference between the native protein structure and the structure with ETPIPG in the
binding site is the movement of the side chain of Met 61, replacement of six water
molecules by ETPIPG and a slight movement of the Arg 55 side chain. CypA native
structure is in green.
As a result of ETPIPG binding, side chains in the binding site of Cyp-A become more
rigid than in the unliganded structure. The overall temperature factor of protein atoms
in the ETPIPG structure is about 24 % higher than in the native structure. However,
the active site of the native structure tends to have higher B factors. The side chain of
Arg 55 was very mobile. In the native structure the mean temperature factor for NH1,
NH2, CZ and NE was 41.37 A2 and dropped to 35.49 A2 (38 % difference) in the
ETPIPG structure. Similar effects were obtained at His 126 where, because of the
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contacts between ETPIPG (ALT1) and His 126 (see Fig. 7.52) the side chain
becomes more rigid. The average overall temperature factor for the five ring atoms is
9.81 A2 compared with 10.47 A2 in the native structure.
Fig. 7.52: Contacts of ETPIPG (ALT 1) with side chain of His 126. The contacts
results is a more rigid side chain in CypA-ETPIPG structure compared with the native
unliganded structure. The average overall temperature factor for the five ring atoms is




ACMPIP was chosen because of the high similarity with ETPIPG (see Table 7.16).
The tail of ETPIPG was very mobile and adopts two conformations in the active site
of CypA. Also it does not form favourable contacts (Fig. 7.23A and 7.23B). This tail
was the first target for modification when the new ligand was designed. The tail (two
carbon atoms and one oxygen atom) was removed and a search by structural similarity
was carried out using the remaining fraction of the ETPIPG molecule. ACMPIP was
the closest structural similar molecule found at that time and binds as predicted in the
same position as the ETPIPG (Fig. 7.53).
The active site of CypA does not change when ACMPIP binds instead of ETPIPG
except the side chain of Arg 55. The Arg 55 side chain was pushed away from the
piperidine ring of ACMPIP. If the Arg 55 side chain adopted the same position as in
the ETPIPG structure it would make a bad contact of 2.2 A with the piperidine ring
of ACMPIP. In all other structures of Cyp-A the Arg 55 side chain adopts one
position. The resulting two alternative conformations for the Arg 55 side chain seems
to be the explanation of the large difference observed in Kd (chapter 4 section 3.3.B)




Fig. 7.53: Overlay of CypA-ACMPIP and CypA-ETPIPG (ALT1) structures.
ETPIPG (ALT1) structure is in green. The side chain of the Arg 55 in the ACMPIP
structure adopts two alternate positions. ACMPIP was the most structurally similar
molecule found at that time and binds as predicted in the same position as the
ETPIPG.
Differences between the native protein structure and the structure with ACMPIP in
the binding site are: the movement of the side chain of Met 61 observed in all other
small ligand structures with CypP; the replacement of six water molecules (W_105,
W_106, W_198 W_109 and W_208) by ACMPIP and the surprisingly different
conformation of the Arg 55 side chain (Fig. 7.54). The rest of the side chains in the
binding site are practically the same.
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W_105 was replaced by the oxygen atom of ACMPIP and W_106 was replaced by a
carbon atom of ACMPIP. This is comparable to the situation in the ETPIPG
structure. W_198, W_109 and W_208 are displaced due to bad contacts with the
ligand (less than 1.9 A O/W to C/ACMPIP). W_208 also makes a bad contact with
the NH1 of Arg 55/ALT2 (1.3 A).
Fig. 7.54: Overlays of native CypA with the CypA-ACMPIP complex. CypA native
structure is in green. Differences between the native protein structure and the
structure with ACMPIP in the binding site are: the movement of the side chain ofMet
61 observed in all other small ligand structures with CypP; the replacement of six
water molecules (W_105, W_106, W_198 W_109 and W_208) by ACMPIP and the
surprisingly different conformation of the Arg 55 side chain.
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As a result of ACMPIP binding, side chains in the binding site of Cyp-A become more
rigid than in the unliganded structure. The difference in the overall temperature factor
of protein atoms between native and ACMPIP structure is about 12 % higher in
ACMPIP structure. The side chain of His 126 was very mobile in the native structure.
The mean temperature factor for CG, CD2, ND1, CE1 and NE2 in the native
structure is 10.47 A2 and 7.58 A2 (30 % difference) in the ACMPIP structure. Similar
effects were observed for Phe 113 where, because of the contacts between the
ACMPIP and Phe (see Fig. 7.27) the side chain became more rigid. The overall
temperature factor for the five ring atoms (CD1, CD2, CE1, CE2 and CZ) is 31.62 A2
compared with 38.19 A2 in the native structure.
7. DCH
DCH has the best interaction with CypA for non peptide ligands tested. DCH binds in
a similar fashion to that with DMSO and TMSO. However the DCH molecule has
little structural similarity with DMSO or TMSO and therefore comprises a new ligand
family of CypA. DCH is currently the only member of this family showing binding
activity.
The main difference seen between the native protein structure and the structure with
DCH in the binding site is in the movement of the side chain of Met 61, replacement
of two water molecules (W_106 and W_109) by DCH and movement of the Arg 55
side chain (Fig. 7.55). W_106 was replaced by a carbon atom from DCH. This is
comparable to the situation in the DMSO structure. W_109 has been replaced by an
oxygen atom. The rest of the side chains in the binding site are practically the same.
W_208 in the native structure is equivalent to W_219 in the DCH structure, in which
it has been displaced by 1.25 A as a result of ligand binding (Fig. 7.55).
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Fig. 7.55: Overlay of native CypA with the CypA-DCH complex. The CypA native
structure is in green. The main difference seen between the native protein structure
and the structure with DCH in the binding site is in the movement of the side chain of
Met 61, replacement of two water molecules (W_106 and W_109) by DCH and
movement of the Arg 55 side chain.
As a result of DCH binding, the side chains of Arg 55 (hydrogen bonding to DCH)
become more rigid than in the unliganded structure. The difference in the overall
temperature factor of protein atoms between native and DCH structure is about 20%
higher than in the DCH structure. The side chain of Arg 55 was very mobile in the
native structure, the mean temperature factor for NH1, NH2, CZ and NE being 41.37
A2 dropping to 36.19 A2 (a 32 % difference) in the DCH structure.
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The DCH ligand binds in the same position as MeVal 11 of the CsA (see Fig. 7.56).
The similarity in the binding is remarkable (see Fig. 7.57), given the very different
sizes and structures of the two ligands (DCH has 10 non hydrogen atoms and CsA has
84 non hydrogen atoms). These structures show that this area of the binding site is a
favourable pocket for dimethyl groups.
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Fig. 7.56: Chemical formula of the immunosuppressant drug cyclosporin.
The similarities between CsA and DCH could be used to design new non peptide
drugs, by extending DCH in the direction shown by the CsA molecule. The dimedone
derivative molecule developed using the above approach would hopefully, possibly
after several successive rounds ofmodification, signicantly improve binding.
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Fig. 7.57: Overlay of complex CypA-DCH with the CypA-CsA complex. The CypA-
CsA structure is in green. The DCH ligand binds in the same position as MeVal 11 of
the CsA. These structures show that this area of the binding site is a favourable




The refined FKBP complex with cyclooctanone (oct_2) was compared with the
available published x-ray structures of native FKPB-12 (lfkk, Keith et al 1995) and
complexed with FK506 (lfkf, Duyne 1991). A least squares fit was carried out on to
the 404 C, N, CA and O (main-chain atoms of residues 1 to 107) of the oct_2
molecule A with lfkk and lfkf structures. The lfikk has an rmsd of 0.336 A and the
lfkf a rmsd of 0.497 A.
An overlay of lfkk structure with the oct_2 structure in the binding site (Fig. 7.58)
shows that three water molecules (W_110, W_112 and W_156) from the native
structure have been replaced by the cyclooctanone. W_112 and W_156 make
hydrophobic contacts (Fig. 7.59) and are likely to be replaced by a carbon atom as
indeed happens when cyclooctanone binds (Fig. 7.58). W_110 is located in
hydrophilic environment (see Fig. 7.59) and has been replaced by the oxygen atom of
cyclooctanone ( see Fig. 7.58).
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Fig. 7.58: Overlay of native FKBP12 structure with the FKBP12-Cyclooctanone
complex. The FKBP12 native structure is in green. Three water molecules of the
native structure have been replaced by cyclooctanone.
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Fig. 7.59: Native (lfkk, Keith et al 1995) FKBP-12 structure with the three water
molecules in the binding site. W_112 and W_156 make hydrophobic contacts and are
likely to be replaced by carbon atoms, this happens when cyclooctanone binds (Fig.
7.58).
Th cyclooctanone molecule is very flexible and is likely to adopt alternative
conformations. When the CSD was searched using cyclooctanone as a template
molecule there were no hits indicating that the cyclooctanone molecule can not be
crystallized on its own because of the many alternate conformations which can be
adopted in solution. The high flexibility of cyclooctanone molecule can be seen when
the structure of 5 different cyclooctanone derivative crystal structures (randomly
selected from CSD) are superimposed (Fig. 7.60). It is likely that a similar disorder
occurs when cyclooctanone binds to the active site of FKBP-12. Unfortunately the
data are not good enough to see and refine each alternate conformation.
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Fig. 7.60: An overlay of different structures of cyclooctanone found in CSD. The
cyclooctanone molecules were part of larger structures selected randomly from the
available examples in the CSD. The high flexibility of cyclooctanone molecule can be
seen and it is likely that a similar disorder occurs when cyclooctanone binds to the
active site of FKBP-12.
The high mobility or low occupancy of cyclooctanone can also be seen from the
average value of the temperature factor of all atoms of cyclooctanone molecule which
is much higher than the surrounding atoms of the protein. The average temperature
factor for the nine protein atoms (listed in Table 7.21) that make contact with
cyclooctanone is about 23 A2 while the temperature factor for the cyclooctanone
molecule is 40 A2. Also the six atoms (CI, C2, C3, C4, C5 and N7 see Fig. 7.61) of
FK506 ligand from the lfkf structure are located at the same position as the
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cyclooctanone and make similar contacts with the protein. They have a mean
temperature factor of about 6 A2. The mean temperature factor for the nine protein
atoms (listed in Table 7.21) in lfkf structure is 7.85 A2.
One application of protein-ligand complexes, demonstrated here by FKBP12-
Cyclooctanone complex, could be the crystallization and structural studies of mobile
or liquid molecules which are difficult to crystallize on theh own.
Fig. 7.61: Overlay of FKBP12-FK506 with the FKBP12-Cyclooctanone complex.
The high mobility or low occupancy of cyclooctanone can also be seen from the
average value of the temperature factor for the cyclooctanone molecule which is 40
A2. The six atoms (CI, C2, C3, C4, C5 and N7) of FK506 ligand from the lfkf
structure (in green) have a mean temperature factor of about 6 A2 and they are




Table 7.21: Contacts of cyclooctanone ligand of molecule A in the asymmetric unit

















Discussion of the structural features of the BrCyp is restricted to the refined
tetragonal crystal form. It is however worth noting that the inserted loop (51-
KISGKPLH-58) adopts the same conformation in the trigonal structure and the
tetragonal structure (described below) and is therefore likely to be independent of
crystal packing effects.
The overall fold of BrCyp is similar that of the other cyclophilins structures (Braun, et
al 1995) with an 8-stranded £-barrel capped by two •-helices. The comparison of
BrCyp with hCypA is shown in Fig. 7.62. The rmsd between corresponding backbone
atoms of 148 residues in hCypA and BrCyp is 0.56 A. (divergent loops and N and C-
terminii residues were not included).
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Fig. 7.62: Overlay of CypA with BrCyp. The CypA structure is in dark grey and the
BrCyp in pale grey. The octapeptide loop (51KISGKPLH58) in BrCyp is labelled as
Brugia loop.
The octapeptide loop (51KISGKPLH58) is one of the most distinctive structural
features differentiating the BrCyp from all other available NMR or X-ray cyclophilin
structures (Taylor et al 1997). The loop is held in place by a tight and very specific
network of hydrogen bonds from the side-chain of Glu-87 (Fig. 7.63). Most
cyclophilin homologues which have the octapeptide insert (including hCyp40,
hnkCyp, and most plant cyclophilins) have an invariant glutamate in that position
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while the group of cylophilins without the octapeptide insert have a lysine at that
position. This loop is a particularly common feature of the nematode cyclophilins, and
is found in 7 of the 11 cyclophilin members from C. elegans (Page et al 1996). The
Glu-87 locks the loop into a particular conformation which may be relevant for
protein-protein recognition. This rather unusual role of a buried glutamate may even
suggest a mechanism forcing a conformational change in the loop on protonation of
the glutamate.
Fig. 7.63: The octapeptide loop of BrCyp (51KISGKPLH58 present with thick
bonds). The four hydrogen bonds from the carboxy group on the side chain of Glu 92
locks the loop into a particular conformation.
Another loop (156-LKTNSKNRP-164) has significantly different conformation and
sequence in hCypA. This loop also provides a subdivision of cyclophilins in which the
sequence (and conformation) of this protruding loop is well conserved in the
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divergent class of cyclophilins and is significantly different in hCypA as seen in Fig.
7.62 (labelled from S 160). The difference in conformation in this loop between CypA
and CypB has been noted previously (Mikol et al 1994). The shape and distribution of
charged amino acids on such protruding loops may well provide specific recognition
signals for partner proteins in the cell.
Recombinant BrCyp has a kcat/Km=7.9 x 106 M'V1 using the substrate succinyl-Ala-
Ala-Pro-Phe-p-nitroanilide, and is almost as efficient as hCypA which has a kcat/Km=
1 x 107M"1s"1 (Liu and Walsh 1990a). Both of the above values are close to those
observed for the same protein purified during this work (chapter 4, section 3.B).
Despite of the similar kcat/Km values, the concentration required to inhibit 50% of the
BrCyp PPIase activity is rather high (860nM) compared with an IC50 value of 19nM
for human CypA (Liu et al 1990b). The X-ray structure of the BrCyp cyclophilin
domain provides a probable explanation of the poor CsA binding.
The active site of the cyclophilins has been well characterised (Taylor et al 1997) and
the 13 residues involved in binding the large inhibitor CsA are shown in Figure 7.64.
All are conserved in BrCyp with the exception of Lysll4 (usually Ala) and Hisl32
(usually Trp). Other differences in the active site of BrCyp compared to that of
hCypA are some small conformational changes in the side chains of Arg66 and
Phe_71 (Fig. 7.64). It is interesting to note that the four most closely homologous
divergent cyclophilins; bmCyp-1, ceCyp-8, hnkCyp and srCyp (Taylor et al 1998) all
have the Tip to His and Ala to Lys/Arg mutations. In line with these observations, the
enzymatically characterised hnkCyp was similarly found to have a low affinity for Csa,
with an IC50 value of 760nM (Rinferet et al 1994).
In this crystal structure Lysl 14 forms a hydrogen bond with the carbonyl oxygen
atom of Gly72 (Fig. 7.64) and the side chain forms a gate-like barrier (see Fig. 7.65)
over the 'Abu-pocket', which is one of the key recognition sites for cyclosporin
binding (Braun et al 1995; Taylor et al 1997).
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Fig. 7.64: Overlay of the active site of BrCyp with the CypA (green) showing the
side chains of the 13 residues known to be involved in substrate and inhibitor binding
of CypA. The main difference in the active site of BrCyp compared to that of hCypA
are the Lysl 14 (instead of an Ala) and Hisl32 (instead of Trp).
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Fig. 7.65: CypA-CsA structure complex (right), shows how CsA binds to CypA. Side
chain of Lys 114 of BrCyp (left) forms a hydrogen bond to the carbonyl O of Gly 83
and blocks the binding site for CsA. The side chain forms a gate-like barrier over the
'Abu-pocket', which is one of the key recognition sites for cyclosporin binding.
It is clear that Lysl 14 protruding into the recognition cleft of the PPIase active site of
BrCyp will play a significant role in substrate recognition (Fig. 7.65). Even in solution
it is likely that the steric bulk of the Lysl 14 side chain in most low-energy
conformations will at least partially block the Abu-pocket. This will prevent tight
binding of the bulky CsA ligand and explains the low affinity of the BrCyp/CsA
complex.
Another interesting observation of the active site of BrCyp in the tetragonal crystal
form is that is occupied by side chains from a crystallographically neighbouring
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molecule (Fig. 7.66). This packing arrangement is such that the hydrophobic pocket is
occupied by the side chain of Met46 which forms van der Waals contacts with Phe71,
Met72, Phel24, Leul33and Hisl37 which comprise five of the 13 residues involved in
CsA-binding in hCypA. The sulphur atom of Met46 bound in the active site
corresponds closely to the position adopted by the valine side chain in Cyp-bound
CsA (see Fig. 7.57) This crystal packing arrangement suggests that the Cyp active site
may be rather promiscuous and acts as a binding site for different hydrophobic amino
acid side chains (Fig. 7.66).
The arrangement of the side chain of Met46 from the crystallographically
neighbouring molecule also shows similarities to the binding of DMSO molecule (Fig.
7.43) ligand of CypA-DMSO complex (section 3.6). This suggests that BrCyp binding
site may be act as binding site for the DMSO family ligand found during this work.
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Fig. 7.65:The active site of BrCyp showing the position from a crystallographically
related neighbouring molecule. Met_46 forms van der Walls contacts with Met_72,
Phe_124, Leu_133 and His_137. Also the arrangement of the side chain of Met46





The first non peptide ligands of CypA have been discovered and their X-ray
structures determined. Six novel non peptide ligands belonging to three different
families have been found and are all bound in the active site of Cyp. Each of these
small ligands could be used as a starting point for developing novel non peptide
ligands for CypA. The fact that they belong to three separate families has the
advantage that different chemistry could be used to develop derivatives.
This is the first work where Kd values for small peptides and non peptide ligands of
cyclophilins have been determined. The structures of a number of dipeptide and
oligopeptide ligands bound to cyclophilins have been reported (see Taylor et al
1997a). However values of those complexes have not been reported nor any other
value related the strength of binding such as K, or IC50. The closest indication of how
tightly Ala-Pro bound to CypA was given by Harrison and Stein (1990) who placed a
conservative lower limit on K; of 20 mM. A Kd (K, and Kd are alternative symbols
for the same constant) value of 18mM for Ala-Pro with CypA has been determined
during this work. The IQ values of small non peptide ligands have also been
determined and all lie in the millimolar range.
A new method for the calculation of IC50 and Kd has been developed. (Fischer et al
1989 see chapter 4 section 3). The method was tested for Cyclophilin A and CsA and
the results were similar to those obtained by other well established methods. The
main advantage of the new method is that it can estimate the IC50 without requiring




Fluorescence was shown to be a very useful and fast method for the determination of
for protein-ligand complexes. The measurement of ligand binding by fluorescence
spectroscopy requires that the optical properties of the protein-ligand complex differ
from those of the free ligand and free protein (Bagshaw and Harris 1987).
There is a possibility that a complex of protein-ligand forms but is not revealed by
fluorescence titration when the binding site is very rigid or the changes due to ligand
binding have no effect on the surrounding environment of Trp. None of the small
cyclophilin ligands found during this work were revealed by fluorescence titration.
Ligation with small non peptide ligands does not change the overall structure of
CypA. However small, but significant changes in the position and the B factors were
observed for some residues in the binding site like Arg55, Met61, Gln63.
The CypA-CsA complex is a very good example where the CsA ligand is revealed by
fluorescence titration (Kallen et al 1998). The above results could be expanded futher
by doing more experiments in order to find out which is the minimum distance
(contact from ligand to Trp) required for change of a fluorescence signal in
tryptophan titration. In the current work the minimum contact measured from crystal
structure was the contact of 5.2 A between NE1/Trpl21 with 02/DCH.)
The CypA structures with the small ligands found during this work reveal new details
of the CypA binding site.
1. The DMSO family of ligands revealed an amphiphilic area of the binding site.
Water molecule 106 from the native structure is located in that area and it is
replaced by a carbon atom when DMSO or TMSO is bound. This carbon atom is
partially charged in the DMSO and probably in TMSO as well.
2. The replacement of one atom in a ligand molecule can have a dramatic effect in
the way it is bound. The structures of TMSO and PNT with CypA show the
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importance of the sulfoxy group and carbonyl group for the ligand binding. The
replacement of a sulfur atom in the TMSO ligand by carbon leads to the PNT
ligand which binds in a different position in the binding site of CypA.
3. The piperidine family of ligands bind similarly to peptide ligands containing
proline residues and can be used as starting molecules for the design of a new
family of tighter-binding ligands which share structural similarity with dipeptides
or oligopeptides. A number of structures of CypA complexed with dipeptide and
oligopeptide are available (Taylor et al 1997) and can be used as a template for
further modification for new piperidine ligands.
4. The dimedone structure reveals a favoured binding site for the dimethyl group.
This dimethyl binding site has been pointed out by two different docking
programs. First the SANDOCK program (Burkhard 1995) found that dimedone is
a putative ligand and later the LIDAEUS program found that 2,2,5-trimethyl-l,3
dioxane-4,6-dione is a putative ligand for that site. Both of the above compounds
share a dimethyl group. Because of this dimethyl group dimedone can act as a
novel valine mimic.
The similarities between N-Met-Val 11 of CsA and dimedone could be used to
design new non peptide drugs, by extending dimedone in the direction shown in
the CsA molecule. The dimedone derivative molecule developed using the above
approach would hopefully, possibly after several successive rounds of




The FKBP-12 structure with cyclooctanone has been solved to 2.05 A with an R
factor of 21.5 % and a free R factor 29.7 %. RMS deviation from ideality in bond
length and bond angle are 0.005 A and 1.67° respectively.
The overall structure of FKBP-12 does not change after cyclooctanone binding. The
rmsd between backbone atoms (C, N, CA and O) of 107 residues in
FKBP12/cyclooctanone and native FKBP12 is 0.336 A.
The cyclooctanone molecule is very flexible (B=40A2)and it is likely to adopt
multiple conformations. One application of protein-ligand complexes, demonstrated
here by the FKBP12-cyclooctanone complex, could be the crystallization and
structural studies of mobile or liquid molecules which are difficult to crystallize on
their own.
3. BrCyp
BrCyp was crystallized in two different crystal forms (trigonal and tetragonal) and
unit cell and space group have been determined for both. The trigonal form could not
be refined to a reasonable R factor due to a possible twinned crystal.
o
The crystal structure of the tetragonal form has been solved to 1.95 A resolution with
R factor of 19.9 % and R free 23.4 %. RMS deviation from ideality in bond length
and bond angle are 0.008 A and 1.426° respectively.
The overall fold of BrCyp is similar that of the other X-ray and NMR structures with
the the 8-stranded 12>-barrel capped by two a-helices. The rmsd between
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corresponding backbone atoms of 148 residues in hCypA and BrCyp is 0.56 A.
(divergent loops and N and C-terminii residues were not included). The octapeptide
loop (51KISGKPLH58) is one of the most distinctive structural features
differentiating the BrCyp from all other available NMR or X-ray cyclophilin
structures.
It is clear that Lysl 14 protruding into the recognition cleft of the PPIase active site of
BrCyp will play a significant role in substrate recognition. Even in solution it is likely
that the steric bulk of the Lysl 14 side chain in most low-energy conformations will at
least partially block the Abu-pocket. This will prevent tight binding of the bulky CsA





Amino acid sequence of proteins purified in current work.
Cyp-B human expressed in E.coli
10 20 30 40
ADEKKKGPKV TVKVYFDLRI GDEDVGRVIF GLFGKT VPKT
50 60 70 80
VDNFVALATG EKGFGYKNSK FHRVIKDFMI QGGDFTRGDG
90 100 110 120
TGGKSIYGER FPDENFKLKH YGPGWVSMAN AGKDTNGSQF
130 140 150 160
FITTVKTAWL DGKHVVFGKV LEGMEVVRKV ESTKTDSRDK
170 180
PLKDVIIADC GKffiVEKPFA LAKE
Cyp-A human expressed in E.coli
10 20 30 40 50
MVNPTVFFDI AVDGEPLGRV SFELFADKVP KTAENFRALS TGEKGFGYKG
60 70 80 90 100
S CFHRIIPGF MCQGGDFTRH NGTGGKSIYG EKFEDENF1L KHTGPGILSM
110 120 130 140
A NAGPNTNGS QFFICTAKTEWLDGKHVVFG KVKEGMNIVE
150 160 165
AMERFGSRNG KTSKKITLAD CGQLE
BrCyp from Brusia malayi expressed in E.coli
10 20 30 40 50
MSKKDRRRVF LDVTIDGNLA GRIVMELYND IAPRTCNNFLMLCTGMAGTG
60 70 80 90 100
KISGKPLHYK GSTFHRVIKN FMIQGGDFTK GDGTGGESIY GGMFDDEEFV
110 120 130 140 150






Table Al: Absorbance units for difference protein concentration using BCA method.








0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18
ABS 562nm
Plot 1:Concentration of BSAsolutions (table Al) plotted against absorbance units.
Using the least square method the series of points in plot 1 fit a linear equation




Table A2: Absorbance units for difference protein concentration using Bradford
method.
















0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16
ABS 595nm
Plot 2:Concentration of BSA solutions (table A2) plotted against absorbance units.
Protein and Coomassie Brilliant Blue G-250 reagent, forms a chromophore absorbs
at 595 nm. The absorbance is proportion to the protein concentration.
Using the list square method the series of points in plot 2 fit a linear equation
(Cone.)=0.5846 (ABS) + 0.0125. The points fits with a square correlation coefficient
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